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ABSTRACT OF DISSERTATION

METHODS DEVELOPMENT IN BIOLOGICAL MASS SPECTROMETRY:
APPLICATIONS IN SMALL MOLECULE RESEARCH AND PROTEOMICS
Technological developments have enabled mass spectrometry (MS) to evolve as
one of the most versatile, sensitive and widely used analytical methods. Key areas of
research in biological MS include the development of analyte-selective MS
methodologies, along with the design of MS compatible separation technology. Analytes
of interest range from small, biologically active molecules in disease progression
research, to macromolecules such as proteins, in proteomics investigations. Advances in
these areas are vital to maintaining the level of sophistication that has become the
benchmark for MS analyses.
Mass spectrometry has found a permanent station in disease progression studies,
particularly in biomarker discovery. This is especially true for Alzheimer’s disease (AD),
a condition marked by widespread lipid peroxidation (LPO) in the brain. The main
hypothesis of the first part of this dissertation is that LPO produces aldehydes that can
potentially be exploited as AD biomarkers. Design of novel LC-MS/MS methods for
brain aldehyde analysis is described. The methods were applied towards aldehyde
quantification in the hippocampus, superior and middle temporal gyrus and cerebellum of
subjects with early AD (EAD), mild cognitive impairment (MCI) and age-matched
controls. Results obtained indicated elevation of neurotoxic aldehydes in MCI and EAD
brain and suggested that LPO occurred early in AD. Understanding AD progression has
become important for developing diagnostic methods and treatments.

Mass spectrometry is also the major analytical tool in proteomics, where gel
electrophoresis is dominant in pre-MS separations. The main hypothesis of the latter part
of this dissertation is that exposure of microbe fermenters including Clostridium
thermocellum to an external stimulus, such as ethanol, can alter the membrane proteome.
Design of novel doubled-SDS-PAGE (dSDS-PAGE) methods for membrane protein
analysis is described, as these proteins are under-represented in standard 2D-PAGE. The
newly developed Bicine-dSDS-PAGE offered superior separation over other methods and
was applied towards analysis of wild type and ethanol-adapted C. thermocellum cell
membranes. Significant differences in protein expression were observed. An
understanding of ethanol adaptation will promote the design of more ethanol-tolerant
strains. Such an outcome can have dramatic effects in the fuel industry as the trend
towards more efficient fuel development gathers momentum.
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INTRODUCTION
Sir J. J. Thompson (1856-1940) made headlines in 1898 for discovering the
electron and revolutionizing the sciences of physics and chemistry. For this, he was
awarded the Nobel Prize in physics in 1906. The following year, he designed and built a
parabola mass spectroscope to support his work on positive ray analysis, and as a
consequence, became the father of mass spectrometry (1). Today, mass spectrometry
(MS) has evolved into a microanalytical technique requiring only a few picomoles of
sample to obtain molecular weight and structural information of the analyte under
investigation (1). This analytical tool is being applied to a wide variety of research areas,
including protein identification and structure determination (proteomics), drug
metabolism, inherited metabolic diseases, the analysis of respiratory gases, viral
identification, forensics, flavor and smell chemistry, organic fossils, atmospheric
chemistry, petroleum and petrochemicals and many other specialized subjects (2). The
ultrahigh detection sensitivity and unsurpassed molecular specificity have contributed to
the prominence of mass spectrometry in analytical sciences.
Continuous innovation and improvement of instrumentation and techniques have
made mass spectrometry one of the most versatile, sensitive and widely used analytical
methods available today. Highly effective and novel approaches and paradigms have
developed in this field that can tackle practical issues in the biochemical sciences, once
beyond the scope of mass spectrometry. This has largely been brought about by
overcoming the roadblocks of converting bioanalytes into gas-phase ions, concerns that
have historically been the Achilles’ heel of mass spectral analysis of large biological
compounds. As a consequence, the applications of this analytical methodology to
biochemical fields have grown in astronomical proportions. A new branch of mass
spectrometry called biological mass spectrometry was born. It actively deals with the
analysis of organic materials derived from biological systems. The spectrometry is
different from organic mass spectrometry in that organic molecules are analyzed from the
standpoint of biological function and the life sciences.
Recent developments in ionization methods, improvements in ion detection,
increases in the mass range of instruments, and improved interfaces for separation
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techniques are providing mass spectrometrists with the resources required to analyze a
plethora of biologically active materials. Speedy advances in the biological sciences,
particularly in the fields of molecular biology and biochemistry, have led to an increased
demand for chemical and structural information on biologically active molecules,
important areas where mass spectrometry outshines most other analytical tools. In the
past 70 years, the applications of biological mass spectrometry have matured from trace
analysis of species with masses below 50 Da to peptide sequencing and the analysis of
100 kDa proteins. In 2002, Koichi Tanaka and John Fenn shared the Nobel Prize in
chemistry for the development of soft desorption ionization methods in the mass
spectrometric analyses of biological macromolecules, an achievement that clearly
highlights the ascension of mass spectrometry into prominence as part of the analytical
tools and technology available to biological scientists today.
Key areas of research and investigation in biological mass spectrometry include
the development of mass spectrometric methods for selective analysis of target analytes,
along with the design of specialized separation technology that is amenable to
interfacing, both online and offline, with mass spectrometry. Analytes of interest range
from small, biologically active molecules in drug development and disease progression
research to macromolecular structures, such as proteins, in proteomic studies. Continued
advances in these areas are vital to maintaining and improving the level of sophisticated
analyses that has become the benchmark for this important area of bioanalytical
chemistry.
In the interest of target compound analysis, mass spectrometry has found a
permanent station in one of the major goals of modern medicine: identification of
biomarkers for the earliest possible stages of disease progression so that prompt clinical
intervention can limit damage, reverse pathological change and ideally effect a complete
cure. This is especially true in the case of Alzheimer’s disease (AD) research. AD is a
debilitating neurological condition that plagues the elderly and is marked by widespread
lipid peroxidation in the brain. Key compounds generated as a result of lipid peroxidation
include biogenic aldehydes, such as C1-C6 aliphatic aldehydes and α,β-unsaturated
aldehydes, including acrolein and 4-hydroxynonenal (4-HNE). The design of an LC-ESI-
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MS/MS methodology is described here that is ideally suited to identify and quantify such
aldehydes in tissues.
The LC-MS method was successfully applied in the quantification of aldehyde
concentrations in the hippocampus, superior and middle temporal gyrus (SMTG) and the
cerebellum of subjects with early signs of AD (EAD), those with mild cognitive
impairment (MCI), as well as and age-matched controls. This was the first study to report
an in-depth comparison of aldehyde levels between these three types of individuals.
Results obtained clearly indicated that HNE and acrolein are statistically significantly
elevated in both MCI and EAD brain and suggested that oxidative stress occurs early in
AD pathogenesis. Understanding the differences between MCI, EAD and normal subjects
has becoming increasingly important in the interest of developing early diagnostic
methods and treatments for AD.
The LC-ESI-MS/MS method for aldehyde analysis designed and described here
makes use of standard LC separation science for small molecule separations. Another
broad area of mass spectrometric applications is in the field of proteomics, where gelbased techniques play a dominant role in pre-MS separations. While chromatography has
found a niche in proteomics in such techniques as multi-dimensional protein
identification technology (MudPIT), 2-dimensional polyacrylamide gel electrophoresis
(2D-PAGE) is still very much the gold standard for protein separations. Nevertheless,
standard 2D-PAGE is wrought with problems, such as under-representation of
hydrophobic membrane proteins due to solubility issues, along with very basic proteins.
As with any separation method, manipulation of the mobile phase and stationary phase of
the 2D-PAGE system can tailor the experiment to the needs of the particular protein
sample at hand.
Proteomic analysis of the cell membranes has emerged as a very important area of
research due to the unique position of this organelle as the site of first cellular contact
with the external environment. The cell membrane is the location of important
biochemical processes intimately associated with cell viability both in eukaryotes and
prokaryotes. Hence, it is no surprise that a major area of research is the development of
better separation methods for membrane proteins that bypass or overcome many of the
disadvantages encountered in 2D-PAGE. The cell membrane is involved in cellular

3

defense, signal transduction, partitioning of organelles and protection of the integrity of
the genome and proteome. Since the membrane is the site of initial communication of the
cell with the exterior, many physiological changes within a cell can be traced back to
changes that occur in the cell membrane. For instance, studies have shown that microbe
fermenters can be selectively conditioned to grow in elevated levels of ethanol due to
fundamental changes that occur in the membrane proteome. These changes enable the
organism to become ethanol-adapted and encourage the production of cellular ethanol.
Clostridium thermocellum, a cellulolytic, thermophilic anaerobe, is a classic example of
such an organism. Understanding these changes will enable a better appreciation of the
mechanism of ethanol adaptation and promote the development of more ethanol-tolerant
strains of this bacterium. This could have dramatic consequences in the fuel industry as
the general trend towards cleaner and more efficient fuel development gathers
momentum.
In the interest of developing better separation methods for membrane proteins,
doubled SDS-PAGE (dSDS-PAGE) methods were designed for the analysis of wild type
and ethanol-adapted C. thermocellum cell membranes. This analytical methodology
features the separation of fully denatured and solubilized proteins in two dimensions and
circumvents problems associated with other gel-based methods. Solubility issues often
encountered with isoelectric focusing (IEF, the first dimension of standard 2D-PAGE
experiments) are avoided and circumvented by performing a molecular weight based
PAGE separation in the first dimension. This is followed by another PAGE experiment in
the second dimension. Orthogonality in the two dimensions can be achieved by varying
an assortment of gel electrophoresis parameters in one dimension with respect to the
other.
Optimization of membrane protein separation was achieved by exploring the
parameter space of dSDS-PAGE. The mobile phase (running buffer) and gel preparation
techniques were manipulated to arrive at the best possible separation conditions for
membrane proteins. Tricine-dSDS-PAGE and a newly developed Bicine-dSDS-PAGE
were investigated and optimized in membrane proteome analysis. It was shown that
Bicine-dSDS-PAGE offered considerable advantages over Tricine-dSDS-PAGE and the
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standard Laemmli experiment (Glycine-dSDS-PAGE) in terms of protein spot resolution
and abundance, amongst other factors.
For the purposes of exploiting the advantages of the newly designed gel
electrophoresis technique in understanding ethanol tolerance, a two-stage Bicine-dSDSPAGE separation was performed to bring different regions of the C. thermocellum
membrane proteome into focus. The two-stage analysis offered increased spot detection
and resolution over a single stage experiment. Furthermore, the two-stage Bicine-dSDSPAGE approach produced comparable results to a 3-stage Glycine-dSDS-PAGE analysis.
The dSDS-PAGE investigations of the C. thermocellum proteome demonstrated
significant differences in membrane protein expression patterns between the wild type
and ethanol-adapted strains. No doubt, these results offered insight into the biochemical
nature of ethanol adaptation.
This dissertation focuses on experimental design and the development of better
separation-based mass spectrometric experiments to selectively analyze target
compounds. Combining the power of separation science and mass spectrometry offers
considerable sophistication to the arsenal of analytical methods available to clinicians and
scientists. Tailoring separation and the mass spectrometric experiment to the compounds
of interest can dramatically improve analysis. Analytical chemistry is a very diverse field
and considerable research and development is focused on methods development for target
analytes. A solid understanding of the chemistry of target species can enable the design
of elegant methodologies, producing optimum analytical results, as clearly demonstrated
in the experiments described in this dissertation.
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PART ONE

LIPID PEROXIDATION BIOMARKER QUANTIFICATION
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Chapter 1.1
Introduction

Alzheimer’s Disease Background
Alzheimer's disease (AD) is a progressive neurological disorder of the elderly that
gradually destroys neurons in the brain, particularly in regions critical to cognition, such
as judgment and reasoning, memory, movement coordination and pattern recognition (1).
Dr. Alois Alzheimer, a German psychiatrist and neuropathologist, identified the disease
in 1906 (2). He noticed unusual changes in the brain tissue of a 51-year old woman who
had died after a 4.5 year episode of progressive dementia. The tissue displayed abnormal
clumps, now called amyloid or senile plaques (SPs), and tangled bundles of fibers,
recognized as neurofibrillary tangles (NFTs). Such artifacts are not normally observed in
patients suffering from other forms of dementia (2). The presence of SPs and NFTs in the
hippocampus, amygdala, cerebral cortex and certain other brain regions are now
considered to be the major histopathological hallmarks of AD. The illness afflicts some
4.5 million Americans today (1). As people live longer, AD is becoming a major medical
and social concern. Risk factors for AD include age, Down syndrome, family history, and
the ApoE genotype. The ApoE gene codes for apolipoprotein E, a macromolecule
involved in processing and transport of cholesterol. The gene has three major alleles: E2,
E3 (most common), and E4. Individuals who inherit copies of the E4 allele show an 80%
increased risk of developing AD by the age of 60-65. Not all individuals with AD have
E4, and not everyone who has this allele will develop AD. It is unknown why E4 is
related to AD development. However, studies have shown that the allele is linked to an
increased number of SPs (3).
The accepted clinical criteria for AD diagnosis include dementia ascertained by
clinical examination and neuropsychological testing, deficiencies in two or more areas of
cognition, progressive decline of memory and other cognitive functions, no disturbance
in consciousness, onset of symptoms sometime between ages 40 and 90 and lack of
differential diagnosis that could attest for the gradual deterioration of cognitive function
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(2). AD diagnosis can only be established clearly by the post-mortem demonstration of
increased numbers of NFTs and SPs as compared with appropriate age-matched controls
(4). While AD has been diagnosed in younger patients, it remains overwhelmingly a
disease of the elderly community. Approximately 5% of men and women between the
ages of 65 to 74 have AD and nearly half of those aged 85 and older are believed to
suffer from this neurological condition (1). It should be noted that AD is not a normal
part of the aging process. To this day, the etiology and pathogenesis of AD remains
elusive and it is resistant to many treatments.
The mechanisms responsible for AD pathology are multifaceted and comprise of
several factors including mitochondrial dysfunction, abnormal protein aggregation,
inflammation and excitotoxicity and eventual death of neurons (2). Autopsy examinations
of the AD brain reveal abnormal fibers that appear to be tangles of brain tissue filaments
(NFTs) and cores of amyloid surrounded by degenerative nerve endings (SPs). The
amyloid fibrils of SPs are mainly composed of aggregated forms of the 39-43 amino acid
peptide defined as amyloid β-peptide Aβ(1-42). This peptide (Figure 1.1.1) is generated
by the abnormal proteolysis of an integral membrane precursor protein (amyloid
precursor protein or APP), and is found in SPs surrounded by dystrophic neurites (5). By
nature, SPs are extracellular formations (~8 nm filaments) that substantially impede
electrical signal transmission by neurons (6, 7). In contrast, NFTs are intracellular ~20
nm cytoplasmic fibers comprised of bundles of paired helical filaments (PHF), the major
component of which is the microtubule-associated protein tau (τ) (8-10). NFTs are
thought to interfere with axonal transport in neurons (1).
One theory on the pathogenesis of AD suggests that neurodegeneration is the
result of oxidative damage to vulnerable cerebral tissue. In a situation of oxidative stress,
the antioxidant cellular mechanisms are inadequate to tackle the production of free
radical oxidant species. It is thought that the molecular mechanism underlying Aβ
toxicity may result from free radical generation enabled by the peptide (11). Studies have
shown that Aβ(1-42) promotes oxidative injury to neuronal proteins and lipids in vitro
and mediates oxidative damage in AD brain (12, 13). Such damage can be inhibited by
addition of antioxidants (14). Butterfield and co-workers (12) postulated that small,
9
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Figure 1.1.1. Sequence of Aβ(1-42) with the R group of methionine residue 35 displayed.
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soluble aggregates of APP-derived amyloid β-peptide insert into the neuronal and glial
membrane bilayer and produce an array of oxygen-dependent free radicals that then cause
lipid peroxidation and protein oxidation. Direct membrane damage results from Aβassociated free radicals, perhaps involving peptide-bound redox metal ions and the
methionine residue at position 35. Indirect membrane damage arises by the action of lipid
free radicals or various LPO products, including 4-hydroxy-2-nonenal (HNE) and 2propenal (acrolein). In addition, Aβ contains several histidine residues (at positions 6, 13
and 14) and a tyrosine residue (at position 10) that have a remarkable ability to chelate
metal ions, including iron and copper. It is thought that chelation of metals by the peptide
can result in its aggregation (15, 16). These complexes, detected in SPs, have pro-oxidant
properties. Furthermore, the chelation reduces transition metals to their highly active, low
valency state, with a concurrent synthesis of free radicals and initiation of LPO (17).
There also appears to exist a clear mechanistic relationship between τ and
oxidative stress (18-20). Compared to normal subjects, τ in the AD brain has been
demonstrated to undergo a host of varied modifications. These include
hyperphosphorylation (21-23), ubiquitination (24-26) and oxidation (27, 28). In addition,
τ can be proteolytically processed and aggregated into filaments (23, 29, 30).
Hyperphosphorylation renders τ unable to bind to microtubules and it therefore fails to
promote or maintain microtubule assembly (10, 30). Studies have indicated that oxidative
stress activates several kinases such as ERK, p38 and JNK, which have been shown to be
activated in AD (31-33) and are capable of phosphorylating τ (34). As with τ and Aβ,
data have also linked oxidative damage to AD, such as accumulation of trace elements
(i.e. iron) as free radical sources, increased protein and DNA oxidation, elevated
antioxidant enzymes (i.e. superoxide dismutase), in situ detection of carbonyls and
increased LPO (35). In particular, the products of LPO have recently received
considerable interest as potential biomarkers for AD.

Lipid Peroxidation Biomarkers for Alzheimer’s Disease
Polyunsaturated fatty acids (PUFA), primarily of the ω-3 and ω-6 variety such as
linoleic (ω-6), arachidonic (ω-6) and docosahexaenoic acid (ω-3), are the major
11

substrates for LPO in lipoproteins and cell membranes (17). In the process of LPO, lipid
constituents of cellular membranes are attacked by free radicals, including hydroxyl,
peroxynitrite and hypochlorite, that have sufficient reactivity to abstract a weakly bound
hydrogen atom from a methylene carbon in their side-chains (36). As a result, a carboncentered radical is left in the fatty acid. The radical then proceeds to bind with oxygen
yielding the peroxyl radical, which can then react with other fatty acids or proteins
(Figure 1.1.2). These reactions result in cell damage and a cascading increase in the
production of free radicals. It has been shown that transition metal ions, such as Cu2+ and
Fe3+, are responsible in exacerbating oxidative damage by the production of highly
reactive hydroxyl radicals through the Fenton reaction (17).
Fe2+ + H2O2 Æ Fe3+ + OH• + OH-

(1.1.1)

Removal of hydrogen bonds is facilitated by the presence of higher numbers of double
bonds in the PUFAs. Compared to other organ systems, the brain contains a high lipid
content, high levels of transition metals, high oxygen and energy consumption rate, large
stores of polyunsaturated fatty acids and relatively poor defenses against lipid
peroxidation (2).
Neuronal membranes readily succumb to oxidative damage because the PUFA
constituent of their phospholipids can easily react with free radicals from cell metabolism
(37, 38). Normal metabolic processes generate free radicals through a variety of sources.
These radicals react with the PUFA component of cell membranes, producing such
compounds as hydroxylated fatty acids (HETEs), prostanoids and lipid aldehydes (37).
Ordinarily, the brain is protected from this type of damage by a carefully controlled
balance between pro-oxidant and antioxidant cellular mechanisms. Vitamins E and C,
glutathione (GSH), albumin, bilirubin, ceruloplasmin, uric acid, along with several
antioxidant enzymes, such as superoxide dismutase, glutathione peroxidase and catalase,
provide protection from free radical damage. Antioxidant protection occurs through
various methods within cells, including prevention of free radical formation, interception
of radicals, oxidative damage repair, eradication of damaged molecules, as well as
nonrepair-recognition of excessively damaged molecules to prevent mutations. A
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Figure 1.1.2. Peroxidation of fatty acids.
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peroxyl radical

situation of oxidative stress arises from an imbalance in free radical production
(particularly reactive oxygen species) and their removal by antioxidants (37).
Increasing evidence supports a role for oxidative damage in the pathogenesis of
AD. Several studies demonstrated increased protein oxidation (11, 39), DNA oxidation
(40-43), decreased levels of PUFAs (4, 44), and increased LPO (45-48) in AD. There
have been reports of increased levels of neurotoxic markers of LPO, including HNE and
acrolein, in the AD brain (49, 50) and cerebrospinal fluid (CSF) (51).
Immunohistochemical studies of the AD brain also showed different markers of oxidative
stress in NFTs and SPs (52-56). It is evident from the literature that an appropriate
biochemical indicator or product of LPO would serve well as a biomarker for AD. Hence,
it is no surprise that a considerable amount of research is currently focused on the
exploration of lipid peroxidation byproducts in their suitability as biomarkers for the
disease.
A major consequence of LPO is the widespread damage to membrane structure
and integrity as a result of the production of fragmented fatty acyl chains, lipid-lipid
cross-links, endocyclization to form a variety of fatty acid esters and lipid-protein crosslinks (57). In total, these processes combine to generate significant changes in the
biophysical properties of membranes that can result in profound effects on the biological
activity of membrane-bound proteins. Another important outcome of LPO is the
generation of secondary, more stable LPO products, which can be categorized into those
formed through a host rearrangement processes and mechanisms as well as those
generated by fragmentation of oxygenated lipids (57).
A small proportion of lipid hydroperoxy radicals go through internal cyclization
reactions to produce endoperoxide intermediates. These species are then converted to
various ringed isomers similar in structure to prostaglandins (57). Such compounds are
called isoprostanes (IsoPs) when they are derived from arachidonic acid. Quantification
of IsoPs rivals that of malondialdehyde, one of the most commonly used biomarkers of
LP, in accuracy and precision (58). However, concern with exploiting these chemicals as
indices for LP and AD stem from the lack of a thorough understanding of the link
between them and oxidant stress processes (59).
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Fragmentation of lipid hydroperoxides in LPO generates low molecular weight,
water-soluble, electrophilic aldehydes and is commonly observed in several different
types of neurodegenerative conditions, such as stroke and AD (57). Notable aldehydic
products include malondialdehyde (MDA), acrolein, and HNE. MDA can be detected
through the thiobarbituric acid-reactive substances (TBARS) assay. The sample to be
tested is heated with TBARS at low pH. Absorbance of a pink chromogen is measured at
532 nm (60). The test is popular because it is quite simple to perform and rather
inexpensive (36). However, it has the disadvantage of being an unspecific index for LPO
in complex biological fluids or in vivo. Furthermore, the results can often be misleading
as many species, including sugars, amino acids and bilirubin, can interfere with the test
(36, 60, 61).
Saturated aliphatic aldehydes (C3-C10) are also generated in LPO through
fragmentation mechanisms, along with the α,β-unsaturated aldehydes such as acrolein
and HNE (62). Aliphatic aldehydes have no evident toxicity, but acrolein (CH2=CHCHO) and HNE (C5H11-CH(OH)-CH=CH-CHO) are neurotoxic and have been detected
by immunohistochemistry in the AD brain, especially in NFTs and SPs (13, 63).
Alkenals, such as HNE and acrolein are strong electrophiles that react in tissues by
alkylating nucleophiles (Michael Addition and Schiff base formation), particularly
sulfhydryl groups, amino groups (i.e., lysine), and the imidazole group of histidine (64).
Such reactions can lead to the structural alteration and/or cross-linking of proteins, which
in turn can cause impairment of protein function. Therefore, these LPO products are
biologically very active and can cause substantial disruption of cell processes at the
genetic and biochemical level. The mechanism of formation of these toxic aldehydes
(Figures 1.1.3 – 1.1.5) has been described previously (38, 65). HNE, a product of ω-6
PUFA peroxidation, is a relatively stable aldehyde that can diffuse into different
subcellular compartments and interact with a host of cell proteins, including τ (30, 66)
and histones (67). Increased production of HNE has been shown to indicate an increased
level of oxidative stress, which may not always be evident using the more common
marker malondialdehyde (MDA) (68). HNE is generated in response to oxidative insults
and can induce neuronal apoptosis (69, 70). HNE has been linked to a host of adverse
cellular effects, including growth inhibition, alterations in glutathione levels, inhibition
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of enzymes and calcium sequestration by microsomes, exhibition of chemotactic activity
toward neutrophils, inhibition of protein and DNA synthesis, as well as induction of cell
death (40, 71). It has been shown to play a major role in oxidative impairment of synaptic
functions, leading to excitotoxic cascades (72-74) and to impair Na+/K+ ATPase activity
(75, 76) as well as glucose and glutamate transport (76). Microtubule organization and
neurite outgrowth are also vulnerable to HNE (77).
Among the α,β-unsaturated aldehydes, including HNE, acrolein shows the
highest reactivity towards nucleophiles, such as lysine (40, 78, 79). This aldehyde is
produced in vivo during the iron-catalyzed oxidation of PUFAs, such as arachidonic and
docosahexaenoic acids (80). It readily reacts with proteins and phospholipids and can
inhibit many enzyme systems including glucose and glutamate transport and Na+/K+
ATPase activity (49, 78). Acrolein is also known to modify DNA bases with the
formation of exocyclic adducts, leading to chromosomal aberrations, sister chromatid
exchanges and point mutations (40, 81) and has recently been linked to abnormal tau
protein phosphorylation (20). It is believed that acrolein may inactivate the reductase
responsible for the reduction of vitamin E radicals and, coupled with the depletion of
glutathione, causes further LPO and neuronal death (13, 80).
Considering the array of cellular constituents that can react with acrolein and
HNE, it is believed that a majority of these aldehydes exist in neurons bound to
macromolecules, particularly proteins. In vitro studies have shown that α,β-unsaturated
aldehydes have a high affinity for proteins (79, 82). In view of this, accurate and precise
quantification of all such aldehydes in the cells can be difficult. However, previous
studies have shown a direct correlation between free unsaturated aldehyde concentrations
and AD progression, particularly in regions of the brain with memory function (49, 50).
As such, a reliable quantification method for free aldehyde analysis (both aliphatic and
unsaturated) would be a useful measure of oxidative stress, and therefore AD.

Vulnerable Regions of the AD Brain
Cortical degeneration, excluding the sensorimotor cortex, occipital poles and
cerebellum, is considered as the primary basis for cognitive decline in AD (83, 84). Areas
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of the brain typically affected in AD include portions of the frontal lobe associated with
intelligence, judgment and social behavior, as well as areas of the temporal and parietal
lobes that have memory and language function. Studies have shown a direct correlation
between the prevalence of NFTs and SPs with levels of lipid peroxidation byproducts,
including biogenic aldehydes, in different brain regions (11, 45, 48-50, 63, 81, 85).
Cognitive deficits, particularly in memory, are associated with atrophy of the medial
temporal lobe (MTL) (86). Structures comprising the MTL include the hippocampus,
parahippocampal gyrus, entorhinal cortex and amygdala. Compared to age-matched
controls, increased AD pathology, to varying levels, has been detected in the
hippocampus, parahippocampal gyrus, superior temporal gyrus and middle temporal
gyrus (Figure 1.1.6). Atrophy of the hippocampal formation is seen in AD patients with
even very mild dementia. In situations of advanced dementia, atrophy extends to the
parahippocampal gyrus and other structures in the temporal neocortex (87, 88).
Phylogenetically one of the oldest regions of the brain, the hippocampus is
located inside the temporal lobe and is part of the limbic system, a group of structures
involved in transferring information into memory. The hippocampus is intimately
associated with the formation and long-term storage of associative and episodic
memories, as well as an individual’s ability to navigate. It is one of the first regions to
succumb to AD pathology (89). Because of this, initial symptoms of AD
characteristically include memory problems and disorientation. As with the hippocampus,
the parahippocampal gyrus is also part of the limbic system. It is located in the most
medial basal part of the temporal lobe and is also very susceptible to damage in AD.
Medial temporal lobe atrophy, particularly the hippocampus and parahippocampal gyrus
of the brain, can substantially impair the storage of new information and is believed to be
site of initial change preceding the expression of AD symptoms.
Regions that show AD pathology in the temporal neocortex include the superior
and middle temporal gyrus. Among other functions, the superior temporal gyrus is
closely associated with an individual’s ability to be insightful. The middle temporal gyrus
is linked to the processing of language and semantic memory, as well as visual perception
and multimodal sensory integration. Patients with damaged temporal lobes have
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Figure 1.1.6. Regions of the human brain investigated (90, 91): hippocampus, superior
temporal gyrus (STG), middle temporal gyrus (MTG), and cerebellum.
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difficulty with remembering names and faces (92). Because of the association of the
superior and middle temporal gyri with memory, it is not surprising that they do succumb
to damage in AD. However, the pathology observed here is not as widespread and intense
as that in the hippocampus and parahippocampal gyrus.
The cerebellum is an example of a part of the brain that exhibits little or no
pathology in AD. It aids in the coordination of voluntary motor movement, muscle tone,
balance and equilibrium. While the cerebellum has limited function in memory for reflex
motor acts, it is not particularly associated with memory formation, processing or storage
(93). Since the prevalence of LPO byproducts appears to be directly associated with the
level of AD pathology, it is to be expected that the greatest concentrations of these
species would be located in the hippocampus and parahippocampal gyrus when
comparing AD brains to age-matched controls. Intermediate concentrations would be
detected in such areas as the superior and middle temporal gyrus that display intermediate
AD pathology while the cerebellum and other structures not predominantly involved with
memory should show little, statistically significant elevations in the levels of these
compounds. A thorough quantitative study of the distribution of biogenic aldehydes or
other LPO products in the brain calls for careful methods development and analysis.

Biogenic Aldehyde Analysis
Several techniques have been explored for the analysis of biogenic aldehydes.
Many of these techniques involve high performance liquid chromatographic (HPLC)
separation and spectrophotometric measurements of chromophoric derivatives, such as
UV absorption of dinitrophenyl hydrazones (DNP) (94-97) and fluorescence detection of
cyclohexanedione (dimedone or CHD) derivatives (62, 98-101). In the absence of
chromatographic separation, spectrophotometric methods fail to distinguish between
specific analytes and other species capable of forming derivatives that also absorb at the
selected wavelength. Coupling spectrophotometric detection with separation techniques
such as HPLC adds greater selectivity, but co-eluting compounds may still interfere with
quantification of aldehydes at low levels. Aldehyde quantification is further complicated
by their reactivity and metabolism in tissues and biological fluids.
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Methods utilizing gas chromatography/mass spectrometry (GC/MS) offer high
sensitivity and the further advantage of mass specificity. This results in a much lower
limit of detection for aldehydes like HNE that are present in biological samples at very
low concentrations (102). Selected ion monitoring (SIM) at masses specific for target
analytes considerably improves instrumental sensitivity. In addition, derivatization (such
as oxime derivatives) can often be employed to direct fragmentation, further improving
limits of detection (103). As such, reduced sample volumes are often needed per analysis
when using GC/MS. Several types of aldehyde derivatives have been explored in
conjunction with GC/MS, most popularly o-pentafluorobenzyl-oxime-trimethylsilyl
(PFB-oxime-TMS) (102-106) and DNP (107) derivatives. PFB-oxime-TMS derivatives
react quantitatively with aldehydes at room temperature within 30 minutes. Other
advantages include small sample size and mild derivatization conditions (105, 106). Due
to low volatility, DNP derivatives are only practical for GC separation of low molecular
weight aldehydes. Also, these derivatives tend to react incompletely if the aldehydes are
in low abundance, which is often the case in biological matrices. Nevertheless, they offer
the benefit of little or no side-reactions (106).
GC/MS methods of aldehyde analysis are well established, however, the use of
HPLC combined with tandem mass spectrometry offers several noteworthy advantages.
For instance, a much greater proportion of the sample can be presented to the system,
thus improving the overall sensitivity of the technique. In addition, while different classes
of aldehydes can be simultaneously analyzed by HPLC/MS, multiple derivatizations are
frequently necessary for the analysis of different classes by GC/MS methods (37). The
temperatures applied in GC/MS for sample vaporization may not be suitable for certain
analytes. Unlike GC/MS, little pre-MS sample cleanup is required in HPLC/MS methods.
Furthermore, tandem mass spectrometry (MSn) coupled with HPLC is a welldocumented, specific and sensitive procedure using modern instrumentation. Scanning
the precursor ions for a common product ion provides a straightforward method for
aldehyde mixture analysis in biological samples, where the aldehyde composition may
vary considerably. DNP (108, 109), ozonide (109) and dimedone (37, 110, 111)
derivatives of aldehydes have been successfully analyzed using HPLC/MS. One report
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described the detection and analysis of HNE by HPLC/MS without any form of
derivatization (112).
A noteworthy advantage of CHD derivatives is that they are formed with
aldehydes only. Other carbonyl compounds simply do not react in this manner. As such,
this method is completely selective for these compounds. The improved selectivity
afforded by HPLC/MS/MS provides significant advantages over the fluorescence
detection of such derivatives, especially in the case of co-eluting compounds. This,
coupled to the fact that CHD-derivatized aldehydes provide over 90% recoveries makes
this procedure ideal for trace aldehyde analysis (100). It has been observed that aldehydes
derivatized with CHD reagents produce analytes that display excellent electrospray
response, a further advantage of exploiting this derivatization technique in conjunction
with HPLC/MS (37).

Liquid Chromatography
Liquid chromatography was brought into existence by the Russian botanist M. S.
Tswett (1872-1919) as a means for the separation of colored plant pigments (113). Since
then, high performance liquid chromatography, a highly developed version of its
predecessor, has become a well established analytical technique. This technique is used
for the separation and determination of organic and inorganic solutes in a variety of
settings, including biological, pharmaceutical, environmental and industrial applications.
HPLC instruments consist of a reservoir of mobile phase, a pump, an injector, a
separation column and a detector (113). The mobile phase reservoirs, along with
associated feed lines should be inert to prevent leaching of chemicals. Solvent feed lines
are typically made of non-permeable Teflon. It is important for the pumps to be able to
deliver mobile phase through the system as reproducibly as possible. Typical flow rates
for microbore chromatography range from 0-150 μl/min. A six-port Valco or Rheodyne
injector is suitable for LC systems (113). Samples are injected by micro-syringe into a
sample loop, the size of which can be chosen to meet experimental needs. The stationary
phase in LC systems usually consists of small diameter (3-10 μm) uniform particles,
packed into a narrow bore (0.01 inches or less) cylindrical column to minimize band
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broadening. Columns are made of resilient material, such as stainless steel or plastic.
They are generally 5-30 cm long with an internal diameter in the range of 0.3-9 mm. In
view of the small size of HPLC column packings, pumps that are able to deliver mobile
phase at high backpressures (~6000 psi) at precise flow rates (<1% variation) are a
necessity (113).
In an LC separation experiment, the sample is first dissolved in the mobile phase
and then passed, under pressure, through an immobile and insoluble stationary phase. The
sample flows through the column by continuous addition of mobile phase, which
completely permeates the stationary phase and elutes the solutes into the detector. The
phases are chosen such that components of the sample have differing partitioning
behavior between them. For instance, an analyte having high solubility in the stationary
phase will take longer to traverse the column, compared to one that is not particularly
soluble in the stationary phase but highly soluble in the mobile phase. The process of
separation becomes possible because of these differences in mobilities between the
analytes. Each analyte migrates through the column at a rate that is dependent on the time
it spends in the mobile phase. At the detector, they each generate a signal which is
recorded. Substantial benefits in the separation process can be achieved by careful
consideration of chromatographic parameters.

Separation Theory
Analyte distribution between phases follows a dynamic equilibrium (113):

Amobile ⇔ Astationary .

(1.1.2)

The equilibrium constant, K, for this process is the distribution coefficient. K is defined
as the ratio of the molar concentration of analyte in the stationary phase and the molar
concentration of the analyte in the mobile phase:

K=

Cs
.
Cm

(1.1.3)

The time lapse between sample injection and a component analyte peak reaching a
detector at the end of the column is the retention time (tR). Each analyte component is
characterized by a different retention time. The time for the mobile phase to pass through
the column is tM (Figure 1.1.7).
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Figure 1.1.7. The separation process. The time interval between sample injection and the
analyte peak reaching the detector is the retention time (tR). The time for the mobile
phase to pass through the column is tM. The peak width at half height is w1/2.
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The capacity factor, k’, can be employed to define retention of an analyte on a
column. For analyte1, the capacity factor is:

k’1 = (mass of analyte1)s / (mass of analyte1)m
=

tR − tM
.
tM

(1.1.4)

Optimization of the chromatographic process is critical to any HPLC experiment.
To this end, band separation and band broadening are of importance. Both are kinetic
processes and a useful separation is only achieved when the rate of band separation is
greater than the rate of band broadening. To obtain the best separations, efficiency and
selectivity issues must be considered. Sharp, symmetrical chromatographic peaks can be
obtained only when column efficiency is optimized.
Plate Theory
It is possible to describe column efficiency by the plate model, which assumes
that the chromatographic column contains a large number of (hypothetical) separate
layers, also known as theoretical plates. Furthermore, analyte equilibration between the
two phases is said to occur at each plate. The analyte moves down the column as a result
of transport of equilibrated mobile phase from one plate to the next. The number of
theoretical plates that a real column possesses can be obtained by examining a
chromatographic peak after elution (114):

⎛ t ⎞
N = 5.55⎜⎜ R ⎟⎟
⎝ w1 / 2 ⎠
where,

2

(1.1.5)
w1/2 = the peak width at half height.

Column efficiency increases as the number of equilibrations or theoretical plates,
increases. If the length of the column is L, then the height equivalent to a theoretical plate
(H) is:

H=

L
.
N

(1.1.6)

The number of theoretical plates is dependent on the length of the chromatographic
column. H is a better indicator of column efficiency as it makes inter-column
comparisons more feasible (113).
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Rate Theory
Chromatographic phenomena inside a column can be better understood when
taking into account the time for the solute to equilibrate between the stationary and
mobile phases (114). This approach is in contrast with the plate model, which postulates
that equilibration is instantaneous. Rate theory highlights the kinetic factors that
contribute to zone or band broadening, as represented by H (115). The resulting
chromatographic peak shape is therefore influenced by the rate of passage of analytes
through the column and by the various routes that solute molecules can take in their
journey through the stationary phase. The different mechanisms that increase band
broadening are described by the van Deemter equation (116):

H = A+

B
+ (C s + C m )u
u

where,

(1.1.7)

u = Average velocity of mobile phase
A = Eddy diffusion
B = Longitudinal diffusion
C = Resistance to mass transfer in the stationary (Cs) and
mobile (Cm) phases.

A plot of plate height versus average linear velocity gives an indication of the ideal flow
rate (Figure 1.1.8). At mobile phase velocities below the optimum, the overall efficiency
of the system is strongly influenced by longitudinal diffusion, or the B term. At velocities
higher than the optimum, the efficiency decreases because resistance to mass transfer (C
terms) becomes more important. Despite the reduced efficiency, it is generally acceptable
to employ mobile phase velocities above the ideal value for the purposes of lowering
analysis time (113).
For packed columns in situations of low velocity where the mobile phase random
walk of solute particles is directed by longitudinal diffusion, the Eddy diffusion or A
term, is eliminated. Eqn (1.1.7) then becomes (116):

H=

B
+ Cs u + Cmu .
u

(1.1.8)
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Figure 1.1.8. The van Deemter plot. H is the plate height, A is the Eddy diffusion term, B
is the longitudinal diffusion term, C is the resistance to mass transfer term and u is the
mobile phase velocity.
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Sometimes, other measures of column efficiencies can prove to be more useful.
Solute separation is intimately tied to selective retention by the stationary phase. This
selectivity by the stationary phase can be expressed as a form of adjusted retention:

α=

k 2' K 2 t R' 2
.
=
=
k1' K1 t R' 1

(1.1.9)

Eqn (1.1.9) clearly shows the thermodynamic basis of this type of separation, as
described by the relationship of the selectivity factor to the distribution coefficient (113).
While the selectivity factor portrays the separation of solute zones, it does not
take peak widths into consideration. As can be seen in Eqn (1.1.10), the resolution, Rs, is
a more informative measure of separation. It considers the difference in retention, as well
as column efficiency (113):
Rs = 2

t R1 − t R 2
wB1 + wB 2

where,

(1.1.10)

wB = peak width at the base.

A more useful expression for resolution can describe the both the thermodynamic and
kinetic aspects of the separation (117):

⎛ N 1 / 2 ⎞⎛ α − 1 ⎞⎛ k avg
⎟⎟⎜
Rs = ⎜⎜
⎟⎜⎜
−
2
α
2
⎝
⎠⎝ 1 + k avg
⎝
⎠
where,

⎞
⎟
⎟
⎠

(1.1.11)

kavg = average k for two peaks of similar retentions.

An increase in column selectivity (α) is a powerful way of improving resolution. As
such, a careful selection of both stationary and mobile phases is critical to the HPLC
process.

Stationary Phase

A variety of particles are used in LC column separations, differing in type, size,
shape and nature. Microparticulate (3-10 μm), porous materials (~300 Å pore diameter)
offer large active surface areas for increased sample loadings, good column efficiencies
and high speed of analysis (118). Silica packings are commonly used for LC columns
because they can tolerate the high pressures created when 10-30 cm columns are packed
with microparticulate materials. Silica is easily functionalized and the chemistry of its
bonding reactions is quite well understood (113). Bonded-silica columns can be used
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Figure 1.1.9. C18 stationary phase (monomeric bonding) for HPLC.
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through a wide pH range (pH 1-10), although reproducibility is assured only in the range
of pH 2-7.5. This is largely because of the fact that long-term exposure to pH extremes
causes hydrolysis of the bonded phase (acid extremes) or degradation of the base silica
(basic extremes) (119). Silica-based columns tend to offer vastly improved efficiencies,
compared to non-silica materials. For the purposes of separating small, hydrophobic
compounds, a carbon-chain bonded phase over microparticulate, porous silica would be
useful. Longer chain bonded phases have more hydrophobic character and greater carbon
loading (119). In the separation of dimedone derivatives of aldehydes, for instance, a
hydrophobic C18 bonded phase would be suitable (Figure 1.1.9). Retention is largely
based on van der Waals interactions.
Column Packing
In the wet-fill (slurry packing) method of column preparation, an appropriate
solvent is used to suspend the stationary phase particles at a reasonable concentration.
This suspension is then pumped under high pressure into an empty column. It is required
that the solvent be able to maintain uniform particle distribution without agglomeration.
The solvent must also thoroughly wet the packing material. LC packings that have low
surface energy, such as C18 functionalized silica, can be packed in solvents of low
polarity, such as a binary acetonitrile:water = 9:1 solvent mixture. To pack a column, the
packing suspension is sonicated, stirred and placed in a specially designed reservoir, also
known as a column bomb, which fits to the inlet end of the empty column. A porous
screen (1-2 μm) or frit is placed at the outlet of the column and the packing material
slurry is introduced into the column under gas pressure, producing a compact stationary
phase bed (113).

Mobile Phase

Solute retention and selectivity also depend on the strength of the interaction
between the solute and the mobile phase. Solvents used as the mobile phase can enhance
or diminish solute ionization and can also screen active adsorption centers on the
adsorbent surface. In typical LC approaches, a logical and intelligent selection of the
stationary phase is made first and then the selectivity is fine-tuned by manipulating the
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mobile phase. Useful solvents will have reduced viscosity, flammability and toxicity.
They will also be compatible with the detection system for the LC instrument and have
little or no impurities (113). Detection of solutes in HPLC occurs online, so it is
imperative that the solvent be compatible with the detection system.
Solvents of low viscosity offer favorable solute diffusivity, which in turn
improves column performance. It is important for solvents to be chemically inert towards
the target analytes and be able to completely dissolve the analytes. In reversed-phase
liquid chromatography (RP-HPLC), there is an inverse relationship between solvent
strength and chromatographic elution power. For instance, pure water is a rather strong
solvent but has little elution power in RP-HPLC. However, mixing water with a small
quantity of an organic modifier with lesser polarity, such as acetonitrile, results in a
solvent system that can elute a solute with a low capacity factor value (a solute with
reduced stationary phase retention). Binary and ternary solvent mixtures provide a simple
means for controlling solvent strength by varying the relative concentration of each
component in the mobile phase mixture that enters the column (113).

Gradient Methods

In LC experiments, it is possible to gradually change the composition of the
mobile phase during the course of a chromatographic run through a process called
gradient elution. This technique is quite similar in principle to temperature programming
in GC, except that changes in solvent strength rather than temperature are used to elute
target analytes (113). Each experiment is begun with a weak eluting solvent, such as
water, followed by steady additions of increasing amounts of a strong eluting solvent,
such as acetonitrile, over the length of the chromatographic run. In high-pressure gradient
formation, the high pressure mixing of the two solvents is brought about by two pumps
and a microprocessor controlling device (113). A gradient is generated by careful control
of the output solvent flow from each pump (Figure 1.1.10). Manipulation of solvent
strength in this manner allows improved resolution of poorly retained solutes at the
beginning of the separation, while the more strongly retained solutes are eluted within a
shorter time. Gradient elution offers significant improvements in peak shape, resolution,
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Figure 1.1.10. High-pressure gradient formation in HPLC.
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detection sensitivity and analysis time. Solvent gradients are widely used with RP-HPLC
since a wide range of compounds can be separated using this approach.

Reversed-Phase HPLC

RP-HPLC utilizes a non-polar stationary phase with a polar mobile phase and is
very useful in separating hydrophobic analytes. Polar sample molecules interact the least
with the stationary phase and are therefore eluted first. As a result, increasing the polarity
of the mobile phase results in increased retention of solute. The hydrocarbon-like
stationary phases have the ability to equilibrate rapidly with changes in mobile phase
composition and are therefore very well suited for use with gradient elution (113). The
mechanism of retention in RP-HPLC is complex and it is believed that various nonspecific hydrophobic interactions between the solute and stationary phase are involved.
However, these interactions alone are much too weak to account for the degree of solute
retention that is characteristic of RP-HPLC. The retention mechanism can be best
described as involving a combination of partition and adsorption processes. Due to the
heterogeneous nature of silica-based materials, it is possible for different mechanisms to
operate over different regions of the stationary phase surface. To further complicate
matters, the mechanism is not always constant over the entire range of mobile phase
compositions. This is largely because mobile phase composition has a significant
influence on the solvation of binding sites on the stationary phase (113).
To date, the solvophobic theory provides the most likely interpretation of RPHPLC retention. Predictions from this theory work best when using aqueous mobile
phases with little organic modifier content. A basic assumption is that the stationary
phase is a uniform layer of non-polar ligand. According to the solvophobic theory, the
solute interacts with the stationary phase, thereby reducing the proportion of its surface
area exposed to the mobile phase. This solvent effect drives the sorption of solute
molecules. In other words, the solute is adsorbed because it is solvophobic. The theory
assumes that aqueous mobile phases tend to be very structured because polar water
molecules will self-associate by hydrogen bonding. Non-polar solutes, lacking hydrogenbonding capabilities, cause a perturbation in this structuring (113). As a result of the very
high cohesive energy of the solvent, the less polar, more hydrophobic solutes are literally
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squeezed out of the mobile phase and are non-covalently bound to the hydrocarbon
portion of the stationary phase.
The solvophobic theory stresses that retention occurs largely due to the strong
interactions between the mobile phase and solute molecules. This implies that the mobile
phase composition has a greater effect on separation selectivity than the stationary phase
in RP-HPLC (113). For polar solutes, the dipolar or hydrogen bonding interaction
between the solute and the mobile phase will resist the transfer of solute. It is the
disparities in interactive energies between the non-polar and polar solutes with the mobile
phase, along with disparities in the hydrophobic solute molecular surface areas that are
the important factors associated with functional group selectivity observed in RP-HPLC
techniques (113).

Electrospray Ionization – Ion Trap Mass Spectrometry

A particularly well-suited detector for LC is a mass spectrometer because it can
be used in the analysis of a wide variety of compounds with diverse functional groups.
Furthermore, MS offers high selectivity and sensitivity, together with considerable
structural information, for the purposes of solving complex analytical problems (120).
Performing LC-MS experiments online extends the well-established GC/MS methods to
thermally labile compounds that are amenable to analysis through HPLC only (121).
Since MS operates under a vacuum, one of the challenges of interfacing any separation
system with this detector is the requirements of a suitable sample introduction method.
Also, it can be difficult to completely eliminate the solvent from LC, maintain adequate
vacuum levels in the mass spectrometer and generate gas phase ions. There are many
reasons why electrospray (ES) is an ideal means of transferring eluent from the LC
instrument into the mass spectrometer, a major one being that electrospray allows ion
formation directly from solution. Also, in electrospray, ionization occurs at atmospheric
pressure. These features have established ESI-MS as a convenient mass detector for
liquid chromatography, as the mobile phase offers a suitable medium for analyte
ionization.
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Electrospray

Electrospray is an ion transport technique that enables the sensitive analysis of
small, large and labile molecules, including such varied analytes as peptides, proteins,
organometallics, oligosaccharides and polymers. Over 20 years ago, Fenn and co-workers
demonstrated the applicability of this technique in directly coupling LC to mass
spectrometry (122-124). In LC/MS, the HPLC line is attached to the electrospray probe, a
metallic capillary surrounded with nitrogen gas flow, and the mobile phase is forced
through the capillary. Solutes analyzed by electrospray undergo ‘soft ionization’ and are
largely left intact in the ionization source. A major source of analyte charging is through
protonation or deprotonation reactions (125). The capillary has a voltage applied to it
while the sampling cone is held at low voltage. The potential difference between them
can be anywhere between +500 and +4500 V. As a result of the voltage on the capillary,
an aerosol of charged droplets is formed, assisted by a concentric flow of nitrogen. The
droplets have both solvent and analyte molecules, and, depending upon the polarity of the
applied voltage, the molecules develop a net positive or negative charge (126). Ionized
molecules eventually discard the surrounding solvent and enter into the atmospheric
pressure region of the mass analyzer through a low-pressure transport region (~1 torr).
This part of the instrument contains a heated capillary, a skimmer and lens arrangements.
The electrospray interface uses an octopole lens (Figure 1.1.11) for ion focusing into the
mass analyzer of the spectrometer (121).
The aerosol droplets generated in electrospray upon nebulization decrease in size
due to solvent evaporation, resulting in an increased charge density on their surface. The
mutual repulsion of like charges in the droplets eventually becomes greater than the
surface tension, causing ions to be ejected from the droplets. Vaporization of these
charged droplets results in the production of singly- or multiply-charged gaseous analyte
ions. The electrospray instrument delivers a continuous current, causing redox reactions
to take place at the source. Oxidation reactions at the metal capillary remove electrons
from negative ions. Likewise, reduction reactions involving the sprayed positive ions
occur at the negative counter electrode (127). It is expected that the reaction having
lowest electrochemical potential will generally occur at the capillary tip. In an attempt to
establish the mechanism for gas-phase ion formation from charged droplets in
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Figure 1.1.11. The electrospray source.
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2 x 10-10 mbar

electrospray, the ion evaporation model (IEM) and the charged residue model (CRM)
have been suggested (127). Since both models have almost equivalent support in the mass
spectrometry community, both are considered when discussing electrospray mechanisms.
Ion Evaporation Model: The increased charge density on the droplet surface
arising from solvent evaporation results in Coulombic repulsion becoming greater than
the liquid’s surface tension. This enables the release of ions from the droplet before it
breaks apart, as shown in Figure 1.1.12(A).
Charged Residue Model: Evaporation of the droplets occurs continuously. The
diameter of the droplet decreases while the total charge remains the same. The increased
charge density, due to solvent evaporation, induces instability on the surface. This causes
large droplets to divide into smaller droplets through a series of sequential fissions,
eventually generating single ions, as shown in Figure 1.1.12(B).
Electrospray offers the best sensitivity with lower flow rates. The effluent flow
from the LC system that enters the electrospray source can be reduced by using a splitter.
Since electrospray is not an ionization method, it is imperative that the mobile phase have
a pH such that the analytes will be ionized. Acidified mobile phase is well-suited for the
analysis of basic compounds using the positive electrospray mode, while a basic pH is
desirable for acidic analytes. It is best to employ volatile buffers for routine use, although
non-volatile buffers, such as phosphate, can be employed as well. It should be noted that
when using non-volatile buffers the salt deposit in the source will have to be periodically
removed. It is important that the concentration of the buffer acid or base used to
manipulate the pH be low. This is to avoid competition between the analyte and
electrolyte ions for conversion into the gas-phase, as it can potentially decrease analyte
response (125).

Quadrupole Ion Trap Mass Spectrometry

Ions generated through electrospray can be detected with a quadrupole ion trap
(QIT), a mass analyzer invented by Wolfgang Paul and co-workers in the 1950’s. Ions are
guided from the source into the trap by focusing through a skimmer and two RF-only
octopoles. Differential pumping with a series of mechanical and turbo pumps maintains a
vacuum in the trap while the electrospray source is at atmospheric pressure. The ion trap
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Figure 1.1.12. Electrospray mechanisms: (A) Ion evaporation model (IEM) and (B)
Charge residue model (CRM).
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is comprised of three electrodes of hyperboloidal geometry: a ring electrode located
between an entrance end-cap and an exit end-cap electrode (Figure 1.1.13). These
electrodes form a cavity within which ions can be trapped and studied. The trapping
volume in a QIT has dimensions r0 and z0, where r0 is the closest distance between the
center of the trap and the ring electrode and z0 is the closest distance between the center
of the trap and either end-cap (128). Both end-cap electrodes have small holes in their
centers through which the ions can travel. Ion entry is controlled using a gating lens that
switches from positive to negative voltages to repel or attract ions toward the entrance
end-cap opening. For positive ion analysis, a negative potential is applied for ion entry
and for negative ion analysis, a positive potential is applied. The ionization period or time
during which ions are allowed entry into the trap is adjusted to maximize signal and
minimize space charge, which can arise from an excess of ions in the trap producing
changes in the electrical fields and decline in trap performance. On the other hand, too
few ions can result in a loss of sensitivity (129, 130).
In a quadrupole ion trap, a rf oscillating electrical potential on the ring electrode
directs and focuses ions to the trap center. Helium gas in the instrument, at a pressure of
about 1 mtorr, collides with the trapped ions and aids in the reduction of their kinetic
energy and causes the contraction of trajectories toward the center of the trap. Ions within
the trapping volume experience a potential described by (128, 131):
Φ x, y ,z =

or, Φ r , z

(U − V cos Ωt ) ⎡ x 2 + y 2 − 2 z 2 ⎤ + (U − V cos Ωt )
⎢
⎣

2

r02

⎥
⎦

2

(
U − V cos Ωt ) ⎡ r 2 − 2 z 2 ⎤ (U − V cos Ωt )
=
+
2

where,

⎢
⎣

⎥
⎦

r02

2

(1.1.12)

(1.1.13)

U = dc amplitude on end-cap electrodes
V = rf amplitude on ring electrode (fundamental rf)

Ω = oscillating frequency of rf (V), typically 1.1 MHz
r=

x 2 + y 2 = radial displacement.

Each ion in this quadrupolar field experiences a force that is dictated by Newton’s law
(128):

G
G
G
Fr , z = E r , z = −e∇Φ r , z = ma r , z

(1.1.14)
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Figure 1.1.13. The quadrupole ion trap (QIT).
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where,

m = mass of ion
e = charge of ion
a = acceleration of ion
Er,z = electric field strength.

The mass (m) and charge (e) of an ion, the size of the ion trap (r0), oscillating
frequency of the applied voltage to the ring electrode (Ω) along with the amplitude of the
voltages on the end-cap (U) and ring (V) electrodes all come together in a second order
differential equation or Mathieu Equation to determine whether or not that ion will have
stable motion in the trap (129, 132).
d 2u
+ (au − 2qu cos 2ξ )u = 0
dξ 2

where,

(1.1.15)

u = coordinate axes x, y and z
ξ = dimensionless parameter Ωt/2 (t is time)
au and qu = dimensionless trapping parameters.

Solutions for the Mathieu equation that provide stable ion trajectories are described by
the parameters qz and az in the axial direction,

qz = −

4eV
mr02 Ω 2

(1.1.16)

az = −

8eU
mr02 Ω 2

(1.1.17)

as well as ar and qr in the radial direction:

ar = −

az
2

(1.1.18)

qr = −

qz
2

(1.1.19)

ξ=

Ωt
(dimensionless parameter).
2

(1.1.20)

In reference to ions, m/z (z is the ion charge) is synonymous with m/e.
Mathieu Stability Diagram
A plot of az vs qz or Mathieu Stability Diagram describes the regions of stability
in the trap for ions of different m/z values (Figure 1.1.14). Depending upon the amplitude
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of U and V, an ion of a given m/z will have a qz value that is located within the
boundaries of the diagram. This means that the ion will have stable motion and be
trapped. An ion can be maneuvered within the boundaries of the stability diagram by
manipulation of U and V. In addition, the trajectory of an ion can be made unstable
through careful selection of U and V, causing it to be selectively expelled from the trap.
Whether or not stability exists for a particular ion within the trap depends solely on the
parameters a and q and not on the initial parameters of ion motion, such as velocity. The
Mathieu equation has two types of solutions (129):
1. periodic and stable: These solutions dictate stable ion trajectories in the trap. Ions
can be stored in a trap provided that their motion is stable in both the r- and zdirections.
2. periodic but unstable: These solutions apply to the boundaries of unstable regions
in the aq map, which represent points at which ion trajectories become unstable.
It should be noted that commercial ion traps generally do not offer the ability to
manipulate dc voltages. With no dc potential applied, all ions are assured radial stability.
Hence, in order to eject ions, they must be made unstable in the axial direction.
On the q-axis (a=0, no dc voltage) there is a stability region extending from 0 < q
< qmax = 0.908, which dictates the low-mass cutoff of the mass analyzer. As such, the
lower m/z ions have q values closer to the exclusion limit, while higher m/z ions have q
values closer to the origin. All masses between ∞ > m > mmin have stable orbits. Scanning
V to higher voltages will make trapped ions move to higher q values and eventually, the

lowest m/z ion reaches, and then crosses the stability boundary. In other words, the ion
gains kinetic energy and its axial motion becomes increasingly larger until it is ejected
from the trap through holes in the end cap aperture. A full scan mass spectrum is
generated by sequentially ejecting ions from low m/z to high m/z and detecting them
using a collision dynode and electron multiplier system. This is known as the mass
selective instability scan (129).

Although the angular frequency of the applied voltage V on the ring electrode is

Ω, ions in the trap do not oscillate at this frequency because of their own inertia. Instead,
the ions oscillate with a frequency known as the secular frequency fz that is lower than Ω
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and decreases with increasing mass. This frequency is proportional to Ω by a constant of
proportionality βz that is dependent on both az and qz (131):
fz = βz

Ω
.
2

(1.1.21)

When qz < 0.4, this constant of proportionality can be approximated in the following
manner:
q z2
β = az + .
2
2
z

(1.1.22)

In situations where no dc voltages are applied to the ion trap and az = 0, the expression
can be simplified to:

βz =

qz
.
2

(1.1.23)

Since the maximum value of βz for a stable ion trajectory is βz = 1, the highest possible
secular frequency fz that an ion can have is half the value of Ω (130).
There is an alternate method to the mass selective instability scan that can be
applied towards ion ejection. This method, termed resonance ejection, involves making
the trajectory of a particular ion unstable through the application of a high-amplitude ac
voltage or supplementary rf potential on the end-cap electrodes. The qz value of the ion is

changed until the secular frequency of the ion matches the frequency of the applied rf
voltage. In a special case of resonance ejection, the supplementary rf frequency is held
constant (corresponding to a qz value less than 0.908) while the rf drive amplitude is
ramped, a process known as axial modulation. In this manner, several or all ions can be
ejected mass selectively. The ions absorb excess energy from the applied field,
sequentially go into resonance, causing the amplitude of oscillations to linearly increase
in the z direction. If the applied voltage is high enough, the oscillations will become so
large that the ions are destabilized and finally ejected from the trap through the end-cap
electrode. Axial modulation creates ‘holes’ in the qz axis so that ions can be expelled at
values of V lower than those needed to attain qz = 0.908 in the standard instability scan.
Furthermore, very large ions that may not be able to achieve this qz value no matter how
high the value of V can be easily ejected with this approach. A full scan mass spectrum
may be obtained by combining resonant ejection with an rf (V) scan, thereby enabling
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successively larger ions to move to the position in the stability diagram where they fall
into resonance with the supplementary rf and are ejected. When the supplementary rf
frequency is decreased, corresponding to a much lower value for qz, axial modulation can
enable extension the mass range of the ion trap (128).
Ion Isolation Methods
It is often desirable to study a particular ion in detail, perhaps for the purposes of
doing ion-molecule reactions or tandem mass spectrometry (MSn) experiments.
Resonance ejection can be employed to isolate an ion of particular m/z, while ejecting all
others. In this case, a supplemental rf waveform may be applied to the end-cap electrodes.
This waveform creates unstable trajectories for all ions except the species that is to be
trapped. Another approach to ion isolation is by a technique called reverse-then-forward
scanning. An ejection hole is formed at low qz by applying a supplemental rf to the end-

cap electrodes. Scanning the rf amplitude on the ring electrode (V) in the reverse
direction results in the ejection of all m/z values larger than that of the desired species
through the ejection hole. Likewise, m/z values lower than that of the ion to be isolated
are expelled from the trap by changing the supplemental rf to form an ejection hole at
high qz. The rf amplitude on the ring electrode (V) is then scanned forward, thus ejecting
all ions of lower m/z (131). If manipulation of dc is an option, then a further method of
ion isolation is possible. By applying an appropriate combination of dc and rf (V)
potentials on the ring electrode, the ion of interest can be isolated at the apex of the
stability diagram, while ejecting all other species (130).
Tandem Mass Spectrometry
Tandem mass spectrometry, abbreviated MS/MS or MS2, is any general mass
spectrometric method of at least two mass analysis stages, either in association with a
fragmentation mechanism or a chemical reaction that modifies the mass or charge of an
ion (130). In the ion trap, it is possible to perform time-dependent multistage MSn
experiments. Analysis of fragment ions generated from tandem experiments offers
considerable structural information of precursor ions. While a high-amplitude
supplemental rf applied to the end-cap electrodes can initiate resonance ejection of ions,
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it is possible to induce ion fragmentation by applying a low-amplitude supplemental rf (a
few hundred millivolts) to the same electrodes. This process is called resonant excitation.
Prior to resonant excitation of a particular ion, all other unwanted ions are excited
and expelled from the trap by applying an appropriate supplemental rf waveform to the
end-cap electrodes. The remaining ions are then focused collisionally to the vicinity of
the center of the trap under the influence of collisions with helium atoms. The process has
been described as ‘ion cooling’ as ion kinetic energies are reduced to ~0.1 eV. At this
point, ion migrations from the center of the trap are less than 1 mm. A low-amplitude
supplemental rf is then applied to the end-caps, causing excitation of ions. As a result, the
ions start to move away from the trap center, resulting in their experiencing a greater
trapping field. Since the supplemental rf has low amplitude, ions undergo low-energy
collisions with helium as opposed to being ejected. Resonance excitation increases ion
kinetic energy and promotes collision induced dissociation (CID) with helium, resulting
in the formation of fragment ions. A mass spectrum (MS2) is generated by successively
ejecting the fragments from low m/z to high m/z by choosing supplemental rf amplitudes
and V potentials that induce instability in the ion trajectories (128).
Mass Spectrometric Experiment Design
With the advent of numerous decision-making algorithms, it has become possible
to perform a wide array of mass spectrometric experiments focused on the needs of the
sample under analysis. Data-dependent algorithms have been used to obtain both MS and
MS/MS data during the course of a single LC/MS run. The ion trap mass spectrometer is
ideal for these analyses because of its high sensitivity in the full scan mode and the ease
of switching from the MS to MS/MS mode. Furthermore, the ion trap employs helium for
both ion collection and fragmentation, which considerably simplifies the experiment. In
data-dependent experiments, the instrument automatically performs MS/MS experiments
on precursor ions in previously acquired full scan mass spectra. The switch from MS
mode to MS/MS mode occurs once a signal threshold is reached. As can often be the
case, some samples have multiple co-eluting species. Data-dependent scanning can easily
be employed to obtain MS/MS information on these species. The mass analyzer performs
an MS/MS analysis on the most intense ion and then puts this ion on an exclusion list.
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The ion is not analyzed further for a pre-selected time window. Then the instrument
proceeds with the analysis of other ions present in the full scan.
The time for completion of one analytical full scan followed by one analytical
MS/MS scan is determined by the duty cycle of the instrument. For the purposes of
enhancing ion statistics, several micro-scans are averaged to produce one analytical scan.
However, in doing so, the duty cycle of the mass analyzer tends to suffer, resulting in
fewer full scans and MS/MS scans being acquired. This can be a substantial issue in
instances of overlapping peaks produced as a result of mediocre chromatographic
resolution. In such cases, fewer analytical scans per unit time are likely to preclude
certain analytes from tandem mass spectrometry experiments. There is some user control
on the rate of analytical scan acquisition through such parameters as the number of
averaged full scans and MS/MS scans as well as the ion trap injection time. Wenner et al.
investigated the factors that influence data-dependent scanning in ion trap MS (133).
Data-dependent scanning enables the rapid analysis of all key components present
in a particular sample. However, sometimes it may be required to perform mass
spectrometric investigations on certain target analytes within the sample and more
focused experiments are necessary. In such situations, it is desirable to perform
segmented MS/MS analyses in which the data acquisition time window is divided into
discrete sections. Each time segment is devoted exclusively for the MS/MS analysis of a
target analyte. Any sections of the time window not involved in the analysis of particular
solutes may be used to do data-dependent scanning to obtain a full picture of the MS
fingerprint of the sample. Segmented analyses have the advantage of greatly improving
the signal-to-noise ratio (SNR). Furthermore, the isolation of a particular analyte in this
manner for exclusive MS/MS analysis can be described as a form of ion purification.
Segmented MS/MS analysis can simultaneously provide structural and quantitative
information on target analytes.

Goals

This chapter has provided a background on the nature and importance of
Alzheimer’s disease. The clinical criteria for AD diagnosis, histopathological hallmarks,
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as well as elements of the etiology that have been established to date were discussed.
Numerous studies have shown the relevance of Aβ and τ in oxidative stress and AD
pathogenesis. These findings have been stressed, along with the connection of Aβ and τ
to the widespread lipid peroxidation and oxidative stress observed in the AD brain. The
importance of LPO byproducts as viable biomarkers for AD, such as the neurotoxic
aldehydic species acrolein and HNE, was explained. Exploiting these compounds as
biochemical indicators of AD requires the development of sensitive, selective and reliable
methodologies for their detection and quantification. The benefits of derivatizing these
biogenic aldehydes with cyclohexanedione reagents for analysis by LC/MS have been
detailed. Furthermore, principles of LC/MS operation as applicable to biogenic aldehyde
quantification were discussed.
Chapter 1.2 describes the development of LC-ESI-MS/MS methods for the
detection and accurate quantification of aliphatic and unsaturated aldehydes of biological
importance, particularly in AD pathogenesis. Several LC and MS parameters were
explored and a description of how their values were optimized in order to arrive at the
most effective methodology is provided. Appropriate calibration curves for quantitative
analysis were constructed using standard aldehyde samples and their reliability and
usefulness was investigated in the analysis of real tissues.
Chapter 1.3 focuses on the application of the developed LC-ESI-MS/MS method
in the analysis of aldehydic products in vivo. Post-mortem samples from several brain
regions of individuals that had been suffering from different stages of AD were analyzed
for biogenic aldehydes. These results were then compared to the analysis of brain tissues
from suitable age-matched controls. Detailed statistical examination of the data is given.
Chapter 1.4 provides some concluding remarks and highlights the significance
and future direction of this work.
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Chapter 1.2
Development of LC-MS Methodologies for the Quantitative Analysis of Biogenic
Aldehydes in Alzheimer’s Disease

Introduction

Liquid chromatography (LC) separations, coupled to a variety of detection
methods, have been employed in the analysis of derivatized biogenic aldehydes. These
include derivatization by 2,4-dinitrophenyl hydrazines followed by UV detection as well
as fluorescence detection of several derivatives (40, 94-96, 98-101, 107). In cases where
analysis was carried out by gas chromatography (GC), the detection method of choice has
been mass spectrometry (MS) (103, 105-107). For instance, Zhang and co-workers (104)
have recently developed a simple, rapid, sensitive, solvent-free GC/MS method with
solid-phase microextraction (SPME) and on-fiber derivatization for the analysis of
aldehyde levels in the blood of lung cancer patients. Aldehydes in blood headspace were
extracted by a SPME fiber and reacted with O-2,3,4,5,6(pentafluorobenzyl)hydroxylamine hydrochloride (PFBHA) on-fiber. The resulting
oxime derivatives were desorbed and quantitatively studied by GC/MS. The blood
samples were shown to contain substantially elevated levels of hexanal and heptanal
compared to controls, suggesting the potential use of these aldehydes as biomarkers for
this disease.
There are some noteworthy reports that describe the use of LC in association with
mass spectrometry in aldehyde analysis of tissue samples (37, 97, 108, 109, 112). Several
derivatization techniques have been explored, including the Hantzsch reaction (110).
Compared to the more frequently used hydrazine reagents, this mode of derivatization
displays some very interesting characteristics. In this reaction, an aldehyde, two βdicarbonyl compounds and ammonia combine to form a heterocyclic system. The
resulting compound, known as a dimedone derivative, has fluorescent properties (110).
Several β-dicarbonyl compounds have been studied. Acetylacetone was the first βdiketone derivatized in this manner, producing a dihydropyridine derivative (134).
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Sawicki et al. described the use of 5,5-dimethyl-1,3-cyclohexanedione as the β-diketone
(135). The products of this reaction are decahydroacridines. Several researchers have also
applied the use of other β-dicarbonyl compounds, such cyclohexanedione (134, 135), in
this type of aldehyde derivatization. The derivatization mechanisms are described
elsewhere (136).
Mallet et al. (37) developed a LC-MS procedure for analyzing hexanal and larger
aldehydes in blood plasma. Aldehyde derivatization using the Hantzsch reaction preceded
analysis by a LC-Quattro instrument with electrospray (ES). Quantification was achieved
by multiple reaction monitoring (MRM), with benzaldehyde as an internal standard. This
is a non-physiological aldehyde of little structural similarity with the target compounds.
The approach has the potential drawback that benzaldehyde reactivity in the
derivatization may not be identical to that of the target aldehydes. However, experimental
data did not suffer and indicated the applicability of LC-MS in plasma aldehyde
quantification. Smaller (C1-C5) straight chain and unsaturated aldehydes were not studied.
Karst and co-workers (110) described LC-MS methods for the determination of
aliphatic aldehydes following derivatization with acetylacetone through the Hantzsch
reaction. The authors employed atmospheric pressure chemical ionization (APCI) and
electrospray in the positive ion mode to ionize the dihydropyridine and
decahydroacridine derivatives, protonated at their basic secondary amine groups. The
oxidation products of the formaldehyde derivatives were identified as side products. The
authors concluded that the combination of LC and mass spectrometry offered
considerably high selectivity in comparison to the conventional detection approaches.
We extended and applied the protocols of Karst et al. and Mallet et al. in
developing methodology for analyzing small aliphatic and unsaturated aldehydes of
biological importance, especially in AD etiology. In contrast to other biogenic aldehyde
studies, dimethyl CHD was our derivative of choice due to improved chromatographic
quality. A range of aliphatic aldehydes were studied (C1-C6), along with acrolein and
HNE. Furthermore, two internal standards were employed (heptanal and octanal) to
accurately quantify low and high abundance aldehydes. Influence of several instrument
parameters on the quality of mass spectral data was explored and a description of how
their values were optimized is provided. We detail the development of sensitive, selective
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and dependable methods for the detection and quantification of biogenic aldehydes in
tissues by LC-ESI-MS/MS.

Experimental

Materials

All aliphatic aldehydes except methanal (Sigma, St. Louis, MO) and ethanal (EM
Industries, Inc., Hawthorne NY) were obtained from Wako Pure Chemical Industries,
Ltd. (Osaka, Japan). HNE was obtained from Cayman Chemical Co. (Ann Arbor, MI).
Acrolein, 1,3-cyclohexanedione (CHD), 5-methyl-1,3-cyclohexanedione (methyl CHD)
and 5,5-dimethyl-1,3-cyclohexanedione (dimethyl CHD) came from Aldrich (St. Louis,
MO). HPLC grade water, acetonitrile (ACN), methanol, glacial acetic acid, PrepSep C18
solid phase extraction (SPE) cartridges and a PrepSep 12-port vacuum manifold were
obtained from Fisher Scientific (Pittsburgh, PA). Ammonium acetate came from Sigma
(St. Louis, MO). Standard solutions to generate calibration curve data for aldehyde
quantification were prepared with Wiretrol disposable micro pipets from VWR Scientific
Products (St. Paul, MN).

Brain Tissue

Specimens of the superior and middle temporal gyrus (SMTG) from one AD
patient and one age-matched control subject were obtained from short post mortem
interval (PMI) autopsies, immediately frozen in liquid nitrogen and subsequently stored
at -80oC until used for analysis (blind experiment, performed in triplicate).

Derivatization of Aldehydes

Aldehyde derivatization was carried out using the procedure of Lovell et al. (62)
Figure 1.2.1. Several dimedone derivatives were explored. Similar schemes were used to
derivatize standard aldehyde solutions and human brain samples. Derivatized standard
aldehyde mixtures were employed in generating calibration curves for quantitative
analysis.
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Figure 1.2.1. Aldehyde derivatization. The reaction proceeded by cyclization of 2 βdicarbonyl compounds and an aldehyde in the presence of ammonia to form a
heterocyclic system (110).
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Derivatizing Agent
Aldehydes were derivatized by heating them with appropriate amounts of a stock
dimethyl CHD derivatizing agent solution, as described below. This solution was
prepared by combining 10 g ammonium acetate, 10 mL glacial acetic acid, 0.25 g
dimethyl CHD and diluting to 100 mL with water. (62) CHD and methyl CHD
derivatizing solutions were prepared in a similar fashion.

Standard Aldehyde Derivatives for Quantitative Analysis
For the aliphatic aldehydes (C1-C6), a standardized aldehyde solution mixture was
prepared by adding precalculated, weighed amounts of stock aliphatic aldehydes (C1-C6)
to a class A volumetric flask and diluting with methanol. A separate solution of heptanal
internal standard was prepared in a similar manner. A set of standardized solutions with
increasing concentration of aldehydes (~1x10-9 g/mL to ~3x10-7 g/mL) was prepared in
volumetric glassware by adding suitable amounts of the aliphatic aldehyde mixture, an
excess of derivatizing agent, a fixed amount of internal standard and diluting to the mark
with methanol. The aldehyde solutions, upon derivatization, were calculated to provide 1
pg/µL to 300 pg/µL. The standardized solutions were incubated in a 60oC water bath for
1 h and subsequently desalted with C18 SPE cartridges. The derivatized aldehydes were
then eluted with 2 mL methanol (Figure 1.2.2).
For the unsaturated aldehydes (acrolein and HNE), standardized solutions of
acrolein and HNE were prepared in a similar manner as described above for the aliphatic
species. The internal standard employed here was octanal (Figure 1.2.2).
Brain Tissue
For aldehyde analysis, 100 mg of tissue sample was homogenized using 5 mL
HEPES buffer (pH 7.4) with 137 mM NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM
MgSO4, pepstatin (0.7 μg/mL), leupeptin (0.5 μg/mL), aprotinin (0.5 μg/mL) and
phenylmethylsulfonyl fluoride (40 μg/mL). Next, 500 μL aliquots of homogenate were
added to glass test tubes, followed by appropriate volumes of standardized internal
standard solution (in methanol). Heptanal was chosen as the internal standard for the
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Figure 1.2.2. Biogenic aldehyde derivatives investigated. Aldehydes derivatized included
(1) methanal, (2) ethanal, (3) propanal, (4) butanal, (5) pentanal, (6) hexanal, (7) heptanal
(internal standard for aliphatic aldehydes), (8) octanal (internal standard for unsaturated
aldehydes), (9) acrolein and (10) HNE.
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aliphatic and octanal for the unsaturated aldehydes. Octanal internal standard was added
at a 10-fold lower concentration compared to heptanal so that solvent concentration of the
final derivatized brain sample by 10 enabled accurate quantification of low abundance
unsaturated aldehydes. A review of the literature on aldehyde quantification in the brain
indicates that this is adequate for acrolein and HNE analysis (49, 50, 62). Samples were
vortexed for 30 sec for aldehyde extraction and centrifuged (850 x g for 10 min). A 500
μL aliquot of supernatant was then mixed with 1 mL of dimethyl CHD derivatizing

reagent and heated in a 60oC water bath for one hour. After cooling to room temperature,
the reaction mixture was added to preconditioned C18 SPE columns, which were then
washed with water to remove excess ammonium acetate. Derivatized aldehydes were
eluted with methanol (62).

Construction of a C18 HPLC Column

Fused silica tubing (Polymicro Technologies) with an internal diameter of 320 μm
and an outer diameter of 440 μm was used to create the HPLC column. All other column
constructing supplies came from Upchurch Scientific. Column length (containing packing
material) was 15 cm. The base of the column was prepared from an assembly of a zero
dead volume (ZDV) union, 2 μm stainless steel frit, poly ether ether ketone (PEEK)
sleeve, ferrule and nut. The column was packed with Macrosphere C18 material with a
300 Å pore size and 5 μm particle diameter (Alltech Associates, Inc.). A 10 mg/ml
solution of this packing material was prepared in a solvent solution of 90% ACN and
10% water. Prior to column packing, the solution slurry was sonicated and thoroughly
stirred to assure homogeneity. The column was packed in-house under helium gas
pressure (1000 psi) using a specially designed stainless steel reservoir, also known as a
column bomb (Figure 1.2.3).

Instrumentation

A Hewlett Packard LC system (1100 series) with a home-made C18 reversed
phase capillary LC column was employed in the separation of aldehyde derivatives for
quantitative analysis. A mobile phase mixture of water and ACN, each containing 0.1%
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1000 psi
helium gas
2 μm
frit

Fused silica capillary

Figure 1.2.3. LC column packing scheme. A 15 cm length reversed-phase column was
packed with 5 μm (300 Å) macrosphere C18 particles.
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formic acid, was used in all experiments. The acid assisted in enhancing chromatographic
peak shape and provided a source of protons in reversed-phase LC/MS. The binary pump
of the HPLC offered gradient generation by high-pressure mixing. Programmed gradient
elution was utilized in these experiments to enhance the separation of analytes. Each
experiment, lasting one hour, was begun with a large excess of the weak eluting solvent
water in the mobile phase, followed by steady additions of increasing proportions of the
strong eluting solvent acetonitrile (ACN) during the course of the separation. For the first
2 minutes of a given run, the mobile phase composition was kept at 5% ACN. In the next
8 minutes, the proportion of ACN was linearly increased to 20%. Another linear increase
in percent ACN occurred for 20 more minutes to reach a concentration of 70%. In the
following 20 minutes, the percent ACN was linearly changed to 90%. During the last 5
minutes of the run, ACN content rose, once again linearly, to a maximum concentration
of 95%. The column was restored to starting mobile phase conditions prior to beginning
the next run (Figure 1.2.4).
LC solvent flow rate was maintained at 4 μL/min throughout the course of each
chromatographic experiment using a laboratory constructed 50 to 1 splitter between the
pump and injector. Manual injections were performed with a six-port Rheodyne injection
valve (model # 7725i) equipped with a 5 μL sample loop.
A Finnigan LCQ Classic quadrupole ion trap mass spectrometer was interfaced to
the LC system for reversed phase LC-MS/MS analyses (Figure 1.2.5). Samples with
derivatized aldehydes were introduced into the LCQ following LC separation or by direct
infusion in which case no chromatographic separation was achieved. The electrospray
source was operated in positive ion mode. Desolvated ions migrated from the source into
the ion trap, guided by several electrostatic focusing elements, including octopole lenses.
Ions in the ion trap were subjected to mass analysis, sequentially ejected and detected by
an electron multiplier.

Tuning LCQ Parameters
Dimethyl CHD heptanal was infused into the LCQ mass spectrometer and
instrument parameters, such as lens offsets, capillary voltages, etc., were tuned for this
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compound to improve the quality of LC-MS/MS data obtained for aldehyde derivatives.
Electrospray source parameters were tuned to the following values: 4 kV applied voltage,
20 arbitrary units of sheath gas flow, 45 V inlet capillary voltage and 175oC inlet
capillary temperature. Other mass spectrometric parameters were as follows: 37 V tube
lens offset, -5 V multipole 1 offset, -9 V multipole 2 offset, 430 Vp-p multipole rf
amplitude, -15 V lens voltage and -10 V trap dc offset. Similar values were assumed for
the other derivatives.

Results and Discussion

Initial experiments were performed to determine retention times for the aldehyde
derivatives. In data-dependent scanning, the instrument acquires a full scan mass
spectrum, evaluates the relative intensities of ions in a given mass range, then isolates the
ion with the highest intensity for fragmentation and analysis (MS/MS mode). Masses
utilized as precursors for MS/MS experiments are placed on an exclusion list and are not
sampled again for a pre-selected time window. CHD, methyl CHD and dimethyl CHD
derivatives of standard aldehyde solutions and several brain tissue samples with
derivatized aldehydes (SMTG), were analyzed in this manner. Apart from its simplicity
and compatibility with LC-MS/MS analyses, the Hantzsch reaction offers a high
efficiency (above 90%), which was well suited for these studies (100).
After determining the retention times for each derivatized aldehyde peak, method
files for segmented analysis were constructed to perform MS/MS analysis on the
aldehyde derivatives. In segmented analysis, acquisition time is divided into segments for
exclusive MS/MS analysis of particular analytes. This offers a dramatically improved
signal-to-noise ratio and the isolation of the desired species in this manner for exclusive
MS/MS analysis is a means of ion purification. When a species is isolated for segmented
analysis, several parameters must be considered and enhanced for spectral data
improvement. It is also desired to obtain as much of the product ions as possible without
completely obliterating the parent species. Therefore, upon establishing the timewindows for segmented analysis of the aldehyde derivatives through data-dependent
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studies, other parameters such as percent normalized collision energy (percent NCE or
percent CID) and CID time were explored to improve the data from such experiments.
This, in conjunction with tuning the ion trap as described in the Experimental section,
enabled improved LC/MS analysis of aldehyde derivatives.
As was discussed in Chapter 1.1, the resonance excitation process is used to
induce fragmentation in an ion trap. Upon increasing the amplitude of the applied
supplemental rf voltage, the precursor ion dissociates to fragments over a narrow energy
range. The collision energy needed to achieve optimum fragmentation has a mass
dependency, which is compensated by the LCQ as normalized collision energy. In other
words, CID is the amplitude of the resonance excitation rf voltage scaled to the precursor
mass as follows: rf amplitude = (%CID/30%)(precursor ion mass × tick amp slope + tick
amp intercept). The tick amp slope and tick amp intercept are instrument-specific values.
CID time is the time during which the resonant rf signal is applied to the end-cap
electrodes for ion excitation. The rf voltage causes increased ion motion between the endcaps, leading to fragmentation by increased collisions with helium gas. Infusion studies
measuring ion intensity as a function of percent CID and CID time were performed to
determine suitable conditions for segmented analysis of aldehyde derivatives.
Aldehyde derivative solutions (nanograms per microliter) were infused into the
LCQ at a rate of 3 μl/min. Percent CID and CID time were separately ramped in
increments of 5% from 0 to 100% while acquiring data on precursor and product ion
intensities. Each data point represents an average of approximately thirty mass spectral
scans. A plot of precursor and product ion intensities as a function of percent CID and
CID time revealed the values of these parameters at which most of the precursor was
converted into products. For the ion intensity versus percent CID plot of dimethyl CHD
heptanal (Figure 1.2.6), conversion of precursor to products at higher collision energies
was about 80%. A similar situation was observed when varying ion intensity with CID
time for this species (Figure 1.2.7). At 38% CID and 30 ms CID time, most (>95%) of
the precursor ion current was converted into products, with a little precursor species
remaining intact. Indeed, all the aliphatic aldehydes provided similar responses.
In the case of ion intensity versus percent CID for dimethyl CHD acrolein,
approximately 50% of precursor ion current was converted to products (Figure 1.2.8)
63

8.0E+06
7.0E+06

Ion intensity

6.0E+06

Precursor (m/z 358)
Product (m/z 203)

5.0E+06

Product (m/z 272)

4.0E+06

Product (m/z 273)
Product (m/z 274)

3.0E+06

Product (m/z 275)

2.0E+06
Sum (products)

1.0E+06

Product (m/z 340)

0.0E+00
0

10

20

30

40

50

60

70

80

CID (%)

Figure 1.2.6. Ion intensity versus percent CID curve for dimethyl CHD heptanal. Data
represents a single infusion experiment. Each data point is an average of thirty mass
spectral scans.
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Figure 1.2.8. Ion intensity versus percent CID curve for dimethyl CHD acrolein. Data
represents a single infusion experiment. Each data point is an average of approximately
thirty mass spectral scans.
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while in the case of the HNE derivative, only a third of the precursor ion current resulted
in product formation (Figure 1.2.9). It is possible that some major products are below the
low-mass cutoff of the ion trap and are therefore not detected.
All aldehyde derivatives required similar percent CID (~38%) and CID times
(~30 msec) for LC/MS analysis. Using the optimized parameters for aldehyde derivatives
in the mass spectrometric methods resulted in >95% reduction in precursor ion counts
and subsequent conversion to products.

Data from Segmented Analysis

Segmented MS/MS analysis of aldehyde derivatives worked very well with LC
gradient elution. The binary mobile phase system of water and acetonitrile generated
well-resolved chromatograms for all the analytes. Gradient elution is particularly useful
when the mixture of solutes to be analyzed has a wide range of capacity factors (ratio of
analyte masses in the stationary phase and mobile phase). This was the case in the
analytes described here, as the larger aldehyde derivatives were more hydrophobic and
had greater retention times compared to their smaller counterparts. Starting mobile phase
composition for every LC run was 5% ACN. It is important to start the gradient with
some organic content in the mobile phase, especially for C18 columns, where the very
long, very hydrophobic alkyl chains can mat down on the silica particle in an effort to get
away from the high aqueous environment. When the alkyl chains mat down in this
manner, they are unable to efficiently capture the target analyte, reducing the overall
efficiency of the separation.
CHD, methyl CHD and dimethyl CHD aldehydes were studied using segmented
analysis. The dimethyl CHD derivatized aldehydes offered the best data in terms of
chromatographic peak quality. A possible explanation for this observation is that the
greater hydrophobic nature of the dimethyl CHD derivatives promoted increased
chromatographic focusing at the head of the column, thereby reducing peak width and
improving the overall separation process. As such, this derivative was used exclusively
for all further experiments.
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Figure 1.2.9. Ion intensity versus percent CID curve for dimethyl CHD HNE. Data
represents a single infusion experiment. Each data point is an average of approximately
thirty mass spectral scans.
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Chromatographic Data
The aliphatic aldehyde derivatives displayed increasing retention times with
increasing mass of aldehyde derivative (Figure 1.2.10) in good agreement with the rise in
hydrophobicity associated with greater mass. Reconstructed ion chromatograms for
dimethyl CHD methanal to dimethyl CHD heptanal formed a stair-step of peaks. For the
unsaturated aldehydes, dimethyl CHD acrolein had a shorter retention time than dimethyl
CHD HNE, as was expected due to the increased mass of the latter (Figure 1.2.11).
Indeed, the acrolein and propanal derivatives showed similar retention times, in
agreement with their similar masses. Keeping with this hydrophobicity trend, the internal
standard for unsaturated aldehydes, dimethyl CHD octanal, had the longest retention time
of all. The R group (Figure 1.2.2) of dimethyl CHD HNE has a hydrophilic –OH group at
the γ position from the dimedone ring which reduces its hydrophobicity compared to
aliphatic derivatives of similar size. So, this species has a shorter retention time than
dimethyl CHD heptanal, which has a 6-carbon chain and no hydroxyl moiety.

Mass Spectrometric Data
The aliphatic aldehyde derivatives fragmented in a characteristic pattern to
produce a base peak of either m/z 273 or 274, depending on the size of the R group
derived from the precursor aldehyde. The MS/MS spectra of aliphatic aldehyde
derivatives is shown in Figure 1.2.12. For smaller aldehyde derivatives (C1-C4), the
appearance of m/z 273 was consistent with a simple C-C bond dissociation between the
dimedone group and the R group, followed by neutral loss of a saturated R radical. For
larger aldehyde derivatives (C5-C8), a hydrogen rearrangement followed by cleavage of
the (R-H) group became more feasible. For these derivatives, the C-H bond dissociation
energies of 2o carbon atoms in the R group were sufficiently low enough for a base peak
of m/z 274 to be generated as a result of the loss of an unsaturated (R-H) species (137).
For all the derivatives, the major bond cleavage was between the R group derived from
the original aldehyde and the heterocyclic ring from the derivatizing agent, with the latter
retaining the charge at the nitrogen atom. Dimethyl CHD acrolein fragmented to produce
a base peak at m/z 272, which appeared to be the loss of ethylene from the precursor
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Figure 1.2.10. Segmented chromatograms of dimethyl CHD aliphatic aldehydes.
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Figure 1.2.11. Segmented chromatograms of dimethyl CHD unsaturated aldehydes.

71

100

272.3

dimethyl CHD methanal
203.1

0

200

100

274.3

216.1 217.1

205

210

215

228.9

220

230

225

254.2

244.0
235

240

245

250

255

230.4
231.4
228.4

217.1

260

265

244.6

280

275

289.2

274.3 285.7

270.5

254.2

270

286.3
288.2

272.5

dimethyl CHD ethanal
203.2

275.3

258.5

0
200 205 210 215 220 225 230 235 240 245 250 255 260 265 270 275 280 285 290 295 300

100

273.2

dimethyl CHD propanal
203.2

0
200

Relative Abundance

100

210

220

240

250

210

220

230

240

250

260

270

280

273.2
274.3
272.3
275.3 286.3

260

270

280

290.4

302.2
300.3
303.9

290

300

310

316.2
298.2 301.8 314.3 317.1

290

300

310

320

274.3

dimethyl CHD pentanal

0
200

272.3

228.2
210

220

230

240

250

260

230

220

230

290

275.3 286.4

240

250

260

300

310

328.2
320

330

340

240

270

280

290

300.3
300

313.1 316.2 326.5 342.5
310

320

330

340

344.2
350

274.3
273.2

244.5 256.3 259.5

210

280

299.0 302.6 312.2

274.3
273.2

dimethyl CHD heptanal
(internal standard)

0
200

270

220.6 230.8 238.9 243.2 256.0
220

330.2

275.3
282.3

256.3

dimethyl CHD hexanal

203.1
0
200
210

100

230

256.4

203.3

100

272.3
274.2
256.3 260.4 267.9
284.3

244.2

228.3

dimethyl CHD butanal

0
200

100

216.3

250

260

270

275.3

286.9 294.8 303.4 315.7

280

290

300

310

320

m/z

Figure 1.2.12. MS/MS spectra of dimethyl CHD aliphatic aldehydes.
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species. In the case of dimethyl CHD HNE, the base peak was at m/z 339 but a
significant peak was also observed at m/z 382 (Figure 1.2.13). It is probable that m/z 382
was produced from the loss of water with a subsequent loss of 43 amu (equivalent in
mass to a propyl radical) resulting in the formation of the m/z 339 species. Mass
spectrometric data for all aldehyde derivatives is summarized in Table 1.2.1. Mechanistic
studies would be required to confirm fragmentation pathways.

Construction of Calibration Plots

Prior to proceeding with quantitative analysis, standard dimethyl CHD heptanal
solutions of increasing concentrations were analyzed by segmented LC-MS/MS to
determine the linearity of a plot of area counts versus concentration. Each solution was
analyzed in triplicate to obtain standard deviation data. Figure 1.2.14 demonstrates that
the plot was linear and so the heptanal derivative was a good choice for an internal
standard in these experiments. Additionally, neither heptanal nor octanal are present in
brain tissues to any significant concentrations, minimizing concerns regarding
contributions of these aldehydes to internal standard peak areas (62). Due to similarity in
structure, the octanal derivative produced a similar response.
For each of the standardized solutions of increasing concentration prepared for
aliphatic and unsaturated aldehyde derivatives, segmented analysis was performed in
triplicate. The area counts of aldehyde derivative ‘X’ was divided by the area counts of
internal standard to obtain the relative response factor (RRF) of aldehyde derivative ‘X’
with respect to its internal standard. Calibration plots were constructed by plotting the
RRF of each aldehyde derivative versus the number of picograms on column delivered in
each LC-MS/MS experiment. A review of the literature indicated that the lowest
concentration of biogenic aldehydes in human brain is on the order of 0.02 nmol/mg
protein (49, 75). Such levels were well-represented in the calibration plots presented here.
For acrolein, 0.02 nmol/mg protein delivered ~15 pg on column. The calibration plot for
this aldehyde derivative had one data point below this value.
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Figure 1.2.13. MS/MS spectra of dimethyl CHD unsaturated aldehydes.
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Table 1.2.1. Mass spectrometric data of dimethyl CHD aldehyde derivatives.

Aldehyde

MW

Parent
Molecular Ion
of Derivative

Product Ion
from Frag.

Methanal

30

[M+H]+ = 274

m/z = 273

--

--

Ethanal

44

[M+H]+ = 288

m/z = 273

CH3

MW = 15

Propanal

58

[M+H]+ = 302

m/z = 273

C2H5

MW = 29

Butanal

72

[M+H]+ = 316

m/z = 273

C3H7

MW = 43

Pentanal

86

[M+H]+ = 330

m/z = 274

C4H8

MW = 56

Hexanal

100

[M+H]+ = 344

m/z = 274

C5H10

MW = 70

Heptanal

114

[M+H]+ = 358

m/z = 274

C6H12

MW = 84

Octanal

128

[M+H]+ = 372

m/z = 274

C7H14

MW = 98

Acrolein

56

[M+H]+ = 300

m/z = 272

C2H4

MW = 28

HNE

156

[M+H]+ = 400

m/z = 382, 339

H2O, C3H7

MW = 18, 43
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Figure 1.2.14. Average area counts versus concentration plot for dimethyl CHD heptanal.
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The aliphatic aldehyde derivatives produced linear calibration plots with r2 values
≥ 0.99 and relative standard deviations (RSD) of approximately ≤ 5% (Figures 1.2.15 to

1.2.20). The RRF values for these derivatives were comparable, with a slight trend
towards lower RRFs with increasing aldehyde derivative mass, in agreement with their
similarities in structure. The ethanal derivative showed a somewhat higher response
factor compared to the others. The greatest RRFs would probably have been expected of
the methanal derivative, which has the smallest mass. It should be noted, however, that
methanal, which is a 37% stock solution, can exist in the form of other species, such as
paraformaldehyde, which may not derivatize efficiently through the Hantzsch reaction or
perhaps form different derivatives. This was evidenced by the observation of several
‘extraneous’ peaks at earlier retention times in the reconstructed ion chromatogram for
dimethyl CHD methanal. As such, it may be that a somewhat lower proportion of the
methanal (compared to the calculated value) is actually partaking in the derivatization
process to form the desired heterocyclic derivative. In other words, if the stock methanal
solution was indeed 37% ‘pure methanal’, then this derivative would probably have
produced the highest RRF values compared to the other aliphatic aldehyde derivatives.
Calibration plots for unsaturated aldehyde derivatives were linear and with r2 and
RSD values comparable to their aliphatic counterparts (Figures 1.2.21 and 1.2.22). The
HNE derivative had a much lower RRF than the acrolein derivative, in agreement with
data from infusion studies (Figures 1.2.8 and 1.2.9). It should be noted that the area
counts versus percent CID infusion experiment for dimethyl CHD HNE generated
product ion curves at much lower intensity values (about a third of the initial ion intensity
of the precursor species at low percent CID) compared to the acrolein derivative. Data
from calibration plots for all the aldehyde derivatives are given in Table 1.2.2.
These calibration plots can be employed in the analysis of real tissue that has been
subjected to oxidative stress for aldehyde content determination. As an example of how
this methodology may be applied towards this purpose, brain samples (SMTG) from an
AD subject and a suitable age-matched control (blind experiment) were analyzed in
triplicate as described above. Data from these findings are summarized in Table 1.2.3.

77

RRF of Dimethyl CHD Methanal

8.00

RSD:
11.3 pg:
113 pg:
226 pg:
564 pg:
1128 pg:
1804 pg:

7.00
6.00
5.00
4.00
3.00

3.72 %
3.10 %
3.06 %
2.67%
2.68 %
1.67 %
2

R = 0.997

2.00
1.00
0.00
0

200

400

600

800

1000

1200

pg on column

Figure 1.2.15. Calibration plot for dimethyl CHD methanal.

78

1400

1600

1800

2000

RRF of Dimethyl CHD Ethanal

7.00
RSD:
8.5 pg: 5.27
67 pg: 4.74
167 pg: 3.70
334 pg: 1.85
501 pg: 2.51
835 pg: 2.85
1169 pg: 2.87

6.00
5.00
4.00
3.00

%
%
%
%
%
%
%
R2 = 0.999

2.00
1.00
0.00
0

200

400

600
pg on column

Figure 1.2.16. Calibration plot for dimethyl CHD ethanal.
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Figure 1.2.17. Calibration plot for dimethyl CHD propanal.
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Figure 1.2.18. Calibration plot for dimethyl CHD butanal.

81

1000

1200

1400

RRF of Dimethyl CHD Pentanal

4.50
4.00
3.50
3.00
2.50
2.00

RSD:
6.5 pg:
65 pg:
122 pg:
306 pg:
612 pg:
979 pg:
1224 pg:

5.82
5.35
3.68
3.11
2.66
1.72
2.94

%
%
%
%
%
%
%

1.50
R2 = 0.996

1.00
0.50
0.00
-0.50 0

200

400

600

800

pg on column

Figure 1.2.19. Calibration plot for dimethyl CHD pentanal.
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Figure 1.2.20. Calibration plot for dimethyl CHD hexanal.
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Figure 1.2.21. Calibration plot for dimethyl CHD acrolein.
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Figure 1.2.22. Calibration plot for dimethyl CHD HNE.
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Table 1.2.2. Calibration plot data for dimethyl CHD aldehydes.
Aldehyde

methanal

r2

0.997

ethanal

0.999

propanal

0.995

butanal

0.996

pentanal

0.996

hexanal

0.996

pg on col.
ald. deriv.

RRF*

RSD**

11.3
113
226
564
1128
1804

0.65
1.40
1.85
2.94
5.03
7.41

3.72 %
3.10 %
3.06 %
2.67 %
2.68 %
1.67 %

8.5
67
167
334
501
835
1169
7.1
57
143
286
429
716
1002
5.9
59
118
294
588
940
1175
6.1
61
122
306
612
979
1224
6.5
65
129
323
646
1033
1292

0.31
0.76
1.24
2.03
2.87
4.48
6.23
0.28
0.47
0.92
1.36
1.74
2.63
3.50
0.05
0.12
0.25
0.91
1.80
2.89
3.95
0.06
0.13
0.21
0.94
1.73
3.13
3.72
0.02
0.12
0.18
0.76
1.67
2.98
3.82

5.27 %
4.74 %
3.70 %
1.85 %
2.51 %
2.85 %
2.87 %
5.31 %
5.93 %
4.35 %
2.87 %
2.70 %
2.95 %
2.90 %
4.71 %
3.36 %
1.00 %
3.41 %
2.88 %
2.13 %
2.01 %
5.82 %
5.35 %
3.68 %
3.11 %
2.66 %
1.72 %
2.94 %
4.77 %
4.83 %
4.56 %
3.33 %
0.94 %
2.94 %
1.97 %

*Relative Response Factor

Aldehyde

r2

acrolein

0.999

HNE

0.996

pg on col.
ald. deriv.

RRF*

RSD**

6.5
52
130
259
389
648
907
6.4
51
128
256
384
639
895

0.19
0.29
0.61
1.06
1.46
2.22
3.10
0.01
0.03
0.05
0.08
0.09
0.16
0.22

5.29 %
5.92 %
4.87 %
4.80 %
3.74 %
4.84 %
2.33 %
5.79 %
5.39 %
4.56 %
3.56 %
3.42 %
3.90 %
3.46 %

**Relative Standard Deviation
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Table 1.2.3. Comparison of aldehyde concentrations in the brains (superior and middle
temporal gyrus or SMTG) of AD versus control subjects.

Aldehyde

Subject with AD
(nmol/mg protein)
Mean ± SEM

Age-Matched Control
(nmol/mg protein)
Mean ± SEM

methanal

133 ± 20

290 ± 39

ethanal

173 ± 21

175 ± 27

propanal

84.9 ± 14.5

91.0 ± 14.7

butanal

6.29 ± 1.09

8.42 ± 0.93

pentanal

9.99 ± 1.56

11.4 ± 2.0

hexanal

56.9 ± 5.7

13.8 ± 1.7

acrolein

1.45 ± 0.21

0.475 ± 0.077

HNE

0.550 ± 0.106

0.209 ± 0.039
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Aldehyde content per milligram of protein from the brain tissue was reported as the mean
value ± SEM (standard error of the mean). The AD sample showed similar levels of most
aliphatic aldehydes and higher levels of unsaturated aldehydes, compared to the control.
It is worth pointing out that AD development has been related to increased production of
unsaturated aldehydes, in agreement with these findings (49, 50, 62, 68). The results
indicated that the protocol outlined here can be effectively applied in aldehyde
quantification in real tissues. Investigations on a larger set of tissues from various regions
of the brain and from individuals presenting different levels of AD histopathology will
provide an understanding on patterns of aldehyde generation in AD versus control
subjects.

Conclusions

These studies aimed to develop sensitive, selective and reliable methods to
analyze aldehydes in tissues using LC-MS/MS. It was shown that aldehydes typically
found in brain tissues plagued by oxidative stress can be derivatized through the
Hantzsch reaction to form cyclohexanedione (dimedone) derivatives, which can easily be
quantified by MS. CHD, methyl CHD and dimethyl CHD derivatives were explored and
it was determined that the dimethyl CHD derivatives provided the best LC/MS data.
These compounds offered better peak quality due to their increased hydrophobicity,
which resulted in greater chromatographic focusing of the sample at the head of the
column. Analyte derivatization coupled with LC-MS/MS provided increased selectivity
over established fluorescence methods (62, 98-101) for the analysis of low abundance
biogenic aldehydes. Unsaturated aldehydes occur in the brain at much lower
concentrations than their aliphatic counterparts and LC-MS/MS proved to be an ideal
method for analyzing these two classes of compounds using two internal standards
differing in concentration by an order of magnitude.
The developed method was applied to the analysis of samples of human brain
(SMTG) from an AD patient and an age-matched control subject. In comparison to the
control sample, the tissue obtained from the AD subject displayed similar concentrations
of most aliphatic aldehydes, however, substantially elevated levels of acrolein and HNE
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were detected. These results confirm that the protocol described here can be reliably
applied in the quantification of aldehydes in brain tissue. Concentration variations of
aliphatic and unsaturated aldehydes have been investigated using the methodology
outlined here by exploring a larger data set of AD and control subjects, as well as by
investigating several different regions of the brain, based on the level of AD pathology.
The findings from this study are detailed in Chapter 1.3.
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Chapter 1.3
Application of LC-MS Techniques to the Quantification of Biogenic Aldehydes in
vivo in Alzheimer’s Disease Brain

Introduction

Several different types of neurodegenerative conditions, such as AD, Parkinson’s
disease and Huntington’s disease, are associated in etiology by the significant prevalence
of lipid peroxidation (LPO) products in the brain (50). The importance of biogenic
aldehydes in LPO and therefore neurodegenerative disease etiology has been well
established by mounting evidence of neuronal damage that they initiate. These
compounds could potentially serve as important biomarkers for AD and as such, a
detailed study of their occurrence and quantification would be worthwhile. Of the
different aldehyde derivatization techniques available for quantitative analysis, the
Hantzsch reaction is well-suited by virtue of its simplicity and efficiency. Quantification
is achieved with a suitable internal standard, using a variety of detection methods, as
detailed in Chapters 1.1 and 1.2. Several reports have described the quantitative analysis
of saturated and unsaturated biogenic aldehydes using this derivatization technique.
Lovell et al. (62) analyzed aldehydic markers of lipid peroxidation in biological
specimens by high-pressure liquid chromatography. Biogenic straight-chain aldehydes
and HNE were first derivatized through the Hantzsch reaction so as to make them
amenable to fluorescence detection. The authors showed aldehydic products to be wellseparated and minimum detection limits achieved for HNE were approximately 0.1 pmol.
Shot to shot reproducibility of standard HNE solutions was about 3-5%, with a signal to
noise ratio of the order of 50. The authors postulated that their results reflected levels of
both free and protein-bound aldehydes. A potential problem associated with this type of
analysis is the co-elution of other compounds with the aldehydes under investigation.
However, the authors maintained that since the derivatization is dependent on the
reaction between the aldehydic group and the β-dicarbonyl compounds, it was unlikely
that other compounds without aldehydic groups would be derivatized.
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Markesbery et al. (50) employed HPLC separation coupled to fluorescence
detection to quantify HNE levels in multiple regions of the AD brain and suitable agematched controls. Biogenic aldehydes in brain samples were chemically modified into
stable, fluorescent, dimedone derivatives through the Hantzsch reaction for facile
detection and quantification. The authors detected statistically significantly elevated
levels of this aldehyde in the amygdala in AD (0.486 ± 0.096 nmol/mg) compared to
controls (0.193 ± 0.062 nmol/mg) (p = 0.008) and in the hippocampus and
parahippocampal gyrus in AD (0.543 ± 0.123 nmol/mg) compared to controls (0.265 ±
0.056 nmol/mg) (p = 0.02). Such areas of the brain typically show the most dramatic
histopathological alterations in AD. The highest mean levels of the aldehyde (AD: 1.490
± 0.376 nmol/mg; control: 1.404 ± 0.363 nmol/mg) were detected in the middle frontal
gyrus. The authors also quantified several aliphatic aldehydes but found no statistical
difference between AD and control subjects. The study demonstrated that HNE may be
an important substance in the pathogenesis of neuron degeneration in AD.
In another report by Markesbery and co-workers (51), elevated HNE levels were
detected and analyzed in the ventricular fluid of AD patients. Using HPLC separation
coupled with fluorescence detection of dimedone derivatives of this aldehyde, free and
protein-bound HNE levels were quantified in AD and control subjects. Free HNE levels
were found to be significantly elevated in the ventricular fluid of individuals with AD
(33.10 ± 8.9 nmol/mg protein), compared to control subjects 13.5 ± 3.8 nmol/mg protein)
(p = 0.0096). The authors also employed dot-blot immunoassay to determine proteinbound HNE and reported that there were no significant differences between AD and agematched controls. The levels of HNE in ventricular fluid observed in this study can
potentially affect a host of molecular systems essential for neuron viability. The authors
concluded that their results indicated increased lipid peroxidation in the AD brain and
suggested a role for HNE in neurodegenerative mechanisms.
Mark et al. (75) explored the influence of HNE in oxidative stress, the disruption
of ion homeostasis and neuronal death brought about by the amyloid β-peptide (Aβ25-35).
To determine whether Aβ induced production of HNE in hippocampal neurons, they
exposed primary hippocampal cell cultures (18-day rat embryos) to 50 μM Aβ for 2 h
and quantified the levels of free HNE in the cells by HPLC analysis with fluorescence
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detection of dimedone derivatives. A 5- to10- fold increase in HNE concentration was
observed as a result of the Aβ exposure, compared to control samples. The concentration
of HNE in these cells was measured at ~4 μM. Western blot analysis of Aβ-exposed
cultured neurons treated with physiologically dangerous HNE concentrations revealed
increased HNE immunoreactivity in proteins, compared to controls. Since HNE had
previously been established to be neurotoxic at physiologically relevant concentrations of
1-100 μM, the authors concluded that this aldehyde mediated Aβ-induced oxidative
damage and eventual neuronal apoptosis.
Compared to HNE, there have been considerably fewer reports on the
quantification and analysis of acrolein in association with neurodegenerative diseases. In
a noteworthy study by Lovell et al. (49), this aldehyde was quantified in AD brain tissue
and its effect on primary hippocampal cultures was investigated. As with other studies
described earlier, aldehyde quantification was achieved by HPLC with fluorescence
detection of dimedone derivatives. Increased mean concentrations of extracted acrolein
were detected in all three brain regions studied, in comparison to age-matched controls.
Statistical analysis of the data clearly demonstrated that acrolein was considerably
elevated (p < 0.05) in the AD amygdala (2.5 ± 0.9 nmol/mg protein) compared to controls
(0.3 ± 0.05 nmol/mg protein), and in the AD hippocampus and parahippocampal gyrus
(5.0 ± 1.6 nmol/mg protein), compared to controls (0.7 ± 0.1 nmol/mg protein). Both
these brain regions are characterized by marked pathological alterations in AD. Acrolein
was also seen to be elevated in the AD inferior parietal lobule, although the disparity was
not considered statistically significant. By exposing primary rat hippocampal neurons to
increasing concentrations of acrolein, the authors demonstrated that this aldehyde is toxic
to the cells in a time-and concentration-dependent manner. Indeed, neuronal death was
shown to be brought about much more aggressively by acrolein exposure, compared to
HNE exposure.
A thorough, quantitative study of biogenic aldehydes in different regions of the
brain at different stages of AD would provide insight into patterns of aldehyde generation
in the course of AD etiology. While there have been studies of HNE and acrolein in latestage AD, there have been few studies of oxidative stress in the brain in subjects with
mild cognitive impairment (MCI) or early AD (EAD). Mild cognitive impairment is
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generally characterized by mild memory disturbances and is considered to be a transition
between normal aging and AD (138-140). To determine if increased lipid peroxidation
and generation of HNE and acrolein are associated with MCI and EAD, we measured
levels of these neurotoxic aldehydic by-products in the hippocampus/parahippocampal
gyrus (HPG), superior and middle temporal gyrus (SMTG) and cerebellum of MCI, EAD
and age-matched control subjects. The methodology used in these investigations,
described in Chapter 1.2, exploited the Hantzsch reaction to synthesize derivatized
aldehyde mixtures for constructing appropriate calibration curves to quantify each
aldehyde of interest (111). Since both aliphatic and unsaturated aldehydes are generated
during lipid peroxidation, we described the analysis of both types of compounds with this
approach. Interpretation of quantitative data from the different brain regions is provided
and an explanation of their statistical significance is given. This is the first study to report
an in-depth comparison of aldehyde levels between these three types of individuals. For
the development of diagnostic tests and medication for AD, a thorough appreciation of
the pathological and biochemical differences between MCI, EAD and normal subjects is
becoming critical. In agreement with previous findings, we detected no statistical
significance in the distribution of aliphatic aldehydes in the different brain regions and
stages of AD under investigation. However, in agreement with earlier studies, the results
presented here clearly show that HNE and acrolein are statistically significantly elevated
in both MCI and EAD brain and suggest that oxidative damage occurs early in the
pathogenesis of AD.

Experimental

Tissue Specimens

Specimens of HPG, SMTG and CER were obtained from short post mortem
interval (PMI) autopsies of 7 subjects with MCI (3M, 4F), 6 subjects with EAD (3M, 3F),
and 7 age-matched control subjects (5M, 2F). Specimens were immediately frozen in
liquid nitrogen and stored at -80ºC until used for analysis. Control subjects were followed
longitudinally in the control clinic of the University of Kentucky Alzheimer’s Disease
Center (UK-ADC) and had neuropsychologic testing annually and physical examinations
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biannually. All control subjects had neuropsychologic scores in the normal range and
showed no evidence of memory decline. Subjects with MCI and EAD were derived from
the control cohort and were followed longitudinally in the memory disorders clinic of the
UK-ADC.
The clinical criteria for diagnosis of amnestic MCI were those of Peterson et al.
(139) and included: (a) memory complaints, (b) expected memory impairment for age
and education, (c) normal general cognitive function, (d) intact activities of daily living
(ADLs), and (e) the subject did not meet criteria for dementia. The clinical criteria for
EAD were: (a) a decline in cognitive function from a previous higher level, (b) declines
in one or more areas of cognition in addition to memory, (c) a clinical dementia rating
score of 0.5 to 1 and (d) a clinical examination that excluded other causes of dementia.
Objective memory test impairment was based on a score of ≤ 1.5 standard deviations
from the mean of controls on the Consortium to Establish a Registry for Alzheimer’s
Disease (CERAD) Word List Learning Task (141). In several cases, the data were
corroborated with the Free and Cued Selective Reminding Test (FCSRT). CERAD was
established in 1986 by a grant from the National Institute of Aging (NIA) to standardize
procedures for the evaluation and diagnosis of patients with AD. The CERAD test battery
includes measures in the areas where impairments associated with AD first occur (verbal
memory, naming) and is highly reliable for assessing memory dysfunction (142). The
FCSRT is also a list-learning test which includes immediate category-cued recall and
provides retrieval practice before the test phase.
Tissue Staining
Histopathologic examination of sections of neocortex, hippocampus, entorhinal
cortex, amydgala, basal ganglia, nucleus basalis of Meynert, midbrain, pons, medulla and
cerebellum were performed by staining with hematoxylin and eosin, the modified
Bielschowsky stain, 10D-5 (for beta amyloid) and α-synuclein.
Hematoxylin and Eosin: This staining method employs two dyes – hematoxylin

and eosin. A hematoxylin-metal complex, dark purple in color, acts as a basic dye and
stains nucleic acids in the nucleus and the cytoplasm dark blue, brown or black. Eosin is
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an acidic aniline dye which imparts a pink color to the more basic proteins within the
cytoplasm and extracellular spaces. (143).
Bielschowsky Stain: This is a silver stain to determine the presence of NFTs,

nerve fibers and SPs in the AD brain. A silver solution is employed to sensitize nerve
fibers. The sections undergo treatment with ammoniacal silver and are then reduced to a
visible metallic silver. Degenerating axons, NFTs and SPs develop a black stain and the
background becomes yellow to brown (144).
10D-5: The 10D5 monoclonal antibody-DAB immunoperoxidase technique

enables the detection of SPs in the AD brain. 10D-5 is an antibody to the Aβ peptide,
which is the key component of SPs (145).
Alpha-Synuclein: This is a normal, unstructured and soluble protein commonly

found in the brain. The function is unknown but it predominantly occurs as presynaptic
neuronal protein and is sometimes detected in glial cells. Alpha-synuclein is a marker for
Lewy bodies, pathologic feature in substantia nigra seen in Parkinson's disease and in
neocortical regions of subjects with mixed Alzheimer's disease and Lewy body
pathology. (146).
All of these staining experiments revealed only age-associated changes in the
brain tissues in control subjects.
Staging of AD Pathology in Subjects
Braak Staging Scheme: The Braak method was employed for staging the severity

of AD pathology in the brain tissues. This method, developed by Braak and Braak (147,
148), makes the assumption that the prevalence and nature of NFTs in the AD brain
develops in a progressive and specific manner in the medial temporal lobe (MTL),
subcortical nuclei and neocortical areas of the brain. A higher Braak score indicates
greater spread of Alzheimer’s pathology in the brain and vice versa. Six stages have been
detailed, with a seventh stage or Stage 0, representing the absence of NFTs in the brain.
The six stages can be collapsed into three stages. Stages I and II are the transentorhinal
stages in which NFT pathology is in effect restricted to the transentorhinal and entorhinal
cortex. Slight pathology may be observed in the CA1/CA2 regions of the hippocampus.
In the limbic stages or Stages III and IV there is acute participation of the entorhinal
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areas, modest pathology in the hippocampus and some expansion into the amygdala,
thalamus, hypothalamus and basal forebrain. Symptoms of AD pathology usually appear
in the neocortical stages or Stages V and VI. At this point, extensive NFT pathology is
seen in the neocortex.
National Institute on Aging (NIA)-Reagan Institute Scheme: The NIA-Reagan

Institute Consensus Conference proposed an AD progression scheme which can be used
to corroborate the Braak scores. This scheme stresses topographic staging of both NFTs
and SPs. It designates cases to categories of high, intermediate or low likelihood that the
dementia is a result of AD (149).
Control subjects in this study showed Braak staging scores of I and II and met the
NIA-Reagan low likelihood criteria for the histopathologic diagnosis of AD. The major
difference between normal controls and MCI patients was a significant increase in
neuritic plaques in neocortical regions and an increase in neurofibrillary tangles in the
amygdala, hippocampus and entorhinal cortex (150). MCI subjects demonstrated Braak
staging scores of III-V and met intermediate likelihood criteria for the histopathologic
diagnosis of AD. EAD subjects showed Braak staging scores of V and met high
likelihood criteria for the histopathologic diagnosis of AD.

Aldehyde Derivatization

Aldehydes were extracted and derivatized with a stock 5,5-dimethyl-1,3cyclohexanedione derivatizing agent solution (0.25 g dimethyl CHD + 10 g ammonium
acetate + 10 mL glacial acetic acid/100 ml water), as previously described (50, 98, 111).
Briefly, 100 mg tissue was homogenized in 5 mL HEPES buffer (pH 7.4) containing 137
mM NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4, and the protease inhibitors
pepstatin (0.7 μg/mL), leupeptin (0.5 μg/mL), aprotinin (0.5 μg/mL) and
phenylmethylsulfonyl fluoride (40 μg/mL) using a chilled Dounce homogenizer.
Heptanal was chosen as the internal standard for the aliphatic and octanal for the
unsaturated aldehydes. Octanal internal standard was added at a 10-fold lower
concentration compared to heptanal so that solvent concentration of the final derivatized
brain sample by 10 enabled accurate quantification of low abundance unsaturated
aldehydes. Aliquots of homogenate (500 µL) were added to glass test tubes and mixed
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with 500 µL of methanol containing 2 μM heptanal and 0.2 µM octanal (Wako Pure
Chemical Industries, Ltd., Osaka, Japan) as internal standards. Samples were vortexed for
30 sec for aldehyde extraction and centrifuged for 10 min at 850 x g. A 500 μL aliquot of
supernatant was mixed with 1 mL of dimethyl CHD derivatizing reagent and heated in a
60oC water bath for one hour. After cooling to room temperature, the reaction mixture
was added to a C18 solid phase extraction (SPE) column (Fisher Scientific, Pittsburgh,
PA) preconditioned with 10 mL methanol and 10 ml water. The column was washed with
2 mL water to remove excess ammonium acetate and derivatized aldehydes were eluted
with 2 mL methanol.
In the interest of quality control, blank, spiked and duplicate analyses were
performed for every brain region under investigation. Dimethyl CHD butanal was used as
the aliphatic and dimethyl CHD acrolein as the unsaturated aldehyde for spiked analysis.
As with the octanal internal standard for unsaturated aldehydes, acrolein was spiked at a
10-fold lower concentration compared to butanal.

Instrumentation

A Hewlett Packard 1100 series HPLC system was interfaced to a Finnigan LCQ
Classic quadrupole ion trap mass spectrometer for reversed phase LC-ESI-MS/MS
analyses. A mobile phase mixture of water and acetonitrile, each containing 0.1% formic
acid, was used in all experiments. Details of HPLC gradient elution, LCQ instrument
parameters and segmented LC-MS/MS analysis were as described previously (111).

Statistical Treatment of Data

Several statistical approaches were used to determine the significance of data
obtained, including ANOVA with Dunnett’s post hoc test (ABSTAT software), 2-tailedt-test and the Mann-Whitney U-test.

ANOVA with Dunnett’s post hoc Test

ANOVA (analysis of variance) is a procedure to compare and contrast the means
of three or more populations, by comparing their variances, for the purposes of
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establishing whether or not they came from identical populations. In situations where
there are more than two populations under investigation, the Student’s t test cannot be
applied, making ANOVA very useful. There are three basic assumptions to ANOVA:
•

The populations are normally distributed

•

The populations have identical standard deviations (σ)

•

The samples are selected independently

When these conditions are met, the F distribution is used as a test statistic. The null
hypothesis (H0) is that the population means are the same. H0 would be rejected if the
computed value of F is greater than the critical value. The strategy in ANOVA is to
estimate the population variance by two separate methods and determine the ratio of
these two estimates. If the ratio is close to 1, then the two estimates are the same and the
population means are interpreted as being identical. If the ratio is different from 1, then it
can be deduced that the population means are different. The F distribution determines
when the ratio is too much different than 1 to have occurred by chance.
First, the sum of squares total (SStotal) is calculated. This is the sum of the squared
differences between each observation and the overall mean:

(∑ X )
−

2

SS total = ∑ X

2

where,

(1.3.1)

n

ΣX2 = X values squared and then summed

(ΣX)2 = X values summed and then squared
n = total number of observations.

Next, the sum of squares due to treatments (SStreatments), or the different populations under
investigation, is determined:
⎛ TT2 ⎞ (∑ X )
= ∑ ⎜⎜ ⎟⎟ −
n
⎝ nT ⎠

2

SS treatments

where,

(1.3.2)

TT = sum total for each treatment/population
nT = number of observations for each treatment/population.

The sum of squares error (SSerror) is computed as follows:
SS error = SS total − SS treatments .

(1.3.3)

Finally, the mean square for treatments (MStreatments) and error (MSerror) is determined:
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MS treatments =
MS error =

SS treatments
df1

(1.3.4)

SS error
df 2

(1.3.5)
df1 = number of treatments – 1

where,

df2 = n – number of treatments.

The F statistic is the ratio of the mean square for treatments and error:
F=

MS treatments
.
MS error

(1.3.6)

The computed value of F is compared to the critical value to accept or reject the null
hypothesis (151).
In situations when ANOVA shows a significant disparity between populations
and one of the populations is a control, the Dunnett’s Test is used as a post hoc test. The

technique allows for comparisons to be made between the experimental populations and
the control population. However, it does not permit experimental populations to be
compared to one another other. In an experiment consisting of a-1 treatments plus a
control group, the Dunnett’s test can test each treatment against the control mean:
H0:

μ1 = μc

H0:

μ2 = μc

H0:

μ3 = μc

H0:

μa-1 = μc
H0 = null hypothesis

where,

μi = mean of experimental population i
μc = mean of control population.
The q’ statistics are calculated as follows:
'
qobs
=

μc − μi

(1.3.7)

SE Dunnett

SE Dunnett =

⎛

(MSerror )⎜⎜ 1

where,

⎝ ni

+

1⎞
⎟
nc ⎟⎠

(1.3.8)

ni = total numbers in population i
nc = total numbers in control population.
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The critical value of the q’ statistic (qcrit’) is compared to the calculated value (qobs’). At a
given confidence level, if qcrit’ < qobs’, then the null hypothesis is accepted (152).

2-Tailed-t-Test

The Student’s t test is a parametric test to determine the significance between
means of two sample sets or between a mean and a theoretical value. The test presumes
that all data points are distributed normally and the ratio of variances in the two samples
is ≤ 3. In a 2-tailed-t-test, the area α under the distribution curve is split in half, placing
half in each tail. The null hypothesis (H0) in this case is a particular value and there are
two alternative hypotheses (H1), one positive and one negative:
H0: μ = a
H1: μ ≠ a

The critical value of t (tcrit), is written with both a plus and minus sign (±). For instance,
the critical value of t when there are 10 degrees of freedom (df = 10) and α is set to 0.05,
is tcrit = ± 2.228. The sampling distribution model used in a 2-tailed-t-test is given in
Figure 1.3.1. When comparing the mean from a sample set to a theoretical or ‘true’ value,
the critical value for rejecting the null hypothesis is as follows:

μ −a =±

ts
N

where,

(1.3.9)
N = total number of measurements
t = statistical parameter
s = standard deviation

μ = mean of measurements
a = true value.

The situation is slightly different when comparing the mean of one sample set to
another, as in the case of Nx replicate analyses of X to yield a mean of μx and Ny analyses
of Y to yield a mean of μy, the data being gathered in a similar manner. It can be
considered that the standard deviations of the two measurement groups are identical. The
2-tailed-t-test can be used to determine if differences in measurements of X and Y are the
result of random errors or because they happen to be two different samples. The null
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Region of rejection
0.025

Do not reject
H0

Region of rejection
0.025

0.95

scale of z

-1.96
critical value

0

1.96
critical value

H0 = null hypothesis
z = distance from the mean in units of standard deviation

Figure 1.3.1. Regions of nonrejection and rejection for a 2-tailed-t-test. Significance
level: 0.05.
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hypothesis (H0) is that X and Y are the same and any disparity (μx - μy) is due to random
errors (153). The standard error of the means μx and μy are expressed as the ratio of the
standard deviation to the square root of the number of data points:
smx =

sx
Nx

s my =

sy

(1.3.10)

(1.3.11)

Ny
smx = standard error of μx

where,

smy = standard error of μy
sx = standard deviation of x
sy = standard deviation of y.

Therefore, the variance sd2 of the difference (d = x - y) between the two means is
described as follows:
2
2
s d2 = s mx
+ s my
.

(1.3.12)

Inserting values of sd, smx and smy into this equation:
⎛ sd
⎜⎜
⎝ N

⎞
⎟⎟
⎠

2

⎛ s
=⎜ x
⎜ N
x
⎝

2

2

⎞ ⎛ sy ⎞
⎟ .
⎟ +⎜
⎟ ⎜ N ⎟
y ⎠
⎠ ⎝

(1.3.13)

It can be supposed that the pooled standard deviation spooled is a reasonable approximation
of both sx and sy:
2
⎛ s d ⎞ ⎛⎜ s pooled
⎜
⎟ =
⎝ N ⎠ ⎜⎝ N x

2

⎞ ⎛ s pooled
⎟ +⎜
⎟ ⎜ N
y
⎠ ⎝

2

⎞
⎟ = s 2 ⎛⎜ N x + N y
pooled ⎜
⎟
⎝ NxNy
⎠

⎞
⎟.
⎟
⎠

(1.3.14)

Substituting into Eqn (1.3.9) generates the following:

μ x − μ y = ±ts pooled

Nx + Ny
NxNy

.

(1.3.15)

As such, the test value of t is given by:
t=

μx − μy
s pooled

(1.3.16)

Nx + Ny
NxNy
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for, df = N x + N y − 2 .

(1.3.17)

This test value of t is compared with tcrit obtained from appropriate statistical tables for
the desired confidence level. If │t│< tcrit, the null hypothesis holds true. If, on the other
hand, │t│> tcrit, it can be reasoned that there existas a significant difference between μx
and μy (153).
Mann-Whitney U Test

Nonparametric tests are often used in place of their parametric counterparts when
certain assumptions about the underlying population are questionable. For example, when
comparing two independent samples, the Mann-Whitney U test does not assume that the
difference between the samples is normally distributed whereas its parametric
counterpart, the two sample-t-test, does. Nonparametric tests may be, and often are, more
powerful in detecting population differences when certain assumptions are not satisfied.
The Mann-Whitney U test is used to test the null hypothesis that two samples come from
the same population (i.e. have the same median) or, alternatively, whether observations in
one sample tend to be larger than observations in the other. The test assumes that the two
distributions are similar in shape.
Consider a sample of nx observations {x1, x2, …, xn} in one group (from one
population) and a sample of ny observations {y1, y2, …, yn} in another group (from
another population). The Mann-Whitney U test is based on a comparison of every
observation xi, in the first sample set with every observation yj in the other sample set.
The total number of pairwise comparisons that can be made is nxny. If the samples have
the same median, then each xi has an equal chance (i.e. probability ½) of being greater or
smaller than each yi. The null hypothesis is as follows:

H0: P (xi > yi) = ½
while the alternate hypothesis is:

H1: P (xi > yi) ≠ ½.
The number of times (Ux) an xi from sample X is greater than a yi from sample Y is
determined and vice versa. Under the null hypothesis, it would be expected that Ux and

Uy are approximately equal.
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First, all observations are arranged in order of magnitude. Each observation is
denoted as being either from population X or Y. The number of ys that are smaller than
every given x are counted (this indicates xi > yj) and vice versa (this indicates yj > xi). The
total number of times (Ux) that xi > yj is determined and vice versa (Uy). It should be
noted that Ux + Uy must equal nxny. Finally, U = min (Ux, Uy) is determined. Statistical
tables for the Mann-Whitney U test are used to find the probability of observing a value
of U or lower. If the test is one-sided, this would be the p-value. If the test is two-sided,
the probability is doubled to obtain the p-value.
If the number of observations is such that nxny is large enough (>20), a normal
approximation can be used with

μU =
σU =

nx n y

(1.3.18)

2

n x n y ( N + 1)

(1.3.19)

12
where,

N = nx + ny.

Sometimes, it may be that two or more observations are the same. If this is the
case, U can still be calculated by allocating half of the tie to the X value and half of the tie
to the Y value. However, in such a situation the normal approximation must then be used
with an adjustment to the standard deviation. This becomes (154):

σU =

⎡ N 3 − N g t 3j − t j ⎤
×⎢
−∑
⎥
12 ⎥⎦
N ( N − 1) ⎢⎣ 12
j =1
nx n y

where,

(1.3.20)

N = nx + ny
g = the number of groups of ties
tj = the number of tied ranks in group j.

Results and Discussion

Aldehyde levels were compared statistically using ANOVA with Dunnett’s post

hoc test for individual differences and the commercially available ABSTAT software
(AndersonBell, Arvada, CO). Age and PMI were compared using a 2-tailed t-test. Braak
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staging scores were compared using non-parametric testing and the Mann-Whitney U
test. Statistical significance was set at P < 0.05 (Table 1.3.1).
Levels of aliphatic aldehydes (C1-C6), HNE and acrolein were measured in the
HPG, SMTG and CER of 7 subjects with MCI (3M, 4F), 6 subjects with EAD (3M, 3F)
and 7 age-matched control subjects (5M, 2F) using an improved mass spectrometric
method (LC/ESI/MS/MS) that provides unequivocal identification of the compounds of
interest (111). Subject demographic data are shown in Table 1.3.1. There were no
significant differences in PMI for any of the three subjects groups. There was a
significant (p < 0.05) difference in age of EAD subjects (89.0 ± 1.8 y) compared to
control subjects (81.4 ± 2.6 y). There was no significant difference in age between
control and MCI subjects (88.4 ± 1.4 y). Median Braak staging scores were significantly
higher in MCI (III) and EAD (V) subjects compared to controls (II). Delayed memory
recall scores from the MMSE were significantly lower in MCI (4.1 ± 0.8) and EAD (4.2
± 0.7) compared to control subjects (7.9 ± 0.7).
No statistically significant differences in the levels of aliphatic aldehydes were
observed for the various brain regions and levels of AD pathology under investigation.
Figure 1.3.2 shows that HNE levels were statistically significantly elevated in a disease
progression-related manner in all three brain regions under investigation. Post hoc testing
showed that HNE was significantly increased (P < 0.05) in EAD HPG (1.45 ± 0.5
nmol/mg protein) and MCI HPG (1.5 ± 0.3 nmol/mg protein) compared to control
subjects (0.4 ± 0.1 nmol/mg protein). Levels of HNE were also significantly elevated in
MCI SMTG (2.4 ± 0.3 nmol/mg protein) and EAD SMTG (2.9 ± 0.3 nmol/mg protein)
compared to control SMTG (0.8 ± 0.1 nmol/mg protein). In contrast to a previous study
of late-stage AD subjects (50), levels of HNE in CER were significantly elevated in MCI
(1.5 ± 0.2 nmol/mg protein) compared to control CER (0.8 ± 0.1 nmol/mg protein). There
were no significant differences in HNE between EAD and MCI for any of the brain
regions analyzed. Comparison of regional differences showed a statistically significant
elevation of HNE in SMTG compared to both HPG and CER in EAD and MCI.
Figure 1.3.3 shows that levels of acrolein increased in a disease progression
related manner with statistically significant increases in EAD HPG (2.7 ± 0.2 nmol/mg
protein) compared to control HPG (1.2 ± 0.3 nmol/mg protein). There were no significant
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Table 1.3.1. Subject demographic data.

Mean ± SEM
Age (years)

Sex

Mean ± SEM
PMI (h)

Median
Braak Score

MCI

88.4 ± 1.4

3M, 4F

4.0 ± 1.0

III*

EAD

89.0 ± 1.8*

3M, 3F

5.4 ± 2.4

V*

Control

81.4 ± 1.4

5M, 2F

2.7 ± 0.3

II

* p < 0.05
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Mean ± SEM 4-hydroxynonenal (nmol/mg protein)

5

* p < 0.05

Control
MCI
EAD

4

*
3

2

*
*

*

*

1

0

HPG

SMTG

CER

Figure 1.3.2. Mean ± SEM 4-hydroxynonenal (HNE) levels (nmol/mg protein) in MCI,
EAD and control hippocampus/parahippocampal gyrus (HPG), superior and middle
temporal gyrus (SMTG) and cerebellum (CER). There was a statistically significant (p <
0.05) elevation of HNE in MCI and EAD HPG and SMTG and in MCI CER.

107

Mean ± SEM Acrolein (nmol/mg protein)

5

* p < 0.05

Control
MCI
EAD

4

3

*

2

*

*

*

1

0

HPG

SMTG

CER

Figure 1.3.3. Mean ± SEM acrolein levels (nmol/mg protein) in MCI, EAD and control
HPG, SMTG and CER. There was a statistically significant (p < 0.05) increase in
acrolein in EAD HPG, SMTG and CER and in MCI SMTG.
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differences in HPG acrolein between MCI and control subjects or between MCI and EAD
subjects. In SMTG, there was a statistically significant increase in acrolein in MCI (1.1 ±
0.1 nmol/mg protein) and EAD (1.3 ± 0.2 nmol/mg protein) compared to control subjects
(0.4 ± 0.1 nmol/mg protein). There were no significant differences in acrolein between
MCI and EAD subjects. In contrast to a previous studies of late stage AD brain (49),
EAD CER showed a significant increase in acrolein (1.3 ± 0.1 nmol/mg protein)
compared to control subjects (0.7 ± 0.1 nmol/mg protein). Correlation analysis of Braak
staging scores and HNE or acrolein levels showed no significant trends. Correlation
analysis of HNE and acrolein levels with delayed memory recall scores showed negative
trends although the results were not statistically significant.
This is the first study to quantify levels of specific, neurotoxic by-products of
lipid peroxidation in brain specimens from subjects with MCI and EAD. The results
clearly showed that HNE and acrolein increase in a disease progression-dependent
manner with statistically significant elevations of HNE in MCI and EAD HPG and
SMTG and in MCI CER. Acrolein levels were significantly elevated in EAD HPG and in
MCI and EAD SMTG. In contrast to a previous study of late stage AD brain (50), the
data presented here suggest that there is a generalized increase in oxidative damage in the
brain in MCI, including the CER. In light of the potential role of lipid peroxidation and
HNE generation in the pathogenesis of neuron degeneration, the observation of elevations
of HNE in MCI CER where there is limited neuropathology may appear contradictory.
However, a previous study of glutathione transferase (GST), the enzyme responsible for
detoxification of reactive aldehydes including HNE and acrolein, showed that GST
activity is significantly decreased in HPG and amygdala but remains unaltered in CER in
late stage AD (155), suggesting that the AD brain retains the ability to detoxify HNE in
areas unaffected by pathology, whereas brain regions showing increased neuropathology
(HPG) do not.
Levels of HNE and acrolein measured in this current study using improved
analytical methodology were comparable to those measured in previous studies of latestage AD and control subjects (49, 50). Using HPLC with fluorescence detection, it has
been shown HNE was significantly elevated in AD HPG (0.54 ± 0.12 nmol/mg protein)
compared to age-matched control subjects (0.3 ± 0.1 nmol/mg protein). Similar to the

109

results of this study, previous analyses of late-stage AD brain showed the highest HNE
levels in SMTG (1.5 ± 0.4 nmol/mg protein (AD); 1.4 ± 0.4 nmol/mg protein (control)).
Levels of acrolein observed in EAD and MCI HPG in this study were also comparable to
those observed in late stage AD (5.0 ± 1.6 nmol/mg protein) and age-matched controls
(0.7 ± 0.1 nmol/mg protein). Slight differences in absolute levels of HNE and acrolein
may be due to differences in analytical methods and slight subject to subject variability.
The increased levels of neurotoxic markers of lipid peroxidation in MCI and EAD
reported here are consistent with previous studies of oxidative stress in extra cerebral
fluids in MCI. Pratico et al. (156) showed substantially increased levels of isoprostane
8,12-iso-iPF2α-VI, a specific marker of lipid peroxidation, in plasma, urine and
cerebrospinal fluid (CSF) of MCI subjects compared with age-matched controls. In a
study of peripheral leukocytes in MCI and late-stage AD, Migliore et al. (157) showed
substantially increased oxidative DNA damage in MCI and AD subjects compared to
age-matched controls using comet assay analysis.
Keller et al. (85) showed substantially increased protein oxidation (protein
carbonyls) in SMTG in MCI but not EAD, compared to age-matched control subjects.
Additionally, significant elevations of thiobarbituric acid reactive substances (TBARs)
and malondialdehyde, an aldehydic marker of lipid peroxidation with limited toxicity,
were observed in MCI and EAD SMTG compared to control subjects. Although TBARs
have been widely used as a marker for lipid peroxidation, the assay is subject to several
interferences. This study, using LC-ESI-MS/MS, allows unequivocal identification of the
target molecules based on their mass spectra and is free of possible confounding
interferences. More recently, statistically significant elevations of 8-hydroxyguanine, a
widely studied marker of DNA oxidation, were observed in nuclear DNA from frontal
and temporal lobe specimens and in mitochondrial DNA from temporal lobe in MCI
compared to age-matched control subjects (158). Statistically significant elevations of the
markers of adenine oxidation (8-hydroxyadenine and 4,6-diamino-5formamidopyrimidine) were also detected in nuclear and mitochondrial DNA in frontal,
parietal and temporal lobes from MCI subjects compared to age-matched control
subjects. No differences in DNA oxidation were observed in CER in MCI.

110

Conclusions

This study was conducted in the interest of obtaining a thorough understanding of
the distribution of aldehydic products from LPO in different brain regions at different
stages of AD. Here, we described the application of a previously developed, sensitive and
selective LC-ESI-MS/MS methodology (111) in the quantification of aldehyde
concentrations in the HPG, SMTG and CER of subjects with MCI and EAD compared to
age-matched controls subjects (159). Individuals with amnestic MCI show memory
impairment compared to normal controls, but lack the broader cognitive deficits of AD
patients and likely represent the earliest stage of AD. Understanding the differences
between MCI, EAD and normal subjects is becoming increasingly important in the
interest of developing early diagnostic methods and viable treatments for this debilitating
disease (159).
In agreement with previous studies, it was observed that aliphatic aldehydes do
not display statistically significant differences when comparing HPG, SMTG and CER
brain regions and different levels of AD pathology (50). The data given here coupled
with other studies suggest that oxidative damage occurs early in the course of AD and
reaches a plateau during EAD, consistent with the hypotheses of Nunomura et al. (160)
and Perry et al. (161). These researchers suggested that oxidative damage is most
pronounced early in AD development. However, a recent clinical study by Petersen et al.
(162) showed that treatment of MCI subjects with Vitamin E did not alter the overall rate
of progression from MCI to AD compared to subjects who received placebos, suggesting
that limiting oxidative damage does not affect the progression of AD. Although the data
presented here appear to contrast with the findings of the clinical study, it has been
suggested that acrolein can inhibit the enzyme responsible for the reduction of Vitamin E
radicals (13, 80) and thus may limit the therapeutic effects of Vitamin E. The observation
of elevations of acrolein in MCI and EAD in this study may help to explain why Vitamin
E showed no protective effects in MCI in the clinical trial. In addition, it has been shown
that Vitamin E taken in conjunction with Vitamin C decreases markers of lipid
peroxidation in CSF of AD patients (163). Vitamin C was not used in the clinical trial by
Petersen et al. (162)
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The observations from this study suggest that oxidative stress occurs as an early
event in the progression of AD and that preventive measures for those at risk for AD
should be initiated in the presymptomatic phase of the disease (at or prior to MCI) to be
effective.
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Chapter 1.4
Conclusions

Alzheimer's disease is a progressive, irrevocable ailment of the brain, the etiology
and cure of which have eluded scientists and clinicians to this day. The disease attacks
and gradually steals the minds of its victims. Symptoms of AD include judgment
deterioration, mental confusion, loss of memory, changes in personality, disorientation,
and impairment of language skills. Alzheimer's disease is the most common form of
irreversible dementia amongst the elderly community. Due to the devastating nature of
AD, considerable research is focused on developing early diagnostic methods, medication
for symptom alleviation, as well as cures for the disease. The AD brain is marked by
considerable oxidative stress and lipid peroxidation, particularly in areas responsible for
cognition and memory. In recent years, various by-products of lipid peroxidation,
including biogenic aldehydes, isoprostanes and neuroprostanes, have piqued the interest
of the AD research community as potential biomarkers for lipid peroxidation and
therefore, AD.
Since acrolein and HNE, amongst other biogenic aldehydes, are produced as a
consequence of LPO, their prevalence above normal concentrations can be indicative of
AD. As such, their quantification can serve as a measure of the progression of the
disease. To this end, a sensitive, selective LC-ESI-MS/MS methodology for the detection
and accurate quantification of acrolein, HNE and the aliphatic aldehydes C1-C6 was
designed (111). This is the first report to describe the use of MS/MS analysis in brain
aldehyde quantification. Researchers have explored spectrophotometric methods coupled
to HPLC in biogenic aldehyde analysis but co-eluting species are difficult to analyze
accurately using these techniques. Methods involving GC/MS come with high sensitivity,
greater mass specificity and lower LODs, although different derivatization techniques are
often required to analyze different classes of aldehydes. LC-ESI-MS/MS techniques are
the some of the best analytical tools for biogenic aldehyde investigations as they offer
greatly improved sensitivity, little sample cleanup and simultaneous analysis of multiple
classes of aldehydes with a single derivatization method. Furthermore, in contrast to GC
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experiments, analytes are not exposed to high temperatures in the analysis, which may
not be suitable for some compounds.
The Hantzsch reaction proved to be a very beneficial means of easily derivatizing
aldehydic species with high efficiencies for trace LC/MS analyses. This derivatization
method offers high selectivity, as other carbonyl compounds do not react in a manner to
generate dimedone derivatives. Furthermore, CHD derivatives of aldehydes have very
good electrospray responses. The dimethyl CHD derivative demonstrated the best
chromatographic response of all derivatives explored. The use of two internal standards
for separate quantification of aliphatic and unsaturated aldehydes enabled accurate
quantification of very low concentrations of acrolein and HNE typically observed in the
brain. Standard aliphatic and unsaturated aldehydes gave linear responses over a wide
concentration range.
The LC-ESI-MS/MS methodology was successfully applied in the detection and
quantification of biogenic aldehydes in vivo (159). For the purposes of determining
whether or not LPO-generation of aliphatic and unsaturated aldehydes occurred early in
the pathogenesis of AD, levels of these aldehydes were studied in HPG, SMTG and CER
of subjects with MCI, EAD and age-matched controls. This is the first study to report an
in-depth comparison of aldehyde levels between MCI and EAD. At a 95% confidence
level, no significant differences were observed in patterns of aliphatic aldehyde
generation in different regions of the brain for MCI and EAD subjects, compared to the
control group. This was in agreement with studies from other laboratories, as discussed in
Chapter 1.3. However, also in agreement with previous findings, the results presented
here clearly indicated statistically significant concentration differences for the
unsaturated aldehydes HNE and acrolein. Noteworthy increases in HNE levels in HPG,
SMTG and CER for MCI subjects were observed, compared to the control group.
Individuals with MCI also demonstrated significantly elevated levels of acrolein in
SMTG, compared to controls. In the case of subjects with EAD, a statistically significant
increase in the production of HNE was detected in HPG and SMTG, compared to the
control group. Furthermore, in contrast to the age-matched controls, significantly high
concentrations of acrolein were observed in HPG, SMTG and CER in subjects with EAD.

114

A comparison of MCI and EAD subjects revealed no statistically significant differences
in aldehyde levels.
The methodology developed here was very well-suited for detecting and
quantifying biologically relevant aldehydes in AD progression. It was evident from the
study of HNE and acrolein levels in different brain regions of individuals at different
stages of AD that lipid peroxidation occurred early in the pathogenesis of AD, at the MCI
stage of development, when little, if any, clinical symptoms are observed. Hence, our
results indicated that effective diagnostic methods for AD must be designed to target the
MCI stage. Furthermore, drug development for symptom alleviation and the ultimate cure
of AD should also focus on subjects with MCI. As with any illness, the best mode of
action is preventive medicine. While considerable research is devoted to determining the
cause of AD, the answers still remain at large. In situations when preventive care is not
possible or simply did not happen, early detection, diagnosis and treatment are the key
ingredients to a better quality of life.
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Chapter 2.1
Introduction

Ethanol Tolerance in Thermophilic Bacteria
Fossil fuels, including coal, oil and natural gas, are the major source of
inexpensive energy that powers modern industrial civilization. These energy sources have
been produced over millennia from the remains of prehistoric plants and animals. As
humanity becomes increasingly advanced in technology, more energy is consumed to
sustain the pace of changing requirements. Aside from heightened concerns about
pollution, global warming and national security issues, existing reserves of this energy
resource are depleting at a rapid rate. Use of fossil fuels has nearly doubled every 20
years since 1900. Petroleum geologists have known for the past 50 years that global oil
production would hit the zenith and begin its inexorable decline soon after the year 2000.
Furthermore, no renewable energy systems to date have the potential to generate more
than a fraction of the power currently being delivered by fossil fuels. As a result, research
in alternative sources of fuel has received considerable focus in recent years. Harnessing
microbes to convert abundant fibrous biomass from the agricultural sector into ethanol
for exploitation as fuel can offer an efficient and environmentally clean answer to the
energy question. The thermophile Clostridium thermocellum, a gram-positive,
chemotrophic, cellulolytic and obligately anaerobic bacterium, has generated
considerable interest in the area of bio-ethanol production due to its ability to ferment
complex carbohydrates, such as cellulose, in a single step reaction, thus eliminating the
need for biomass pretreatment (1). When this organism grows on cellulose as the sole
carbon source, ethanol, acetic acid, lactic acid and CO2 are generated. The ability of C.
thermocellum to ferment cellulose is a remarkable advantage over fungal species such as
yeast, which can only ferment simple sugars via multi-step mechanisms.
Despite the benefits, C. thermocellum is strongly inhibited at low ethanol
concentrations (< 2% v/v) and provides reduced ethanol yields compared to established
industrial fermenters, including yeast (> 6% v/v). The restrained growth of the ethanolchallenged species displays a short time span of little or no inhibition followed by a
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period of growth impediment, and finally a time of stunted but sustained exponential
growth (2). This is in contrast to ethanol inhibition observed in yeast, where an
immediate cessation of growth occurs. Studies have shown that inhibition of fermentation
is due to a staling effect, which refers to accumulation of toxic metabolic byproducts
from the organism (3). Recovery of alcohol at such low concentrations with conventional
distillation techniques becomes unfavorably expensive. In order for C. thermocellum to
be effectively exploited in ethanol production, it is necessary to increase the growth rate,
improve cellulase activity and increase ethanol tolerance and production (4). Through
sequential transfer techniques, several ethanol-tolerant strains have been developed, some
able to tolerate as high as 8% ethanol (1, 4-7). The ability of these bacteria to sustain
themselves on cellulose indicates the presence of a viable cellulase system that can
generate ethanol. While none of the strains to date can match fungal ethanol tolerance, an
understanding of the biochemistry behind this phenomenon can offer insight into the
future development of more ethanol-tolerant derivatives of this organism.
The effects of ethanol on microbes have been investigated in some detail (2, 3, 812). The capacity of this alcohol to shut down metabolism is related to its partitioning
between the aqueous and hydrophobic milieu in the cell. It has been shown that most of
the effects of ethanol do not involve specific interactions or receptors but are the
aftermath of a more generalized mechanism associated with hydrophobic associations
(11). Nonionized species in the cellular matrix, including ethanol, influence membrane
physiology through partitioning in lipid bi-layers and interfering with lipid-lipid and
lipid-protein interactions (2). It is believed that the effect of ethanol may be due to
physical disturbances of the bi-layer or perhaps more direct interactions with membrane
proteins, such as permeases. Roberts and co-workers (2) have shown that when ethanol is
added to C. thermocellum cultures, changes in membrane composition occur after the
period of growth arrest. They reported an increase in the proportion of normal and
anteiso-branched fatty acids (lower melting points) at the expense of iso-branched fatty
acids (higher melting points), leading to increases in fluidity and permeability of the
membrane. Studies have shown that key targets for microbe growth inhibition are
hydrophobic in nature and that cessation of growth is directly proportional to the
concentration of perturbing molecules that have partitioned into the hydrophobic
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environment (2). Such evidence clearly highlights the vulnerability of the cell membrane
to ethanol-induced changes.
Since a significant contributor to bacterial death at elevated ethanol
concentrations is the disruption of the cellular permeability barrier (3), it is most likely
that a majority of the changes brought about by ethanol adaptation center around the
membrane proteome (Figure 2.1.1). Herrero et al. proposed that effects of ethanol on
membrane fluidity and inhibition of certain enzymes associated with sugar metabolism
lead to low tolerance of the bacterium to ethanol (2). In ethanol-challenged systems, the
leakage of appreciable quantities of proteins also indicates membrane disruption (11).
Hydrophobic associations are elemental in the preservation of membrane integrity and
structure, protein folding and quaternary structure of proteins. The hydrogen bonding
network of water is largely responsible for the strength of hydrophobic associations.
While ethanol does form hydrogen bonds, its presence in aqueous solutions can limit the
freedom of the hydrogen bonding lattice structure. This decline in the strength of the
hydrophobic interactions can weaken the membrane by weakening van der Waal’s
interactions among acyl chains and hydrophobic protein surfaces, further increasing
membrane permeability (3). It is also believed that ethanol can increase the polarity and
dehydrate the cell membrane. By replacing water, ethanol induces altered protein folding
and interactions within the bi-layer (11). While the exact mechanism of bacterial growth
inhibition and adaptation to ethanol is unknown, analysis of differentially expressed
membrane proteins in wild type and ethanol-adapted strains through proteomics studies
can provide the insight necessary to tackle questions about the nature of ethanol
tolerance.

Proteomic Analysis of Cell Membranes
Proteomics is the study of the structural and functional aspects of the protein
complement of the genome. The term was created to draw parallels with genomics,
although it is significantly more complicated. While the genome of an organism is rather
static, the proteome can differ radically and is constantly changing through biochemical
interactions with the genome and the environment. Protein expression can also vary with
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changing stages of the cell cycle and environmental conditions. Needless to say,
proteomics investigations have played a dominant role in the field of biological mass
spectrometry in the aftermath of the human genome project. As such, a considerable
amount of resources and manpower have been dedicated to the improvement of protein
separation and analysis techniques. Despite its limitations, sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) is still the gold-standard of protein
separation for subsequent analysis by mass spectrometry. Pre-fractionation techniques
(i.e. to separate hydrophobic membrane proteins from cytosolic proteins) coupled to
SDS-PAGE have been useful in studying the proteome at increasingly detailed levels.
However, the cell membrane sub-proteome is frequently under-represented on 2D gel
maps. This has largely been attributed to their low abundance, hydrophobicity and
solubility issues encountered in the first dimension or isoelectric focusing step of
standard 2D-PAGE (13). By virtue of the unique nature of the cell membrane as the site
of first contact of the external environment with the cell, a detailed understanding of the
membrane proteome is critical in many biological investigations.
In recent years, shotgun analyses have become popular ‘gel-free’ alternatives.
MudPIT (Multidimensional Protein Identification Technology) is a technique for the
separation and identification of complex protein and peptide mixtures that has developed
considerable interest (14-16). In place of 2D gel electrophoresis, MudPIT separates
peptides in 2D liquid chromatography, which allows the direct interfacing with a mass
spectrometer. In the MudPIT experiment, biphasic columns are constructed of strong
cation exchange (SCX) stationary phase in series with reversed phase (RP) material
inside fused silica capillaries. The chromatography proceeds in cycles, each comprising
an increase in salt concentration to free peptides from the SCX resin, after which they
bind to the RP resin. A typical RP gradient to increasing hydrophobicity is then applied to
progressively elute peptides from the RP into the ion source for analysis by mass
spectrometry. A disadvantage to this methodology is that data interpretation and analysis
is often not as straightforward compared to 2D-PAGE (17).
Despite the problems encountered with gel-based approaches, they are effective in
providing a useful analytical tool for the generation of membrane protein profiles, along
with quantitative comparisons of numerous proteins concurrently. Significant research
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and methods development has been focused in the gel electrophoresis of membrane
proteins to exploit the many advantages of this technique in membrane proteome
analyses. Organic solvents and chemical modifiers in IEF solubilization buffers followed
by analysis on one-dimensional gels or carefully modified two-dimensional gels
(excluding isoelectric focusing) provide effective alternatives for improving membrane
protein representation in these techniques. However, it should be noted that no approach
offers a universal solution for all membrane proteins, and, experimental conditions ought
to be optimized for the particular membrane-enriched sample at hand.

Polyacrylamide Gel Electrophoresis
The polyacrylamide gel electrophoresis technique (PAGE) was introduced by
Raymond and Weintraub in 1959 (18). Since then, the methodology has been improved
and adapted to various applications in a variety of scientific fields. SDS-PAGE is the
most widely used method for qualitatively analyzing protein mixtures. Separation is
based primarily on molecular weight (19). SDS (CH3-(CH2)10-CH2OSO3-Na+) is an
anionic detergent that can bind to hydrophobic portions of a protein (one SDS anion to
two amino acids), disrupting its three dimensional structure and allowing it to exist stably
in solution in an extended conformation. As a result, all the proteins contain primary
structure only, have a large negative charge and the length of the SDS-protein complex is
proportional to its molecular weight.
During an SDS-PAGE experiment, current is applied to opposite ends of an
acrylamide gel support matrix (stationary phase) in the presence of an appropriate
running buffer. Sample proteins are loaded on the cathode end of the assembly. The
current from the cathode repels the negatively charged SDS-protein complexes while the
anode, on the opposite end of the gel, simultaneously attracts them. The macromolecules
are thus forced to move through the pores when electrical current is applied. Their rate of
migration through the electric field depends on the strength of the field, size and shape of
the molecules, relative hydrophobicity of the samples and the ionic strength and
temperature of the buffer in which the molecules are moving. After staining, the
separated macromolecules can be observed on the gel. The relative ease of execution and
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wide application of SDS-PAGE have made it an important analytical technique in many
areas, particularly macromolecular separations.

Electrophoresis Theory
Electrophoresis instruments are simple electrical circuits that operate in
accordance with Ohm’s law:
V = IR

(2.1.1)
where,

V = electrical field in volts
I = current in milliamperes
R = resistance in ohms.

For a given an amount of voltage, a constant amount of current will flow through the
circuit. With increasing resistance across any element, the total applied voltage increases.
The resistance is inversely proportional to the ionic strength of the buffer, as well as the
cross sectional area of a given element. As such, gel analysis can be fine-tuned by
manipulating these parameters.
The electrophoresis technique is based on the property of charged molecules
migrating in an electric field (20). A particular molecule with charge q in an electric field
(E) experiences a force (F) as follows:

F = qE .

(2.1.2)

The molecule quickly reaches a velocity (v) in which the electric field is balanced by the
frictional force:

qE = fv
where,

(2.1.3)
f = frictional coefficient.

The electrophoretic mobility of the molecule (μ) is the velocity per unit field strength. It
is expressed as a ratio of the net charge to the frictional coefficient.
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μ=

v q
= (cm2/V-sec).
E f

(2.1.4)

The frictional coefficient can be defined as:

f = 6πηr
where,

(2.1.5)

η = viscosity of the medium
r = stokes radius of the molecule.

In ‘free’ electrophoresis, mobility is dependent on charge-to-mass-ratio. However, there
are some complications to this simplistic view. The charges and frictional coefficients of
a molecule are not only determined by size, shape and composition but by solvent
conditions as well, including pH, counter-ions and temperature. Furthermore, counterions can shield the migrating analyte from the electric field, reducing the effective field
strength it experiences.

Acrylamide Polymerization

First introduced by Chrambach and Rodbard (21), polyacrylamide is a synthetic
polymer prepared by polymerizing the acrylamide monomer into long chains, crosslinked into three-dimensional structures. Cross-linked gels are prepared from the
polymerization of acrylamide monomer in the presence of smaller amounts of N,N’methylene-bis-acrylamide (bis), as shown in Figure 2.1.2. This type of polymerization is
an example of free-radical catalysis, brought about by the addition of ammonium
persulfate (APS) and the base N,N,N’,N’-tetramethylenediamine (TEMED). TEMED
catalyzes the decomposition of the persulfate ion to produce a free radical (22):
S2O82- + e- → SO42- + SO4-•

(2.1.6)

The polymerization reaction can be represented as follows:
R• + M → RM•
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RM• + M → RMM•
RMM• + M → RMMM• and so forth
where,

(2.1.7)

R• = sulfate radical
M = acrylamide monomer.

In this manner, long chains of acrylamide are synthesized, which are then cross-linked by
the introduction of the occasional bis-acrylamide molecule. Oxygen has a tendency to
quench free radical reactions and so the gel mixture is normally degassed prior to
addition of catalyst. The polymerization efficiency can range from 95 – 98%. The
polyacrylamide gel serves two purposes. It facilitates the diffusion of convective currents
that would result in localized heating in the matrix, causing irregular migration patterns.
The gel also provides a molecular sieve that enhances analyte separation based on
molecular weight.

The SDS-PAGE Experiment

Gel solutions for SDS-PAGE are usually prepared with appropriate amounts of
SDS (to maintain denaturing conditions) and Tris buffer (to maintain the desired pH and
create a greater ionic strength within the gel). The stacking gel is usually prepared with a
pH of 6.8 while the separating gel has a pH of 8.8. Catalysts are added immediately
before pouring the gel sandwich between two glass plates. The main separating gel
solution is poured first and allowed to polymerize. Next, a shorter stacking gel is poured
on top of the separating gel, and it is in this gel that wells are formed and proteins loaded.
Samples for SDS-PAGE analysis are boiled for 5 min in sample buffer (pH 6.8) to
denature the proteins. The β-mercaptoethanol in this buffer is added to prevent oxidation
of cysteine residues of protein disulfide bridges while SDS binds to the proteins. The end
result is a collection of completely denatured, rod-shaped protein-SDS complexes with
net negative charge. These charges overwhelm the inherent charge of the proteins and
give every protein the same charge-to-mass ratio. Bromphenol blue or some other
ionizable dye in the sample buffer allows the progress of the electrophoresis experiment
to be tracked. The cathodic and anodic ends of the electrophoresis setup are filled with
Tris-based running buffer. Sucrose or glycerol, present in the sample buffer, increases the
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density of the sample solution thus enabling the sample to settle through the
electrophoresis buffer to the bottom when injected into the loading well.
Electrophoresis is conducted under constant voltage or constant current
conditions. Once all samples have passed through the stacking gel and entered the
separating gel, the negatively charged protein-SDS complexes continue to move toward
the anode. Since they have the same charge per unit length, these complexes migrate into
the separating gel with the same mobility for a given electric field. During passage
through the separating gel, the proteins separate as a result of the molecular sieving
properties of the gel. Smaller proteins can travel more quickly compared to larger ones,
which are successively retarded by frictional resistance. Being a small molecule, the
bromphenol blue dye is almost totally unretarded and therefore indicates the
electrophoresis front. As soon as the dye front reaches the bottom of the gel, the power is
turned off and the gel is removed from between the glass plates for subsequent protein
staining and analysis.
Polyacrylamide gels can be cast in a single percentage of acrylamide or with
varying gradients. The gradient gels provide continuous decrease in pore size from the
top to the bottom of the gel, either exponentially or linearly, and can offer improved
resolution of proteins. During electrophoresis in gradient gels, proteins continue to
migrate until the decreasing pore size impedes further advancement. Once the pore limit
is reached, the protein banding pattern remains more or less the same with time, although
migration does not cease completely. The main advantage of using gradient gels is that a
much greater range of protein MW range can be interrogated, compared to a fixedpercentage gel. It is possible for larger proteins to enter the gel but they start to separate
immediately because of the sieving effect of the gel (22).
The use of a short stacking gel on top of the separating gel also allows for better
resolution. The stacking gel aids in the concentration of the protein sample into a sharp
band prior to entering the main separating gel. By preparing a stacking gel with large
pore size, the proteins can migrate freely and concentrate under the electric field, as a
result of isotachophoresis. This band sharpening effect relies on the fact that the trailing
ions (i.e. glycine in standard Laemmli-SDS-PAGE) in electrophoresis buffers have a
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lower electrophoretic mobility than the protein-SDS complexes, which in turn have lower
mobility than the leading ions (i.e. Cl-) in regions of high field strength (22).

Protein Visualization

A suitable staining protocol can be used to visualize separated proteins on a
polyacrylamide gel. The Colloidal Coomassie (Coomassie Brilliant Blue G 250) staining
protocol offers a sensitive, consistent, simple method and provides nanogram-level
detection of proteins (23). The technique is based on the colloidal properties of
Coomassie Blue dyes generated in methanol-water binary solvents containing inorganic
acids and high salt concentrations (Figure 2.1.3). The anionic form of the dye is produced
in acidic staining media and combines with the protonated amino groups of proteins
through electrostatic interactions. The free dye in solution is greatly reduced due to the
hydrophobic effect, resulting in low background staining and high affinity binding of the
dye to the proteins fixed in the gel.
In the Colloidal Coomassie Blue staining protocol, gels are fixed for one hour
with a solution containing 80% water, 20% methanol and 1% o-phosphoric acid. This
ensures that the separated proteins do not diffuse and migrate. Overnight staining is
performed in an aqueous solution of 0.001 g/mL Coomassie G-250 dye, 0.08 g/mL
ammonium sulfate, 20% methanol and 1.6% o-phosphoric acid. The gel is then
transferred into neutralization buffer (0.1M Tris, pH 6.5) for 1-3 min. This is followed by
washing with 25% methanol for less than a minute. Then, the gel is immersed in an
aqueous stabilizing solution of 0.2 g/mL ammonium sulfate. The gels can be safely stored
in 1% aqueous glycerol solutions until further analysis.

In-Gel Digestion

As staining methods with increasing sensitivity were developed, protein
identification became limited by the sensitivity of Edman sequencing, since this was the
most well-established method for protein analysis. With the development of ESI-MS and
MALDI-TOF-MS, mass spectrometry became recognized as a much more sensitive and
worthwhile tool for such purposes. Following separation on a polyacrylamide gel,
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proteins are excised, digested and the resulting peptides subjected to peptide mass
fingerprinting (PMF) methods. For protein identification, PMF uses the peptide masses to
search the protein databases for in silico or theoretical digest patterns that match the
experimental data. Mass spectrometric analyses can now be performed on picomole and
sub-picomole levels of PAGE-separated proteins following in-gel digestion procedures to
fragment the proteins into peptides.
In-gel digestion techniques can vary from laboratory to laboratory but they all
share some basic components. It is essential that contamination from human keratins be
reduced as far as possible, so that peptide signals are not suppressed during mass
spectrometric experiments. Protein spots/bands are excised from the gel. SDS,
unpolymerized acrylamide and other buffer constituents that could potentially generate a
high background in MS analyses are removed from the excised gel plugs in several
NH4HCO3/ACN washing steps. One particular method employs a 25 mM NH4HCO3 as
the first wash (10 min), followed by a 1:1 mixture of 25 mM NH4HCO3 and ACN (10
min), terminating with a pure ACN wash (10 min). The washing steps dry the gel pieces,
which are subsequently rehydrated with a 25 mM NH4HCO3 buffer containing a
proteolytic enzyme, such as trypsin. In most work, trypsin is the protease of choice of
peptide mass fingerprinting because it is very reliable and substrate-specific. Tryptic
digests produce peptides with C-terminal basic residues (Arg and Lys), rendering them
easily ionizable, thus facilitating mass spectrometric analyses. Approximately 10% of all
bonds in a protein are suitable cleavage sites for this enzyme. Trypsin is usually dissolved
in ice cold buffer, just prior to use, so as to limit auto-proteolysis. The gel pieces are
incubated in trypsin at 4oC for 40 min, following which the enzyme solution is removed
and fresh 25 mM NH4HCO3 buffer (~10 μL) is added. After incubation of the gel pieces
at 50oC for 4 hours, 1 μL of formic acid is added to encourage protonation of tryptic
peptides. The resulting peptides are then subjected to mass spectrometric analysis.

MALDI-TOF-MS

Matrix-assisted laser desorption/ionization or MALDI was first introduced by
Karas and Hillenkamp in 1988 (24). They discovered that the incorporating the analyte
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into the crystalline structure of small UV-absorbing organic molecules (matrix) provided
a vehicle for ions to be created from polar or charged biomolecules. This assured that the
once restrictive mass limitations of laser desorption/ionization could be circumvented.
Since then, MALDI has evolved into a powerful ionization method for biological
molecules and synthetic polymers. MALDI coupled to time-of-flight MS (TOF-MS), a
mass analyzer designed in 1955 by Wiley and McLaren (25), has evolved into the
workhorse and benchmark macromolecule analyses. Since MALDI ions are produced by
a pulsed laser, these ion sources can be conveniently coupled to TOF mass spectrometers,
which require a well-defined start time. With the establishment of proteomics as a key
area of research in mass spectrometry, interest in the analysis of biomolecules has risen
dramatically and with it, interest in MALDI-TOF-MS.

The MALDI Process

In the MALDI technique, the sample is mixed with an excess of an appropriate
matrix and irradiated with a laser beam of short (10 – 20 ns) pulses. The laser power is
normalized with respect to the irradiated area (~ 50 μm), with power densities in the
range of ~106 W/cm2 irradiance power (26). Multiple laser pulses are usually averaged to
enhance signal-to-noise ratio (SNR). The primary function of the matrix is to absorb
radiation at the wavelength of the laser and subsequently transfer it to the analyte.
Absorption of energy from the laser beam causes desorption of the matrix, along with
analyte molecules. Ionization of the analyte follows through gas-phase proton-transfer
reactions. MALDI is amenable to both positive and negative ion analyses. The MALDI
mass spectra of proteins and peptides typically display singly protonated analyte
molecules, along with their oligomeric ions (i.e. [M+H]+, [2M+H]+, etc.). In some
instances, doubly and triply charged protonated ions of low abundance can also be
generated. The higher the mass of the analytes, the greater their propensity to form
multiply charged ions.
Sample Preparation
In a MALDI experiment, analyte and matrix is spotted onto a MALDI target
(Figure 2.1.4) and subjected to laser irradiation. There are several methods available for
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Figure 2.1.4. The MALDI process.
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sample preparation and a good choice is made based on the needs of the sample at hand.
For the analysis of tryptic peptides, the fast matrix evaporation method can be used (27).
Matrix solution (in a volatile solvent, such as acetone) is applied to the surface of the
MALDI target (Figure 2.1.5) to create a thin film of crystals. HCCA or α-cyano-4hydroxycinnamic acid (Figure 2.1.6) is a well-suited matrix for peptide samples. This
matrix can be prepared as a 10 mg/mL solution in acetone : 0.1% aqueous TFA = 9:1.
Once the matrix layer is dry, about 0.8 μL of a protein digest is added on top of the
polycrystalline film. Upon drying, the sample spots are washed with 0.1% aqueous TFA
to remove unwanted salts. The matrix/analyte spots are dried again and subjected to MS.
Analysis by MALDI-TOF-MS is very sensitive to sample preparation and so care
must be taken at each step to avoid contamination and eliminate any potential
interference that could mask peptide peaks. By virtue of the homogeneous crystal
structure generated, the fast matrix evaporation approach provides higher resolution,
sensitivity and signal reproducibility compared to other sample preparation methods.
Mechanism of Desorption and Ion Formation
The mechanism by which molecules are desorbed and photoionized is not very
well understood (Figure 2.1.4). However, three different models are now recognized as
viable candidates for explaining this phenomenon. The first one involves quasithermal
evaporation as a result of increased molecular motion. The second model describes the
expulsion of upper lattice layers in the MALDI process. Finally, the third possibility
explains desorption/ionization from a standpoint of increases in the hydrodynamic
pressure due to rapidly expanding molecules in the crystal lattice (26). Regardless, all
three hypotheses agree that the MALDI matrix plays a pivotal role in sample ionization.
A good MALDI matrix should have high molar absorptivity at the selected laser
wavelength (337 nm for a nitrogen laser), be able to form microcrystals with the analyte,
have low sublimation temperature and possess the ability to engage in photochemical
reactions (27). Laser radiation strikes the matrix, causing absorption of energy and
heating of matrix crystals when they emit the absorbed energy. Matrix molecules sublime
due to the heat generation, sending both matrix and analyte molecules into a dense
gaseous plume.
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Figure 2.1.5. The MALDI target.
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Figure 2.1.6. MALDI matrix: α-cyano-4-hydroxycinnamic acid (HCCA).
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Since the analyte is embedded within the matrix during sample preparation, this process
can also remove buffer and salt contaminants (26).
One popular hypothesis (26) states that following desorption as neutral species,
the analyte molecules become ionized through acid-base reactions with the protonated
matrix. This is said to occur within the plume of particles ablated by the laser pulse and
just above the matrix layer. The protonated matrix molecules are produced by
photochemical reactions. Another possibility is that the singly excited matrix molecules
(and not the photoionized matrix molecules) are responsible for analyte ionization.
According to this model, two excited matrix molecules are needed to produce ionized
gaseous analyte ions. Karas et al. (28) suggested the formation of initial matrix clusters,
protonated/deprotonated analyte molecules and counter-ions, as well as the desolvation of
desorbed clusters to generate free ionic species through acid/base reactions and
evaporation of neutrals. Electrons generated during matrix photoionization are captured
by charged clusters to form singly charged ions. Electron capture is also believed to be
responsible for fragmentation (26).

TOF-MS

A time-of-flight mass spectrometer is one of the simplest mass analyzing devices
(Figure 2.1.7) available. It is commonly used for MALDI-MS because ion pulses
produced in MALDI provide the sampling mode required by TOF analyzers. A TOF
mass spectrometer is a velocity spectrometer, in which ion separation occurs as a result of
velocity differences. Following laser desorption, a short pulse of ions leaves the MALDI
source and is dispersed in time by allowing it to drift in a field-free region (FFR) of a
long flight tube. It is in this FFR where separation based on m/z occurs. TOF mass
analyzers offer a variety of advantages, including high analysis speed, simplicity of
design, high transmission, (theoretically) unlimited mass range, concurrent detection of
all ions (multiplex advantage), as well as compatibility with pulsed ionization sources,
such as MALDI (26).
Ions produced by a laser pulse through MALDI are extracted into the TOF
analyzer by an electrical field V. The principle behind the mass analysis is that after
acceleration to a constant kinetic energy, the ions travel at velocities, v, that are inversely
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Figure 2.1.7. Time-of-flight (TOF) mass spectrometry.
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proportional to the square root of their m/z values. The kinetic energy can be expressed as
follows (27):
KE = zeV

(2.1.8)

where,

z = charge of molecular ion
e = charge of an electron (Coulombs)
V = electric field strength (Volts).

In ideal situations, all ions, small and large, enter the FFR with the same kinetic energy.
According to Newton’s law:
2

⎛1⎞
⎛ 1 ⎞ ⎛ dx ⎞
KE = ⎜ ⎟mv 2 = ⎜ ⎟m⎜ ⎟ .
⎝2⎠
⎝ 2 ⎠ ⎝ dt ⎠

(2.1.9)

Therefore,
2

⎛ 1 ⎞ ⎛ dx ⎞
zeV = ⎜ ⎟m⎜ ⎟ .
⎝ 2 ⎠ ⎝ dt ⎠

(2.1.10)

Compared to the flight path and time of flight, the source region is very short and ions
spend comparatively little time there. Thus, the velocity can be considered to be constant
in these equations. As such, the instantaneous velocity can be expressed as a ratio of the
total field free flight path (Δx) and flight time (Δt). The m/z for a given ion can be
calculated as follows (27):
Δt 2
m / z = 2eV
Δx 2
where,

(2.1.11)
m = mass (kg)

Δx = flight path length (m)
Δt = flight time (s).
The short ion pulse is eventually dispersed into packets of iso-mass ions, as it travels
through the flight tube. Ion arrival time can be used to perform mass analysis:
Δx
⎛ m ⎞
Δt =
= Δx⎜
⎟
v
⎝ 2 zeV ⎠

1/ 2

.

(2.1.12)

If all ions obtain the same kinetic energy, the ions of lesser m/z will have greater velocity
than ions of greater m/z. Therefore, as ions traverse the analyzer, they separate in space.
A detector is positioned at the end of the analyzer to measure the arrival time of ions. The
ions of lesser m/z arrive first, followed by ions of greater m/z (26).
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Since MALDI typically generates singly charged ions, a mass analyzer with high
mass range is required. In theory, TOF has an unlimited mass range, which places strict
requirements on the detector because they are velocity-sensitive detectors. Due to the fact
that velocity decreases inversely with the square root of the mass, the sensitivity of TOFMS is lower for larger ions.
Pulsed Ion Extraction
When ions are formed in MALDI, they have a kinetic energy, directional, spatial
and temporal spread due to the ionization process, which can cause peak broadening. By
generating ions in a weak electric field and applying a high voltage extracting field
following a time delay, the effect of this spread can be minimized. Ions are first allowed
to expand into a field-free region in the source and after a certain delay (hundreds of
nanoseconds to several microseconds) a voltage pulse is applied to extract the ions
outside the source (26).
The Reflectron
Further improvements in resolution can be achieved by incorporating a reflectron
(29) in the TOF instrument. Due to the large kinetic energy spread of the ions (which
increases with mass) produced at the surface of the sample/matrix spot, linear TOF
(Figure 2.1.8) analyzers are unable to offer high mass resolution in the absence of any
compensation. The reflectron TOF (Figure 2.1.9) features two linear field-free regions
and an ion mirror, which corrects for kinetic energy and spatial dispersions of ions of the
same m/z. The ion mirror consists of an array of electrical lenses, each having
progressively higher repelling potential. The initial spatial spread is translated to a
velocity spread, which can be easily corrected by the mirror.
Ions entering the reflectron, after traversing the first FFR, are slowed down and
then their direction of motion is reversed. This is followed by acceleration into a second
FFR. Ions of a given m/z with faster velocities spend less time in the drift regions, but
penetrate to a greater depth into the reflecting field. As a result, they spend more time in
the reflectron, which compensates for the shorter flight times of faster ions in the drift
regions. The end result is that all ions of the same m/z arrive simultaneously at the
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Figure 2.1.8. Linear mode TOF-MS operation.
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Figure 2.1.9. Reflectron mode TOF-MS operation.
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detector, situated at the end of the flight path. Considerable improvements in mass
resolution can be achieved in this manner. An additional contributing factor in improving
the mass resolution is the longer path length provided by reflectron. Dramatic
improvements are realized over linear TOF-MS instruments for <10 kDa molecular mass
compounds. The total flight time of an ion in the reflectron is given by:
⎛ m ⎞
t =⎜
⎟
⎝ 2 zeV ⎠

1/ 2

where,

(L1 + L2 + 4d )

(2.1.13)

L1 = first field-free region
L2 = second field-free region
d = depth of ion penetration into the reflecting field.

Reflectrons can be either single-stage or dual-stage. A single-stage reflectron is a simple
ion mirror that provides a singe retarding-reflecting field. The device consists of an
entrance grid electrode and a series of ring electrodes. With a single-stage reflectron, first
order correction for the kinetic energy spread is achieved. Dual-stage reflectrons feature
two linear retarding voltage regions separated by an additional grid and can provide
improved resolution at the expense of sensitivity (26).
Protein Identification by MALDI-TOF-MS
MALDI-TOF-MS is a powerful technique for proteomics analyses. Mass
spectrometric analysis generates a mass fingerprint or profile which is unique to a
particular protein. Comparison of this peptide mass fingerprint (PMF) with databases of
known protein digest fingerprints provides the means of protein identification. PMF
works well with analytical proteomics because it combines a conceptually simple
approach with robust, high-throughput instrumentation. The quality of protein
identifications made depend on the quality of the MS data, the accuracy of the databases
and power of the search algorithms and software used.

Database Searching

An algorithm is a set of rules that specify how to solve a well-formulated problem
in a finite number of steps. The problem is described in terms of inputs and outputs and

152

the algorithm facilitates the conversion of inputs to outputs. As the field of proteomics
acquires momentum in the wake of the genomics era, several algorithms and computer
programs have been described for protein identification. Many programs involve the
interrogation of a sequence database with mass spectrometric data from the unknown
protein. An in silico digestion of the entire sequence database according to suitable
fragmentation rules (depending upon the proteolytic enzyme being used) produces a list
of theoretical peptide mass values which can be compared to the experimental data.
Equivalent peptide masses are tallied or scored such that the peptide or protein providing
the closest match with experimental data can be identified (30).
In situations where the target protein is not present in the database, entries with
homology similar to the protein in question are identified. These entries are usually
proteins of similar structure and/or function from related organisms. Of the protein
identification algorithms available, the MASCOT algorithm offers the substantial
advantage of probability-based scoring. In this approach to peptide mass scoring, a
straightforward mathematical rule can be employed to evaluate the significance of the
result, thereby avoiding false positives. Furthermore, it is possible to draw comparisons
between these scores and those derived from other types of searches, including
determination of sequence homology. Finally, the search parameters can be optimized
through iteration (30).
With MASCOT, the database can be searched using a peptide mass fingerprint
(PMF), sequence query and MS/MS information from target proteins. MASCOT was
originally designed as an extension of the MOWSE (Molecular Weight Search) scoring
algorithm (31). In a typical MOWSE search, the theoretical peptide masses for all the
entries in the sequence database are compared with the experimental data. A match is
said to occur when a calculated value falls within a pre-defined mass tolerance of an
experimental mass. A molecular weight range for the intact protein from gel
electrophoresis data can be applied as a pre-filter. MOWSE assigns a statistical weight to
each peptide match by considering several empirically determined factors.
In the MOWSE approach, a matrix F of all the weighting factors of in silico
peptides is calculated during the database build stage. Each row in this matrix represents
a 100 Da interval in peptide fragment mass while each column is an interval of 10 kDa in
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intact protein mass. With the analysis of each sequence entry, the appropriate matrix
elements fij are incremented to generate statistical information on the size distribution of
peptide masses as a function of protein mass. Matrix normalization is achieved by
dividing the elements of each 10 kDa column in F by the largest number in the column.
This produces the MOWSE factor matrix M:
mij =

f ij
f ij

.

(2.1.14)

j max

Experimental mass values are searched against the theoretical peptide mass database and
the score for each entry is determined:
Score =

50000
M prot × ∏ mij

(2.1.15)

n

where,

Mprot = molecular weight of the entry.

The product term in the denominator is determined from the MOWSE factor elements for
each match between the experimental data set and peptide masses calculated from the
entry (32).
The MASCOT algorithm uses a probability-based approach of the MOWSE
algorithm. As such, it incorporates the significant benefits of MOWSE, including the
ability of this program to accurately model the behavior of a proteolytic enzyme. There
are noteworthy differences between MOWSE and MASCOT aside from probabilitybased scoring, such as the removal of pre-built indexes (30). A FASTA format of the
sequence database is directly compatible with MASCOT. To maximize search speed, the
FASTA format can be compressed and incorporated into the computer memory.
The basic modus operandi in MASCOT is the determination of the likelihood that
the observed match between the experimental data set and each sequence database entry
occurs at random. The match securing the lowest probability is reported as the best
match. This match may or may not be a significant one, depending upon the size of the
database. A generally accepted significance threshold is that the probability of the
observed result being a chance event is less than 5% (p < 0.05). MASCOT reports the
scores as -10Log10P, where P is the probability. MASCOT accepts MS data as lists of
centroided mass values (peak lists), and if preferred, with associated intensity values as
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well. When using MS/MS data, it is also necessary to detect the peaks in the
chromatogram. Several spectra from a single peptide may be added together while at the
same time eliminating spectra from the chromatogram baseline that would otherwise
contribute to noise (32).
One of the challenges in using PMF data with MASCOT is the elimination of
false positive results. Some basic assumptions are associated with a MASCOT search.
Experimental data are considered to be independent measurements taken from the larger
population of all possible measurements. In situations when data are not independent, the
absolute score becomes an unreliable indication of significance. Another problem is the
frequent observation of identical masses. For pairs of duplicate masses, if one matches,
then so will the other. The score determined on the presumption that these are
autonomous matches, is higher than it should be. In PMF data, this can occur because the
mass error window specified by the user is too large. Another possibility is that the peaks
are split by noise or poor calibration. For MS/MS data, scans for a single
chromatographic peak may not have been averaged. In some situations, particularly when
non-quantitative modifications are applied, data lacking duplicate values can produce
statistically significant scores in searches against the random database. It is possible that
the data contain pairs of masses differing by the mass difference of the modification. For
these pairs, if one of the values happens to match a theoretical sequence containing the
modifiable residue, the likelihood of the other value matching the same sequence
becomes significant. The experimental data are then not independent and the score is
higher than it ought to be (30). While the use of probability-based scoring in MASCOT is
a significant improvement over other approaches, there is certainly much room for further
improvements in protein identification technology.

Goals

The importance of research in alternative sources of fuel, particularly biofuels
research, has been highlighted in this chapter. The applicability of bacterial fermenters in
industrial bio-ethanol production was considered and an overview of the current
knowledge in bacterial ethanol tolerance and adaptation has been provided. In light of

155

evidence suggesting that a majority of changes associated with ethanol adaptation occur
in the bacterial membrane proteome, a closer look at membrane protein expression
patterns is warranted. The advantages and pitfalls associated with membrane protein
analysis using gel-based approaches were discussed, along with other gel-free
alternatives. A review of the literature clearly indicates that gel electrophoresis methods
are still the gold standard of protein separation. A description of gel-based proteomic
analyses is provided, including a discussion of polyacrylamide gel electrophoresis, in-gel
digestion of proteins, methods for protein visualization, MALDI-TOF mass spectrometry
of protein digests, as well as protein identification using database searching.
Through careful study of the gel electrophoresis experiment, a new and more
improved SDS-PAGE methodology was developed which could be effectively applied to
the analysis of membrane proteins, particularly those of the bio-ethanol producer
Clostridium thermocellum. Information from these investigations should provide a better
understanding of ethanol adaptation by this organism. Chapter 2.2 describes the design of
doubled SDS-PAGE (dSDS-PAGE) methodologies for membrane protein analysis. The
wild type C. thermocellum membrane proteome was chosen as the model system for
these experiments. Standard glycine-based running buffers (Laemmli protocol) (19),
along with tricine-based (33) and the newly developed bicine-based buffer systems (34)
were examined in their suitability for separation of such proteins. The parameter space of
gel preparation in Tricine- and Bicine-dSDS-PAGE was explored and a description of the
optimization of these parameters is given. The compatibility of these dSDS-PAGE
methods with mass spectrometric analysis of digested proteins extracted from the gel was
investigated. The improved suitability of bicine-based running buffers in membrane
proteome analyses was explained through capillary electrophoresis experiments.
Chapter 2.3 focuses on the application of the Bicine-dSDS-PAGE methodology in
the analysis of membrane proteins derived from wild type and ethanol-adapted C.
thermocellum strains. Definitive changes in membrane protein expression patterns were
observed between these bacteria and a discussion of differentially expressed proteins in
the backdrop of ethanol tolerance is provided.
Chapter 2.4 offers some concluding remarks and highlights the significance and
future direction of this work.
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Chapter 2.2
Methods Development in Two-Dimensional Polyacrylamide Gel Electrophoresis for
Membrane Proteins

Introduction

Since Laemmli’s introduction of the discontinuous SDS-PAGE system (19),
several modifications and improvements have led to significant strides in gel-based
protein separations. Inclusion of urea has shown benefits in terms of resolution and
enabling the use of higher levels of cross-linker (%C - N’,N’-methylenebisacrylamide or
Bis) for the separation of low molecular weight proteins (35-38). However, despite these
benefits, urea can carbamylate proteins, thus complicating proteomic analysis,
particularly for larger proteins. Other reports have explored high Tris concentrations in
the buffer and gel (39), glycerol in the gel (40) and running buffer modifiers (35, 36, 41)
in lieu of or in addition to urea. These investigations have led to benefits in dynamic
range, resolution and protein representation. The advent of 2D-SDS-PAGE enabled
orthogonal protein separation by both charge and size, further improving the technique
and vastly increasing protein representation (42). However, with all these advances also
came the realization that the cellular proteome is comprised of many sub-proteomes
which often require different sample preparation conditions for optimum separation.
One particular sub-proteome that has been notoriously resistant to detailed
analysis by 2D-SDS-PAGE includes the proteins associated with cell membranes. Many
of these proteins are hydrophobic in nature, which makes them very difficult to solubilize
in the first dimensional or isoelectric focusing (IEF) step (13). Typically used IEF sample
buffers are detergent free and are not adequate to dissolve these proteins and furthermore,
dissolved membrane proteins have a tendency to precipitate at their isoelectric points
(15). As a consequence, they are quite consistently under-represented in traditional 2DSDS-PAGE. Improvements that have been suggested include the use of various ionic,
zwitterionic and nonionic detergents, as well as different combinations of these, to
promote solubilization (43-54). Other reports described the substitution of dithiothreitol
(DTT) with the uncharged reducing agent tributyl phosphine (TBP; (44, 55-57)), which
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assists in maintaining reducing conditions during IEF and lowers the likelihood of
precipitation that could occur through aggregation initiated by disulfide bonding.
Subproteomics and prefractionation techniques have recently been explored to improve
representation of membrane proteins expressed in low copy numbers (58, 59). Selective
enrichment of certain classes of proteins, such as periplasmic proteins, to enhance their
abundance in 2D gels has also been described (60). While all these approaches have
improved membrane protein analysis to some extent, solubility issues associated with IEF
have not been fully eliminated.
Since the main problems with membrane protein separation arise during IEF
separation, alternatives to the standard 2D-PAGE approach that circumvent this step have
been considered. Schägger and co-workers (17) described a doubled SDS-PAGE (dSDSPAGE) experiment in which SDS-PAGE separation of membrane proteins in the first
dimension was followed by an additional SDS-PAGE separation in a second dimension
to generate a diagonal arrangement of protein spots. The effectiveness of this dSDSPAGE approach is influenced by the type of buffer system (e.g. glycine- or tricinebased), presence of urea and acrylamide content in the gels. Indeed, highly hydrophobic
membrane proteins from bovine heart mitochondria were successfully separated with this
approach (17). In a similar set of experiments, Sánchez et al. (61) separated outer
membrane protein complexes and heat-modifiable proteins in Neisseria strains. The
authors explored different combinations of non-denaturing and denaturing conditions in
1D and 2D for the purposes of optimizing separation. Eliminating β-mercaptoethanol
from the 1D sample buffer enhanced spot resolution. They also postulated that
incubating the 1D sample strip under denaturing conditions prior to running the second
dimension offered better separation and spot resolution compared to incubation under
non-denaturing conditions. Despite these benefits of dSDS-PAGE, the technique is still
not widely used and in fact, there are few other reports of its application (62, 63).
Tricine-based running buffer systems (17) have been successfully applied in the
separation of various types of proteins (17) and cell surface structures (e.g., bacterial
lipopolysaccharides) (33, 64-73). Advantages of tricine over glycine-based buffers
include improved protein migration, especially in the presence of potentially interfering
substrates (72); and improved stacking and destacking of middle (64) and low (67)
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molecular weight proteins, resulting in better resolution. This improved resolution was
theoretically (74-76) and experimentally (77) explained by increases in ionic strength, as
would be associated with a Tricine-SDS-PAGE buffer system.
As with any separation method, modification of the mobile phase or running
buffer can change the separation process. Since Tricine-dSDS-PAGE is a powerful tool
in membrane protein separation, we explored other buffer systems in conjunction with
the dSDS-PAGE approach and describe an orthogonal Bicine-dSDS-PAGE method for
the analysis of membrane proteins from the anaerobic bacterium, Clostridium
thermocellum. This organism produces ethanol from fibrous biomass but has low
tolerance to ethanol build-up in the medium. Recently, strains able to tolerate up to 8%
ethanol have been developed and studies have shown that changes in the membrane
proteome are elicited by ethanol (78). Comparisons of Bicine-dSDS-PAGE to TricinedSDS-PAGE and the standard Glycine-dSDS-PAGE (Laemmli method) revealed a
considerably better separation method for membrane-associated proteins, as well as
highly basic proteins, in addition to the advantage of circumventing solubility issues in
the first dimension of standard 2D-SDS-PAGE experiments. These differences between
bicine, tricine and glycine were explained through capillary electrophoresis investigations
of electrophoretic migrations. Both Bicine- and Tricine-dSDS-PAGE were amenable to
protein spot analysis and identification by mass spectrometry.

Experimental

Materials

All materials and chemicals for the growth of bacterial cultures were from Sigma
(St. Louis, MO) except yeast extract, which was obtained from Difco Laboratories
(Detroit, MI). Laemmli sample buffer, Coomassie stains, Tris base, SDS, acrylamide,
N,N-methylene-bis-acrylamide (bis), ammonium persulfate (APS), N,N,N,N-tetramethylethylenediamine (TEMED), glycine and tricine were obtained from Bio-Rad (Hercules,
CA). Bicine, ammonium bicarbonate and the MALDI matrix α-cyano-4hydroxycinnamic acid (HCCA) came from Sigma. Methanol, glycerol, o-phosphoric
acid, hydrochloric acid, formic acid, trifluoroacetic acid (TFA), boric acid, acetonitrile
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and trypsin were purchased from Fisher Scientific (Pittsburg, PA). Ammonium sulfate
was obtained from EMD Chemicals (Gibbstown, NJ).

Bacterial Strains and Growth Conditions

Clostridium thermocellum ATCC 27405 was obtained from the American Type
Culture Collection and cultured in a medium that contained 10.8 mM Na2HPO4, 11.05
mM KH2PO4, 9.35 mM NH4Cl, 3.79 mM (NH4)2SO4, 0.44 mM MgCl2.6H2O, 0.27 mM
CaCl2, 2.0 g/L yeast extract, 0.5 g of cysteine, 10 mL of a vitamin standard mixture (79),
5 mL of a modified micromineral mixture (79) and 1 mg/L of the oxygen indicator
resazurin. The stock micromineral mixture was modified to provide 10 mg of
Na2WO4.2H2O and 1 mg of Na2SeO3 per liter of medium. The basal medium was
adjusted to pH 6.7 with 10% NaOH and autoclaved for 10 min to remove dissolved
gases. Carbon dioxide was then immediately bubbled through the solution until it was
cooled to room temperature and an anaerobic solution containing 4 g of Na2CO3 was then
added. The medium was anaerobically dispensed into culture tubes and bottles and
sterilized by autoclaving for 20 min. This basal medium was supplemented with an
anaerobic solution of cellobiose to provide a final concentration of 4 g/L.
Cell cultures were grown at 55ºC and harvested once the optical density at 600
nm had reached approximately 1.0. The cultures were then centrifuged at 15,000 x g for
10 min at 4oC. The supernatant was discarded and the pellets re-suspended with 40 mL of
50 mM Tris, pH 7.5. This was followed by another 10 min centrifugation and an
additional wash step. Cell pellets were finally re-suspended in the Tris buffer to a final
optical density of approximately 50. The concentrated cells were stored at -80oC.

Preparation of Membrane Protein Fractions

Concentrated C. thermocellum cells were thawed and
phenylmethylsulfonylfluoride (PMSF) and DTT were added to achieve final
concentrations of 5 mM for each. The cells were then lysed by passage through a French
Press (SLM Aminco, Urbana, IL) three times at 137 MPa. The broken cells were
centrifuged for 10 min at 5,700 x g and 4oC. The pellets were discarded and the
supernatant centrifuged at 200,000 x g and 4oC for 45 min. The resulting membrane
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pellet was re-suspended in 10 mL of 10 mM Tris, pH 7.5. Next, the pellet was
centrifuged twice (200,000 x g, 4oC, 45 min), and finally re-suspended in 10 mM Tris,
pH 7.5, to obtain a protein concentration of approximately 6.4 mg/mL. Protein content
was determined using the Lowry assay (80). Aliquots of re-suspended proteins were
stored at -80oC until further use.

The dSDS-PAGE Experiment

Small (7 cm x 8 cm) and large (20 cm x 20 cm) format gel experiments were
performed at 4oC with Mini PROTEAN II and PROTEAN II xi electrophoresis cells
(Bio-Rad), respectively. Linear acrylamide gradients in the second dimension of dSDSPAGE were generated using a Model 485 Gradient Former and all gels were run at 4oC.
The first dimension of a dSDS-PAGE experiment consisted of a 4% acrylamide stacking
gel and a 10% separating gel. Gel thickness was 0.75 mm and 1.0 mm for small and large
formats, respectively. The Laemmli protocol (19) was used to separate the proteins in the
first dimension for Glycine-, Tricine- and Bicine-dSDS-PAGE. Small format gels were
run at a constant 200 V, with run times of approximately 50 min. The large format gels
were run at 16 mA/gel for protein migration through the stacking gel, and this was then
increased to 24 mA/gel when the dye front entered the separating gel. Run times for large
format 1D gels were approximately 7 h.
Membrane proteins were then further resolved in the second dimension by a 912% linear acrylamide gradient gel. After staining with Coomassie R-250 overnight, gel
strips (approximately 5 mm wide) were excised from the first dimension, swelled for 30
min in buffer (100 mM Tris, 150 mM HCl, approximately pH 2) (17), and then placed in
between the glass plates and on top of the separating gel of the second dimension (Figure
2.2.1). Gaps between the excised gel lane and spacers of the second dimension were
filled with gel mixtures that contained 10% acrylamide, the same composition as in the
1D strip. Gel and running buffer preparation for the second dimension of Glycine-dSDSPAGE followed the Laemmli protocol (19). In the case of Tricine-dSDS-PAGE, the
second dimension running buffer was prepared as described by Hunte et al. (81) and a
similar system was designed for Bicine-dSDS-PAGE (Table 2.2.1). In the interest of
methods development and optimization, a series of experiments were performed for the
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First dimension

Second dimension
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Figure 2.2.1. Doubled SDS-PAGE (dSDS-PAGE) experiment with molecular weightbased separations in two dimensions. A first dimensional separation was performed
(Laemmli protocol) using a 4% stacking gel and 10% resolving gel. The 1D sample strip
was then further separated in the second dimension by a 9-12% linear acrylamide
gradient gel using glycine-, tricine- or bicine-based buffer systems.
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Table 2.2.1. Running buffer composition of second dimension dSDS-PAGE gels.
Glycine-dSDSPAGEa

Bicine-dSDSPAGE

Tricine-dSDSPAGEb

Anode Buffer

25 mM Tris
192 mM glycine
0.1% SDS
pH 8.3

200 mM Tris
pH 8.9

200 mM Tris
pH 8.9

Cathode Buffer

25 mM Tris
192 mM glycine
0.1% SDS
pH 8.3

100 mM Tris
100 mM bicine
0.1% SDS
pH 8.3

100 mM Tris
100 mM tricine
0.1% SDS
pH 8.3

a

As previously described (19)

b

As previously described (33)

163

second dimension of Tricine- and Bicine-dSDS-PAGE. In all second dimension
experiments, the gel thickness for the small and large formats was 1 mm and 1.5 mm,
respectively. For the second dimension of Bicine- and Tricine-dSDS-PAGE small format
gels, electrophoresis was performed by applying a constant 100 V for 30 min to allow
protein migration through the width of the 1D strip and overlay gel. When the dye front
entered the separating gel, the voltage was increased to and maintained at 150 V. Run
times were typically 2.5 h. For large format gels in the second dimension of Bicine- and
Tricine-dSDS-PAGE, running conditions were 90 V for the first 30 min and 120 V
thereafter, with run times of approximately 24 h. All second dimension gels were stained
with G-250 Colloidal Coomassie (23).

Image Analyses

Gel images were captured using a Bio-rad Versadoc Imaging System and analysis
of 1D and 2D images was performed by Bio-Rad Quantity One and PDQuest software,
respectively. Images shown in figures are Gaussian representations generated by the
software.

Protein Identification

Tryptic digests of membrane proteins were examined in positive ion mode using a
Bruker Autoflex MALDI-TOF or a Finnigan LCQ Classic quadrupole ion trap mass
spectrometer. HCCA was used as the matrix of choice for protein samples. MALDI
spectra were internally calibrated using peptides generated from trypsin autolysis. Peptide
mass fingerprinting data (PMF) with monoisotopic peak mass lists were analyzed using
the MASCOT algorithm and the C. thermocellum database (82). Protein spots that could
not be identified by MALDI were subjected to LC-ESI-MS/MS and C. thermocellum
database searching with MASCOT.
A Hewlett Packard LC system (1100 series) with a custom-made C18 capillary LC
column was interfaced to the ion trap mass spectrometer for reversed phase LC-MS/MS
analyses. A mobile phase mixture of water and acetonitrile (ACN), each containing 0.1%
formic acid, was used in all experiments. Gradient elution was employed in these studies,
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similar to the profile described in Chapter 1.2 of Part 1. LCQ data was also analyzed by
the MASCOT algorithm and the C. thermocellum database.

Capillary Electrophoresis

Capillary electrophoresis (CE) experiments were performed on a Groton
Biosystem CE equipped with a UV detector (Boxborough, MA). The detection
wavelength was set at 290 nm. An uncoated fused silica capillary (Polymicro
Technologies, Phoenix, AZ) with dimensions of 95 cm (70 cm effective length) x 75 μm
I.D was used for separation. A background electrolyte (BGE) containing 100 mM borate
buffer at the desired pH and 10 mM 2-methyl-1,3-cyclohexanedione was used in all
experiments. Prior to use, the capillary was rinsed with 1.0 M NaOH for 10 min,
followed by 0.1 M NaOH for 10 min, water for 5 min and finally with BGE for 10 min.
After each run, the capillary was rinsed with 0.1 M NaOH for 1 min, methanol for 1 min
and with BGE for 5 min. Samples were injected hydrodynamically at a pressure of 50
mbar for 6 seconds. BGE was replaced after every alternate run. Analytes were identified
by indirect UV detection and 2-methy-1,3-cyclohexanedione was included in the BGE as
a UV-absorbing probe.

Results and Discussion

Optimization of the dSDS-PAGE Experiment

As with any separation experiment, manipulation of the mobile and stationary
phases can often yield improved sensitivity and resolution. Therefore, the parameter
space of gel preparation (stationary phase) and the running buffer system (mobile phase)
were manipulated to arrive at the optimal separation conditions for C. thermocellum
membrane proteins. Tricine-dSDS-PAGE and the newly developed Bicine-dSDS-PAGE
were explored in this regard. Bicine or N,N-bis(2-hydroxyethyl)glycine is a tertiary
amine and has buffering capacity for the pH range of 7.6 – 9.0 (pka1 = 1.84 and pka2 =
8.35). Tricine or N-tris-(hydroxymethyl)-methylglycine is a secondary amine buffer for
the pH range of 7.4 – 8.8 (pka1 = 2.3 and pka2 = 8.15). SDS-PAGE gels and running
buffers are normally operated in the 6.6 – 8.8 pH range, which makes bicine- and tricine-
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based buffer systems somewhat more suitable as the range is within a reasonable
proximity of their pka2 values. To ensure maximum buffering action of bicine and tricine,
the pH of running buffers based on these ions were adjusted to be close to their pKa2
values. Operating at higher pH to accommodate the pH range of 8.8 – 10.6 buffering
region of the primary amine glycine (pka1 = 2.35 and pka2 = 9.78) used in the Laemmli
approach of dSDS-PAGE is not advised due to the susceptibility of acrylamide to
hydrolysis (83).
Optimization of gel preparation parameters was performed using small format
gels. We previously determined that a 10% acrylamide gel in the first dimension,
followed by a 9-12% linear gradient gel in the second dimension of dSDS-PAGE
provided reasonable protein spot resolution across the entire molecular weight range of
the C. thermocellum membrane proteome (84). An overlay gel containing the same
acrylamide percentage as the 1D sample strip and 150 mM Tris-HCl, pH 7.4, provided
electrical conductivity similar to that of the 1D strip and maintained a neutral pH for
efficient polymerization of acrylamide (17). Running buffer compositions for all
experiments are given in Table 2.2.1. The method of Schägger et al. (81) was used to
prepare running buffer for Tricine-dSDS-PAGE and a suitable protocol was designed for
Bicine-dSDS-PAGE. Preliminary investigations involved applying the standard Laemmli
gel preparation protocol with these two buffer systems. Bicine- and Tricine-dSDS-PAGE
resulted in similar spot number, which was much poorer compared to Glycine-dSDSPAGE. Considerable vertical streaking was observed and overall, it was evident that the
Laemmli method for gel preparation was not well-suited for use with these buffer
systems, as shown in Figures 2.2.2(A) and (B).
There have been reports of enhanced electrophoretic performance by
incorporating glycerol in the gel, due to improved sieving (36) and mechanical stability
(40). Enhanced resolution, particularly for peptides, is a result of either exclusion or
ordering of water in the resolving gel (39). Furthermore, due to its viscous nature,
glycerol is believed to aid in the separation and staining processes by reducing diffusion
(40). In our experiments, addition of glycerol to the gel solution while keeping all other
ingredients similar to the Laemmli protocol did not result in any significant increases in
spot numbers for Tricine-dSDS-PAGE, although there were marginal increases in the

166

(A)
kDa

31 spots
97.4
66.2

45.0
31.0
21.5
14.4

(B)
kDa

38 spots
97.4
66.2

45.0
31.0
21.5
14.4

Figure 2.2.2. Standard Laemmli protocol in gel preparation for (A) Bicine-dSDS-PAGE
and (B) Tricine-dSDS-PAGE.
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case of Bicine-dSDS-PAGE. Vertical streaking remained a significant problem.
However, there appeared to be improvements in spot resolution, particularly in TricinedSDS-PAGE, as shown in Figures 2.2.3(A) and (B).
The effect of increasing the Tris concentration in the gel solution was also
investigated, as theoretical (74-76) and experimental (39, 77) evidence suggested that
increased ionic strength can play a pivotal role in the successful stacking, migration and
resolution of proteins. Just as with glycerol, high amounts of Tris in the resolving gel is
also believed to improve resolution by excluding or ordering water in the gel (39).
Keeping all other gel preparation parameters the same as the Laemmli protocol, higher
concentrations of Tris were explored in the gel recipie for Bicine- and Tricine-dSDSPAGE. Compared to the gels with glycerol, no detectable increases in protein spot
numbers were observed in either case. Problems with vertical streaking were improved,
especially for Tricine-dSDS-PAGE. In addition, spot resolution was better (spots less
diffuse) for both Bicine- and Tricine-dSDS-PAGE, as shown in Figures 2.2.4(A) and (B).
Dramatic improvements were observed when both glycerol and increased Tris
concentrations were incorporated into the gel solutions for Bicine- and Tricine-dSDSPAGE. Gels that had glycerol and a high Tris concentration displayed remarkable
improvements in spot number for Bicine-dSDS-PAGE. Spot resolution was better in both
systems and furthermore, vertical streaking was negligible. The improved gel sieving
offered by glycerol in conjunction with a high ionic strength produced a stationary phase
with better resolving power, as shown in Figures 2.2.5(A) and (B). A tighter separating
gel mesh with narrower sieve was also investigated for the purposes of improving the
separation. Previous studies have indicated that such a gel offers better resolution and
reduced leakage of low molecular weight proteins from the gel during the protein staining
process (38). Gels made with a higher percentage cross-linker (6%) showed improvement
in spot number for Bicine- and Tricine-dSDS-PAGE, as shown in Figures 2.2.6(A) and
(B). Spot resolution improved and virtually no vertical streaking was observed. Other
parameters, such as presence of different types of spacer gels, were explored (data not
shown) and determined to have little effect in enhancing the separation process. Based on
these results, the optimized parameters for gel preparation in Bicine- and Tricine-dSDS-
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(A)
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97.4
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45.0
31.0
21.5
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(B)
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Figure 2.2.3. Effect of glycerol in gel preparation for (A) Bicine-dSDS-PAGE and (B)
Tricine-dSDS-PAGE.
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97.4
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Figure 2.2.4. Effect of increased Tris buffer in gel preparation for (A) Bicine-dSDSPAGE and (B) Tricine-dSDS-PAGE.
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(A)
kDa
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97.4
66.2

45.0
31.0
21.5
14.4

(B)
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44 spots
97.4
66.2
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31.0
21.5
14.4

Figure 2.2.5. Effect of glycerol and increased Tris buffer in gel preparation for (A)
Bicine-dSDS-PAGE and (B) Tricine-dSDS-PAGE.
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(A)
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97.4
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45.0
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(B)
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97.4
66.2
45.0
31.0
21.5
14.4

Figure 2.2.6. Effect of glycerol, increased Tris buffer and high percentage cross-linker in
gel preparation for (A) Bicine-dSDS-PAGE and (B) Tricine-dSDS-PAGE.
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PAGE were 10.7% glycerol, 1 M Tris, 0.1% SDS and 6% bis-acrylamide cross-linker,
along with 0.05% APS and 0.05% TEMED for polymerization.

Large Format Gel Experiments with Optimized Parameters

To further improve protein representation and increase protein loading capacity of
the gel, large format experiments for Laemmli-, Bicine- and Tricine-dSDS-PAGE were
performed using optimized gel preparation protocols, as shown in Figures 2.2.7 to 2.2.9.
Comparing these optimized large format gels for the three buffer systems, it was clear
that Bicine dSDS-PAGE offered significant improvements in spot number over Tricineand Glycine-dSDS-PAGE. Tricine-dSDS-PAGE showed a 112% increase in protein spot
number and Bicine-dSDS-PAGE showed a 151% increase over Glycine-dSDS-PAGE.
Spot resolution in Bicine-dSDS-PAGE was also dramatically better, particularly in the
high molecular weight range. Although Tricine- and Glycine-dSDS-PAGE showed
similar spot count, resolution of spots was superior in the former. Protein spot excision,
in-gel digestion and MALDI-TOF analysis demonstrated that both Bicine- and TricinedSDS-PAGE were compatible with mass spectrometry (Figures 2.2.7 to 2.2.9). The
dSDS-PAGE experiment was well-suited for the analysis of hydrophobic proteins and
highly basic proteins, unlike traditional 2D-PAGE approaches. Combining this power
with the added advantages of improved spot resolution and protein representation
observed in a bicine-based system produced a separation method that is amenable to
detailed probing of the membrane proteome.
Since all dSDS-PAGE techniques investigated involved identical first dimensions
using the Laemmli protocol, the resolving power of each method can be effectively
demonstrated when considering the conversion of total number of protein bands in the
first dimension to total number of protein spots in the second dimension in large format
gels. For Glycine-dSDS-PAGE, 42 bands in the first dimension were translated into 109
second dimensional protein spots. In the case of Tricine-dSDS-PAGE, 42 1D bands were
converted into 122 second dimension spots. Finally for Bicine-dSDS-PAGE, 42 protein
bands were resolved into 165 protein spots in the second dimension. The identical first
dimensional experiments in each protocol served as a normalizing factor in clearly
demonstrating the relative resolving capabilities of each dSDS-PAGE technique.
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kDa
109 spots

36

97.4
66.2
45.0

35

19
23

31.0

21.5

14.4

Figure 2.2.7. Standard Laemmli-dSDS-PAGE separation of C. thermocellum membrane
proteins. A 10% acrylamide 1D experiment was followed by a 9-12% 2D acrylamide
gradient gel separation. Proteins identified by mass spectrometry included S-layer
proteins (#35 and 36), extracellular solute-binding protein (19) and small GTP-binding
protein domain (23).
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45.0
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36

97.4
66.2
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35
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14.4

Figure 2.2.8. Tricine-dSDS-PAGE of C. thermocellum membrane proteins. A 10%
acrylamide 1D experiment was followed by a 9-12% 2D acrylamide gradient gel
separation. Proteins identified by mass spectrometry included S-layer proteins (#35 and
36) and molecular chaperone (31).
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kDa
97.4
66.2
45.0

165 spots

33

19

35
36
16

31.0

21.5
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14.4

Figure 2.2.9. Bicine-dSDS-PAGE of C. thermocellum membrane proteins. A 10%
acrylamide 1D experiment was followed by a 9-12% 2D acrylamide gradient gel
separation. Proteins identified by mass spectrometry included S-layer proteins (#35 and
36), glycoside hydrolase family 10 enzyme (33), ribosomal protein L16 (26),
extracellular solute-binding protein (19) and ABC transporter (16).
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A closer look at the electrophoresis process offers insight into the observed
differences in resolving powers for the three dSDS-PAGE methods. Tricine-based buffer
systems have been typically used for the separation of low-molecular weight proteins and
peptides. The stacking of low molecular weight polypeptides (5 kDa) by Glycine-SDSPAGE is complicated by the fact that their complex with SDS has about the same size as
that of the SDS micelle (18-32 kDa) (33). The small proteins stack together with the SDS
from the sample buffer and they co-migrate in the resolving gel together with SDS,
producing inferior resolution. Substituting the trailing ion glycine in the electrode buffer
with the faster moving tricine prevents stacking of the SDS ions with the low molecular
weight protein bands, thus improving their resolution. Ion mobility depends on charge
density of a molecule and the voltage gradient. Under gel electrophoresis pH conditions,
more tricine is in the migrating anionic form, compared to glycine. As a result, tricine
migrates faster than glycine under such conditions, despite the fact that tricine has the
higher molecular weight (Table 2.2.2). Evidence from previous studies suggests that
highly hydrophobic peptides are unable to bind with SDS at high SDS:protein ratios,
suggesting a greater role of the trailing ion in electrophoretic separations (85). A similar
argument can be considered for hydrophobic membrane proteins, indicating that a faster
ion than glycine would be more suitable to obtain better resolution. Unlike peptides,
however, membrane proteins are considerably larger in size and less mobile. As such, a
very fast ion, such as tricine, would not be able to provide sufficient time and opportunity
for optimum separation and resolution.

Capillary Electrophoresis Experiments

The driving force for ion motion in gel electrophoresis is electrophoretic mobility,
as electroosmotic flow is non-existent. An examination of the electrophoretic mobilities
of trailing ions in the three buffer systems can provide insight into the selectivity and
separation efficiency offered by Glycine-, Bicine- and Tricine-dSDS-PAGE. To this end,
capillary electrophoresis with indirect UV detection was performed on glycine, bicine,
and tricine. In CE, ion mobility is a vector addition of electroosmotic flow (μeo) and
electrophoretic mobility (μe). Electroosmotic flow is the movement of a liquid in contact
with the solid capillary surface when a tangential electric field is applied. The migration
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Table 2.2.2. Charge states of various gel electrophoresis buffers.
pH
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OH

N
OH
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14

O
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HO

HO

pka1 = 1.84
pka2 = 8.35

13

of a charged species under the influence of this electric field is known as electrophoretic
mobility. Analyte mobility is dependent not only on the charge density of the solute but
on the dielectric constant and viscosity of the electrolyte as well. The apparent mobility
of a species (μ) in CE is expressed as (86):

μ = μ eo ± μ e .

(2.2.1)

A positive sign indicates that μe for the ion has same direction as μeo and vice-versa.
For a given CE experiment, μeo is a constant and dominant factor in the apparent
mobility of analytes. Therefore, separation of analytes will be exclusively dictated by
differences in their μe, as given by the following (86):

μe =

lL
.
V (t eo − t )

(2.2.2)

where L is the capillary length, l is the capillary length to the detector, V is the applied
voltage, teo is the μeo front migration time and t is the analyte migration time.
In the standard CE operation mode, the sample is injected at the anodic end of the
capillary and detection occurs at the cathodic end. The electroosmotic flow front under
such conditions will travel from anode to cathode. On applying a suitable voltage,
analytes migrate toward the electrode of opposite charge according to their μe. If μe were
the dominant or sole driving force in ion mobility, anions, such as bicine and tricine at
basic pH, would hardly migrate from the anode and never reach the detector. Since the
magnitude of μeo is much greater than that of μe, the apparent mobilities of all species
dictate a unidirectional flow from anode to cathode. The direction of μe for cations is the
same as that of the electroosmotic flow front, enabling cations to migrate faster than μeo
and reach the detector first. Neutral species travel along with μeo, reaching the detector
after cations. The anions reach the detector last, as their μe vector is in the opposite
direction of μeo.
The electrophoretic mobilities of glycine, bicine and tricine at pH 8.3 and 8.9
were evaluated by performing standard CE experiments on mixtures of these analytes.
These pH values were chosen because they are identical to the pH of gel electrophoresis
running buffers in dSDS-PAGE. For identification purposes and to determine migration
times, individual analytes were also run separately at each pH. The electropherograms
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generated from experiments conducted at BGE pH 8.3 and 8.9 are given in Figures
2.2.10(A) and (B). At both pH values, glycine displayed the shortest migration time,
followed by bicine, and tricine had the longest migration time. Since apparent mobility
(μ) is inversely proportional to migration time (86), these experiments demonstrated that
of the three analytes, glycine showed the highest μ, followed by bicine, with tricine
having the lowest μ.
Eqn (2.2.1) dictates that μ for anions will be less than the μeo. Thus, a higher value
of μ implies a smaller μe since μeo is constant for a given system. So glycine displayed the
smallest μe (0.12 x 10-4 cm2V-1s-1), followed by bicine (1.50 x 10-4 cm2V-1s-1), and tricine
displayed the highest μe (2.27 x 10-4 cm2V-1s-1). These results are in direct agreement with
the pH-dependent charge states of the various analytes (Table 2.2.2). The predominant
equilibrium for all analytes at the experimental pH values occurs between the zwitterionic
and anionic forms. At pH 8.3, approximately 50% of bicine is anionic, slightly greater
than 50% of tricine exists as anions, and a large majority of glycine is zwitterionic. Since
a larger fraction of tricine is anionic compared to the other analytes, tricine migrated the
slowest. The constant re-equilibration between the zwitterionic and anionic glycine
during the course of migration was enough to retard this species and give it a slightly
greater migration time than μeo. A similar migration order with longer migration times
was observed for pH 8.9, at which greater amounts of each analyte exists as anions. As in
CE, bicine would also show intermediate μe in gel electrophoresis experiments. It is
likely that the intermediate μe of bicine provides the key to better resolution in dSDSPAGE of hydrophobic membrane proteins compared to tricine and glycine.

Conclusions

With the typically low abundance of membrane proteins in biological systems, it
is imperative that analytical protocols for studying such proteins afford the highest
resolution and protein representation possible. Increased resolution and representation of
membrane proteins was achieved by exploring electrophoretic buffer systems other than
the traditional Laemmli approach. Tricine-dSDS-PAGE provided better spot count and
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Figure 2.2.10. Electropherograms of a mixture of glycine, bicine and tricine dissolved in
background electrolyte (BGE). The BGE used was 100 mM borate + 10 mM 2-methyl1,3-cyclohexanedione at (A) pH 8.3 and (B) pH 8.9; capillary dimensions 75 μm x 100
cm; distance to detector 75 cm.
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resolution compared to Glycine-dSDS-PAGE (112% increase in spot count over GlycinedSDS-PAGE) and Bicine-dSDS-PAGE (151% increase in spot count over GlycinedSDS-PAGE) provided the best separation conditions of all. Gels with low water content,
high ionic strength and improved sieving capabilities were better suited for Tricine- and
Bicine-dSDS-PAGE, compared with the standard Laemmli protocol for gel preparation.
Due to the hydrophobic nature of membrane proteins, they typically have low
SDS:protein binding ratios and as such, their migration in an electric field is more
strongly dictated by the trailing ion in the running buffer. Tricine-dSDS-PAGE, with a
faster trailing ion than the glycine-based system, provided better electrophoretic
separation of membrane proteins, as demonstrated by increased spot number in the
optimized gels. Tricine-based systems have been previously demonstrated to be wellsuited for analysis of peptides, due to their low molecular weight and high mobilities, in
an electric field. However, with slower moving membrane proteins, a slightly slower
trailing ion such as bicine can provide adequate time for improved stacking and
separation. Capillary electrophoresis experiments with indirect UV detection suggested
that CE data can provide a suitable guide for selection of the trailing ion in gel
electrophoresis running buffers. In this way, the dSDS-PAGE experiment can be
appropriately tailored to the particular sample under investigation so as to produce
optimum separation conditions. The Bicine-dSDS-PAGE approach has been successfully
applied towards the analysis of differentially expressed proteins in wild type and ethanoladapted C. thermocellum membranes to obtain a better understanding of the nature of
ethanol tolerance (Chapter 2.3).
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Chapter 2.3
Analysis of Proteomic Profile Changes in Membranes of Ethanol-Adapted
Clostridium thermocellum

Introduction

The effects of ethanol on microbes have been investigated extensively (2, 3, 812), but the mechanisms contributing to growth inhibition are many and complex. A
major cause of the negative effects of elevated ethanol levels is disturbance and
disruption of membrane permeability (3), and so it is likely that changes induced by
ethanol adaptation involve membrane physiology and the membrane proteome. A
thorough analysis of membrane protein expression in wild type and ethanol-adapted cells
would shed light on the biochemistry of ethanol tolerance. Due to the disadvantages of
membrane protein analysis using 2D-PAGE, Schägger and co-workers (17) described a
doubled SDS-PAGE (dSDS-PAGE) experiment in which SDS-PAGE separation of
membrane proteins in the first dimension is followed by SDS-PAGE separation in the
second dimension. They applied tricine-based and standard glycine-based running buffers
in the analyses. While these buffer systems were suitable for membrane protein analysis,
the newly designed Bicine-dSDS-PAGE method (34), described in Chapter 2.2, offered
the best resolution and protein spot representation of the three approaches. A two-part
Bicine-dSDS-PAGE analysis was performed on wild type and ethanol-adapted C.

thermocellum membrane proteins to bring different regions of the membrane proteome
into focus and obtain a clear picture of differential protein expression patterns.
Although wild type strains of C. thermocellum are typically inhibited by ethanol
concentrations less than 2%, strains able to tolerate as high as 8% have been generated (1,
2, 8-10) through sequential transfer techniques. Previous investigations (78) indicated
that cell surface proteins could be accumulating at the site of manufacture (cytosol) in
ethanol-adapted cells. Based on the hypothesis that membrane protein expression in wild
type and ethanol-tolerant strains is different, the proteomes of these cultures were
evaluated and compared. Understanding membrane protein expression changes instigated
by ethanol adaptation is essential in the interest of developing more robust microbes with
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increased abilities to tolerate and produce biogenic ethanol. To our knowledge, this is the
first investigation on differential membrane protein expression in C. thermocellum.

Experimental

Materials

All chemicals and materials for the growth of bacterial cultures were purchased
from Sigma (St. Louis, MO) except yeast extract, which was obtained from Difco
Laboratories (Detroit, MI). Laemmli sample buffer, Coomassie G-250, Coomassie R-250,
Tris base, SDS, acrylamide, N,N-methylene-bis-acrylamide (bis), ammonium persulfate
(APS) and N,N,N,N-tetramethyl-ethylenediamine (TEMED) were obtained from Bio-Rad
(Hercules, CA). Bicine, ammonium bicarbonate and the MALDI matrix α-cyano-4hydroxycinnamic acid (HCCA) came from Sigma. Methanol, glycerol, o-phosphoric
acid, hydrochloric acid, formic acid, trifluoroacetic acid (TFA), acetonitrile and trypsin
were purchased from Fisher Scientific (Pittsburg, PA). Ammonium sulfate was obtained
from EMD Chemicals (Gibbstown, NJ).

Bacterial Strains and Growth Conditions

C. thermocellum ATCC 27405 was obtained from the American Type Culture
Collection. Adaptation of wild type cells to 5% ethanol was brought about using a
sequential transfer procedure as previously described (78). Briefly, the wild-type strains
were initially grown in a basal medium containing 0.5% (w/v) ethanol. The rate and
extent of growth were monitored and upon cessation of growth, cultures were
immediately transferred to fresh medium containing ethanol at 0.5% (w/v). Several
(typically 3 or 4) repeated transfers of this sort were performed to ensure that ethanol
tolerance was not lost. The ethanol concentration was then raised to 1%. Additional
rounds of repeated transfers were performed and involved incrementally increasing the
ethanol concentration by 0.5% to arrive at bacteria that could tolerate 5% ethanol.
The organisms were cultured in a medium that contained 10.8 mM Na2HPO4,
11.05 mM KH2PO4, 9.35 mM NH4Cl, 3.79 mM (NH4)2SO4, 0.44 mM MgCl2.6H2O, 0.27
mM CaCl2, 2.0 g/L yeast extract, 0.5 g of cysteine, 10 mL of a vitamin standard mixture
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(79) and 5 mL of a modified micromineral mixture stock (79). This micromineral mixture
also contained 10 mg of Na2WO4.2H2O and 1 mg of Na2SeO3 per liter of stock, as well as
1 mg/L of the oxygen indicator resazurin. The basal medium was adjusted to pH 6.7 with
10% NaOH and autoclaved for 10 min to remove dissolved gases. Carbon dioxide was
then immediately bubbled through the solution until it was cooled to room temperature,
following which an anaerobic solution of Na2CO3 was added to provide 4 g per liter
(final concentration). The medium was then anaerobically dispensed into culture tubes
and bottles and sterilized by autoclaving for 20 min. This basal medium was
supplemented with an anaerobic solution of cellobiose (final concentration of 4 g/L).
Ethanol-adapted cell cultures were grown in a similar medium that also contained 5%
(w/v) ethanol.

Preparation of Crude Membrane Protein Fractions

Cell cultures were grown at 55ºC and harvested once the optical density at 600
nm had reached approximately 1.0. The cultures were then centrifuged (15,000 x g, 10
min, 4oC) and the supernatant was discarded and the pellets re-suspended with 40 mL
buffer (50 mM Tris, pH 7.5). This was followed by another 10 min centrifugation and
finally by an additional wash step. Cell pellets were then re-suspended in buffer to a final
optical density of approximately 50. The concentrated cells were stored at -80oC until
further use.
Concentrated cells were thawed and phenylmethylsulfonylfluoride (PMSF) and
dithiothreitol (DTT) were added to achieve final concentrations of 5 mM for each. The
cells were then lysed by passage through a French Press (SLM Aminco, Urbana, IL) three
times at 137 MPa. The broken cells were centrifuged (5,700 x g, 10 min, 4oC). The
pellets were then discarded and the supernatant centrifuged (200,000 x g, 45 min, 4oC).
The resulting membrane pellet was re-suspended in 10 mL of 10 mM Tris, pH 7.5 and
this was centrifuged twice (200,000 x g, 45 min, 4oC). The washed pellets were finally
re-suspended in 10 mM Tris, pH 7.5, to obtain a protein concentration of approximately
6.4 mg/mL using the Lowry assay (80). Aliquots of re-suspended proteins were stored at
-80oC until further use.
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Sucrose Isopycnic Density Gradient Centrifugation

In order to obtain a more defined membrane fraction for subsequent mass
spectrometric analyses, the crude membranes from wild type and ethanol-adapted C.

thermocellum were subjected to sucrose isopycnic density gradient centrifugation
(SIDGC). The gradient was prepared by layering solutions of increasing sucrose
percentages in 11 mL centrifuge tubes (bottom to top) as follows: one part 55%, two parts
45%, two parts 40%, two parts 35%, three parts 30% and finally one part sample. The
tubes were then centrifuged in a swinging bucket rotor (270,000 x g, 47 h, 4oC). Aliquots
(0.5 mL) were removed and protein concentration was estimated by absorbance at 280
nm. Fractions were pooled based on their absorbance and these pools were diluted
approximately 3-fold with 10 mM Tris (pH 7.5). Membrane proteins were then collected
by centrifugation (48,300 x g, 2 h, 4oC). The resultant pellets were washed twice with 10
mM Tris (pH 7.5) and the final resuspension yielded a protein concentration between 11
and 20 μg/μl.
Bicine-dSDS-PAGE

A previously developed Bicine-dSDS-PAGE approach (34) was used to separate
membrane proteins. Large (20 cm x 20 cm) format gel experiments were performed with
the PROTEAN II xi electrophoresis cell (Bio-Rad). Linear acrylamide gradients in the
second dimension of dSDS-PAGE were generated using a Model 485 Gradient Former
and all gels were run at 4oC. The first dimension of a dSDS-PAGE experiment consisted
of a 4% acrylamide stacking gel and an 8 or 11% separating gel (1 mm thick). The two
separating gel percentages provided enhanced resolution of different regions of the
bacterial membrane proteome. The Laemmli protocol (19) was used to separate the
proteins in the first dimension of Bicine-dSDS-PAGE and gels were run at 16 mA/gel for
protein migration through the stacking gel. This was then increased to 24 mA/gel when
the dye front entered the separating gel. Run times for large format 1D gels were
typically 7 h.
Membrane proteins were then further resolved in the second dimension by a 712% linear acrylamide gradient gel of 1.5 mm thickness. After staining with Coomassie
R-250 overnight, gel strips (approximately 5 mm wide) were excised from the first
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dimension, swelled for 30 min in buffer (100 mM Tris, 150 mM HCl, approximately pH
2), and then placed in between the glass plates and on top of the separating gel of the
second dimension (17). Gaps between the excised gel lane and the spacers of the second
dimension were filled with gel mixtures that contained 10% acrylamide, the same
composition as in the 1D strip. Gel and running buffer preparation for the second
dimension of Bicine-dSDS-PAGE were described previously (34). Running conditions
for second dimensional gels were 90 V for 30 min and 120 V thereafter, with run times of
approximately 24 h. All second dimension gels were stained with G-250 Colloidal
Coomassie (23).

Image Analyses

Gel images were captured using a Bio-rad Versadoc Imaging System and analysis
of 1D and 2D images was performed by Bio-Rad Quantity One and PDQuest software,
respectively. Images shown in figures are Gaussian representations generated by the
software.

Protein Identification

Tryptic digests of membrane proteins were examined in positive ion mode using a
Bruker Autoflex MALDI-TOF or a Finnigan LCQ Classic quadrupole ion trap mass
spectrometer. HCCA was used as the matrix for MALDI-TOF protein analyses. MALDI
spectra were internally calibrated using peptides from trypsin autolysis (m/z 842.51 and
2211.10). Peptide mass fingerprinting data (PMF) with monoisotopic peak mass lists
were analyzed using the MASCOT algorithm and the C. thermocellum database (82).
Protein spots that could not be identified by MALDI were subjected to LC-ESI-MS/MS.
A Hewlett Packard LC system (1100 series) with a custom-made C18 capillary LC
column was interfaced to the ion trap mass spectrometer for reversed phase LC-MS/MS
analyses. A mobile phase mixture of water and acetonitrile (ACN), each containing 0.1%
formic acid, was used in all experiments. Gradient elution was employed in these studies,
as described in Chapter 1.2 of Part 1. LCQ data was also analyzed by the MASCOT
algorithm and the C. thermocellum database.
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Results

The Bicine-dSDS-PAGE analysis provided a diagonal arrangement of C.

thermocellum membrane protein spots and a total of 145 proteins were identified from
crude and SIDGC membrane preparations using MALDI-TOF MS and MASCOT
database searching. The MALDI-TOF mass spectrum of a histidine kinase identified
from C. thermocellum membrane preparations is given in Figure 2.3.1. Analysis of crude
membrane fractions revealed that 45% of all proteins identified from this fraction were
cytosolic (based on the absence of protein transmembrane domains or TMDs). In
contrast, the highly purified samples from SIDGC contained dramatically lower amounts
(14%) of such proteins. Since the SIDGC fractions were more highly enriched with noncytosolic proteins, these samples were used in subsequent experiments.
The Bicine-dSDS-PAGE analysis of highly purified membrane fractions revealed
similar spot diversity for wild type and ethanol-adapted C. thermocellum in both the high
and low molecular weight ranges. Gel experiments aimed at better resolution and
representation of high molecular weight proteins (8% first dimension separating gel)
resolved 76 spots in the wild type organism (Figure 2.3.2(A)) and 72 spots in the ethanoladapted strain (Figure 2.3.3(A)). For dSDS-PAGE experiments geared towards low
molecular weight protein analysis (11% first dimension separating gel), wild type C.

thermocellum membranes yielded 123 spots (Figure 2.3.2(B)) whereas the ethanoladapted organism provided 117 spots (Figure 2.3.3(B)). Despite the similarities in protein
spot numbers between the two cultures, it was evident that many proteins were present at
higher levels in wild type membranes compared to ethanol-adapted bacteria. Analysis of
the relative expression values indicated a fairly even distribution of differentially
expressed proteins throughout the molecular weight range under investigation (Table
2.3.1).
Further examination of the proteins from the SIDGC fractions by measures of
relative hydrophobicity can provide information on their propensity of being membraneassociated. TMD analyses revealed that a majority of these proteins have two or more
TMDs and nearly half had positive Grand Average of Hydropathicity (GRAVY) scores
(Table 2.3.2). As a general trend, higher numbers of TMDs corresponded with more
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Figure 2.3.1. MALDI-TOF mass spectrum of histidine kinase, HAMP region: bacterial
chemotaxis sensory transducer (#32: gi 67874049).
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Figure 2.3.2. Bicine-dSDS-PAGE of the wild type C. thermocellum membrane proteins:
(A) 8% acrylamide and (B) 11% acrylamide 1D experiments were followed by a 9-12%
2D acrylamide gradient gel separation. Highlighted proteins identified by mass
spectrometry include glycoside hydrolase (#45: gi 67874975), SecA (#6: gi 67916795),
chemotaxis sensory transducer (#37: gi 67873910), flagellar biosynthetic protein FlhB
(#67: gi 67875429), Mg2+-transporter protein, CorA-like (#26: gi 67875293), divalent
cation transporter (#61: gi 67916199), amino acid-binding ACT: MgtC/SapB transporter
(#51: gi 67916179) and S-layer proteins (#18: gi 67917201 and #23: gi 67916324).
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Figure. 2.3.3. Bicine-dSDS-PAGE of the ethanol-adapted C. thermocellum membrane
proteins: (A) 8% acrylamide and (B) 11% acrylamide 1D experiments were followed by
a 9-12% 2D acrylamide gradient gel separation. Highlighted proteins identified by mass
spectrometry include glycoside hydrolase (#45: gi 67874975), SecA (#6: gi 67916795),
chemotaxis sensory transducer (#37: gi 67873910), flagellar biosynthetic protein FlhB
(#67: gi 67875429), Mg2+-transporter protein, CorA-like (#26: gi 67875293), divalent
cation transporter (#61: gi 67916199), amino acid-binding ACT: MgtC/SapB transporter
(#51: gi 67916179) and S-layer proteins (#18: gi 67917201 and #23: gi 67916324).
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Table 2.3.1. Proteins identified from purified membrane fractions: gel analysis data.

#

gi

Protein Name

MW

pI

MOWSE
Score

Seq.
cov.
(%)

Ratio*
WT/EA

1
2

67876078
67876077

57474
10156

4.96
5.22

425
38

43
30

0.88
1.35

3

67874556

64507

8.72

177

37

1.05

4

67874931

33398

6.62

652

43

1.19

5

67916452

56020

6.30

33

12

2.73

6

67916795

104612

6.38

132

24

2.57

7

67916027

65363

5.30

159

30

1.18

8

67875538

68124

6.55

102

22

1.23

9

67916533

64013

6.25

34

11

1.78

10

67916676

43966

7.12

34

14

1.39

11

67916856

105247

6.03

38

7

2.12

12

67916907

102415

5.61

33

6

1.18

13

67874442

36292

5.39

100

17

2.42

14

67875254

68642

5.57

32

6

3.21

15
16

67875618
67917396

40466
34968

5.64
4.98

32
43

5
25

2.54
2.08

17

67916519

60641

5.95

32

9

1.18

18

67917201

64851

4.50

354

12

3.78

19

67875524

100621

5.29

32

5

2.20

20

67874774

Chaperonin Cpn60/TCP-1
Chaperonin Cpn10
AMP-dependent synthetase
and ligase
Cysteine synthase K/M:
Cysteine synthase K
Anthranilate synthase
component I
SecA protein
H+-transporting two-sector
ATPase
NADH dehydrogenase
(ubiquinone)
Ferredoxin: 4Fe-4S ferredoxin,
iron-sulfur binding domain:
Iron hydrogenase, small
subunit: Hydrogenase large
subunit, C-terminal
Acetate kinase
Clostridium cellulosome
enzyme, dockerin type I:
Carbohydrate binding module,
family 6
Glycoside hydrolase, family 5:
Clostridium cellulosome
enzyme, dockerin type I:
Carbohydrate binding domain,
family 11
Polysaccharide deacetylase
Glycoside hydrolase, family 9:
Clostridium cellulosome
enzyme, dockerin type I
Conserved hypothetical protein
Periplasmic binding protein
Peptide chain release factor 3:
Small GTP-binding protein
domain
S-layer protein (SLH domain):
Bacterial Ig-related
Glycoside hydrolase, family 9:
Clostridium cellulosome
enzyme, dockerin type 1:
Carbohydrate-binding, CenClike: Glycoside hydrolase
family 9, N-terminal, Ig-like
Glycoside hydrolase, family 9:
Bacterial type 3a cellulosebinding domain: Clostridium

82122

5.49

32

5

4.17
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21

67876088

22

67916212

23

67916324

24

67875819

25

67917091

26

67875293

27

67916045

28

67916751

29

67916159

30

67916443

31

67916720

32

67874049

33

67916032

34

67875125

35

67873911

36

67874822

37
38

67873910
67875410

39

67876339

40

67916760

41

67874555

cellulosome enzyme, dockerin
type 1
Clostridium cellulosome
enzyme, dockerin type I
Putative esterase: Glycoside
hydrolase, family 10:
Clostridium cellulosome
enzyme, dockerin type 1:
Carbohydrate-binding, CenClike
Similar to S-layer domain
Hypothetical protein
CtheDRAFT_2053
ATP-binding region, ATPaselike: Histidine kinase A, Nterminal
Mg2+ transporter protein,
CorA-like
CheW-like protein:ATPbinding region, ATPase-like:
Signal transducing histidine
kinase, homodimeric domain:
Hpt
Glycosyl transferase, group 1:
Phospholipid/glycerol
acyltransferase
Clostridium cellulosome
enzyme, dockerin type I:
Glycosyl hydrolase, BNR
repeat
Protein of unknown function
DUF 1432
Glycosyl transferase, family 2
Histidine kinase, HAMP
region: Bacterial chemotaxis
sensory transducer
AAA ATPase, central region:
Peptidase M41, FtsH
Glycoside hydrolase, family 9:
Bacterial type 3a cellulosebinding domain: Clostridium
cellulosome enzyme, dockerin
type 1
ABC1
MotA/TolQ/ExbB proton
channel
Chemotaxis sensory transducer
Flagellar FliF M-ring protein
UDP-N-acetylglucosamine 1carboxyvinyltransferase
ATP-binding region, ATPaselike: Histidine kinase A, Nterminal
Serine-type D-Ala-D-Ala
carboxypeptidase

55169

8.55

97

17

2.01

119664

5.45

33

3

2.76

89952

5.12

32

7

2.08

17520

9.61

48

25

2.96

39499

7.33

86

19

1.62

36590

4.91

73

25

0.44

78305

4.94

95

5

0.40

71359

9.80

36

6

2.35

92364

5.19

73

7

2.44

35303

8.73

253

56

2.95

36155

8.69

48

13

2.76

68286

5.02

46

21

0.50

43874

8.82

132

24

1.32

79810

5.23

51

10

2.22

64815

6.29

113

20

2.26

30847

5.62

98

10

1.60

45710
57822

4.92
4.90

103
41

32
8

0.38
0.43

44383

7.80

112

10

0.99

40280

5.46

83

15

1.65

47984

6.95

44

5

2.54
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42

67916336

43

67876447

44

67874093

45
46

67874975
67916154

47

67876065

48

67917031

49

67917112

50

67873242

51

67916179

52

67916824

53

67875449

54

67916023

55

67915993

56

67916702

57

67875027

58

67916960

59

67916966

60

67876364

61

67916199

62

67916249

63

67873370

64
65
66

67875548
67874594
67916392

67

67875429

68

67875120

69

67875688

Chemotaxis sensory transducer
Serine-type D-Ala-D-Ala
carboxypeptidase
Hypothetical protein
CtheDRAFT_3149
Glycoside hydrolase, family 15
Conserved hypothetical protein
Peptidase C39, bacteriocin
processing
Putative sugar transport system
permease ABC transporter
protein
ABC transporter,
transmembrane region
Similar to Flp pilus assembly
protein TadB
Amino acid-binding ACT:
MgtC/SapB transporter
Histidine kinase, HAMP
region: Cache domain:
Bacterial chemotaxis sensory
transducer
Holin, toxin secretion/phage
lysis
H+-transporting two-sector
ATPase, C subunit
MscS Mechanosensitive ion
channel
ABC transporter,
transmembrane region: ABC
transporter
Hedgehog/Intein hint domain,
N-terminal
Lipopolysaccharide
biosynthesis
Glycosyl transferase, family 2
CDP-diacylglycerol-glycerol3-phosphate 3phosphatidyltransferase
Divalent cation transporter
Amino acid ABC transporter,
permease protein, 3-TM
region, His/Glu/Gln/Arg/opine
GGDEF: Uncharacterized
HDIG domain
Small basic protein
Permease
Cobalt transport protein
Flagellar biosynthetic protein
FlhB
Hypothetical protein
CtheDRAFT_2575
ABC transporter,
transmembrane region: ABC
transporter

46229

4.99

33

6

0.25

46650

5.68

53

17

2.14

30329

9.31

49

7

1.84

73680
25138

5.52
9.09

32
74

7
26

2.29
1.86

33754

8.55

102

22

2.10

18113

9.30

76

12

2.92

29046

8.97

35

7

1.80

30626

5.42

55

9

0.49

25495

9.04

50

10

0.35

91309

5.06

32

13

0.91

14926

8.31

32

6

1.13

15977

6.62

48

13

1.45

31354

8.80

42

9

0.47

71856

8.51

58

18

2.44

60427

6.41

98

19

0.73

47526

5.18

75

22

1.11

44800

8.88

103

33

1.10

22566

9.59

27

2

2.30

50239

5.03

48

8

0.24

24788

9.54

53

13

2.22

60702

8.34

36

4

2.11

13797
13024
30127

9.27
9.60
9.36

77
42
44

12
11
15

2.08
3.02
0.59

44294

9.52

49

13

0.50

37170

9.00

55

10

1.85

70505

7.19

73

3

1.70
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H+-transporting two-sector
ATPase, A subunit
Phosphatidate
71 67917176
cytidylyltransferase
Cation transporting ATPase,
N-terminal: Haloacid
dehalogenase-like hydrolase:
72 67873913
Cation transport ATPase, Cterminal: E1-E2 ATPaseassociated region
* Spot density ratio
70

67873849

28464

5.59

39

8

0.99

22273

9.14

61

9

2.06

93885

6.40

75

10

2.28
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Table 2.3.2. Proteins identified from purified membrane fractions: Grand Average of
Hydropathicity (GRAVY) and transmembrane domain (TMD) analysis.
#

gi

Protein Name

1
2
3
4
5
6
7
8

67876078
67876077
67874556
67874931
67916452
67916795
67916027
67875538

9

67916533

10

67916676

11

67916856

12

67916907

13

67874442

14

67875254

15
16

67875618
67917396

17

67916519

18

67917201

19

67875524

20

67874774

21

67876088

22

67916212

23
24

67916324
67875819

25

67917091

26

67875293

27

67916045

28

67916751

Chaperonin Cpn60/TCP-1
Chaperonin Cpn10
AMP-dependent synthetase and ligase
Cysteine synthase K/M: Cysteine synthase K
Anthranilate synthase component I
SecA protein
H+-transporting two-sector ATPase
NADH dehydrogenase (ubiquinone)
Ferredoxin: 4Fe-4S ferredoxin, iron-sulfur
binding domain: Iron hydrogenase, small
subunit: Hydrogenase large subunit, C-terminal
Acetate kinase
Clostridium cellulosome enzyme, dockerin
type I: Carbohydrate binding module, family 6
Glycoside hydrolase, family 5: Clostridium
cellulosome enzyme, dockerin type I:
Carbohydrate binding domain, family 11
Polysaccharide deacetylase
Glycoside hydrolase, family 9: Clostridium
cellulosome enzyme, dockerin type I
Conserved hypothetical protein
Periplasmic binding protein
Peptide chain release factor 3: Small GTPbinding protein domain
S-layer protein (SLH domain): Bacterial Igrelated
Glycoside hydrolase, family 9: Clostridium
cellulosome enzyme, dockerin type 1:
Carbohydrate-binding, CenC-like: Glycoside
hydrolase family 9, N-terminal, Ig-like
Glycoside hydrolase, family 9: Bacterial type
3a cellulose-binding domain: Clostridium
cellulosome enzyme, dockerin type 1
Clostridium cellulosome enzyme, dockerin
type I
Putative esterase: Glycoside hydrolase, family
10: Clostridium cellulosome enzyme, dockerin
type 1: Carbohydrate-binding, CenC-like
Similar to S-layer domain
Hypothetical protein CtheDRAFT_2053
ATP-binding region, ATPase-like: Histidine
kinase A, N-terminal
Mg2+ transporter protein, CorA-like
CheW-like protein: ATP-binding region,
ATPase-like: Signal transducing histidine
kinase, homodimeric domain: Hpt
Glycosyl transferase, group 1:
Phospholipid/glycerol acyltransferase
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F.
Class*

GRAVY†

#
TMDs‡

O
O
I
E
EH
U
C
C

-0.081
-0.068
0.193
-0.129
-0.276
-0.546
-0.228
-0.209

0
0
0
0
0
0
0
0

C

-0.202

0

C

-0.089

0

G

-0.238

1

G

-0.456

1

G

-0.264

1

G

-0.445

1

S
P

-0.639
-0.346

1
1

O

-0.319

1

V

-0.208

1

G

-0.532

1

G

-0.327

1

G

-0.212

1

G

-0.358

1

V
S

-0.190
0.193

2
2

T

-0.034

2

P

0.036

2

T

-0.148

2

G

-0.029

2

29

67916159

30
31

67916443
67916720

32

67874049

33

67916032

34

67875125

35
36
37
38

67873911
67874822
67873910
67875410

39

67876339

40

67916760

41
42
43
44
45
46
47

67874555
67916336
67876447
67874093
67874975
67916154
67876065

48

67917031

49
50

67917112
67873242

51

67916179

52

67916824

53
54
55

67875449
67916023
67915993

56

67916702

57
58
59

67875027
67916960
67916966

60

67876364

61

67916199

62

67916249

63
64
65
66
67

67873370
67875548
67874594
67916392
67875429

Clostridium cellulosome enzyme, dockerin
type I: Glycosyl hydrolase, BNR repeat
Protein of unknown function DUF 1432
Glycosyl transferase, family 2
Histidine kinase, HAMP region: Bacterial
chemotaxis sensory transducer
AAA ATPase, central region: Peptidase M41,
FtsH
Glycoside hydrolase, family 9: Bacterial type
3a cellulose-binding domain: Clostridium
cellulosome enzyme, dockerin type 1
ABC1
MotA/TolQ/ExbB proton channel
Chemotaxis sensory transducer
Flagellar FliF M-ring protein
UDP-N-acetylglucosamine 1carboxyvinyltransferase
ATP-binding region, ATPase-like: Histidine
kinase A, N-terminal
Serine-type D-Ala-D-Ala carboxypeptidase
Chemotaxis sensory transducer
Serine-type D-Ala-D-Ala carboxypeptidase
Hypothetical protein CtheDRAFT_3149
Glycoside hydrolase, family 15
Conserved hypothetical protein
Peptidase C39, bacteriocin processing
Putative sugar transport system permease ABC
transporter protein
ABC transporter, transmembrane region
Similar to Flp pilus assembly protein TadB
Amino acid-binding ACT: MgtC/SapB
transporter
Histidine kinase, HAMP region: Cache
domain: Bacterial chemotaxis sensory
transducer
Holin, toxin secretion/phage lysis
H+-transporting two-sector ATPase, C subunit
MscS Mechanosensitive ion channel
ABC transporter, transmembrane region: ABC
transporter
Hedgehog/Intein hint domain, N-terminal
Lipopolysaccharide biosynthesis
Glycosyl transferase, family 2
CDP-diacylglycerol-glycerol-3-phosphate 3phosphatidyltransferase
Divalent cation transporter
Amino acid ABC transporter, permease
protein, 3-TM region, His/Glu/Gln/Arg/opine
GGDEF: Uncharacterized HDIG domain
Small basic protein
Permease
Cobalt transport protein
Flagellar biosynthetic protein FlhB
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G

-0.298

2

S
G

0.177
0.130

2
2

T

-0.284

2

O

-0.151

2

G

-0.360

2

O
U
T
N

-0.034
0.084
-0.057
-0.403

2
2
2
2

M

0.130

2

T

-0.159

2

O
T
O
S
G
S
O

-0.054
-0.179
0.069
-0.140
-0.335
0.657
0.120

2
2
2
2
3
3
3

G

0.957

3

R
N

0.528
0.217

3
3

E

0.356

3

T

-0.244

3

V
C
V

0.635
1.126
0.223

3
3
3

R

0.036

3
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-0.239
-0.093
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0.776
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0.265
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E

0.793

4

FT
S
R
P
N

0.064
0.791
1.046
0.619
-0.011

4
4
4
4
4

68

67875120

Hypothetical protein CtheDRAFT_2575
ABC transporter, transmembrane region: ABC
69 67875688
transporter
70 67873849 H+-transporting two-sector ATPase, A subunit
71 67917176 Phosphatidate cytidylyltransferase
Cation transporting ATPase, N-terminal:
Haloacid dehalogenase-like hydrolase: Cation
72 67873913
transport ATPase, C-terminal: E1-E2 ATPaseassociated region
* Function class of protein (see Appendix for function class names)
†
Grand Average of Hydropathicity (GRAVY) score
‡
Number of transmembrane domains (TMDs)
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S

0.416

4

R

0.132

5

C
F

0.793
1.005

5
5

P

0.159

9

positive GRAVY values, indicating greater hydrophobicity of the protein. Overall, these
results showed that the SIDGC fractions indeed were enriched with relatively
hydrophobic proteins that are probably associated with the cell membrane.
Approximately 60% of the identified proteins in the purified fraction were
differentially expressed in the wild type and ethanol-adapted strains. Of these
differentially expressed proteins, 74% were up-regulated by a factor of two or more in the
wild type strain with the remaining 26% up-regulated in the ethanol-adapted bacterium.
Approximately half of the up-regulated proteins in the wild type organism were involved
with carbohydrate transport and metabolism. Some of the up-regulated proteins in the
ethanol-adapted species were associated with chemotaxis and signal transduction.

Discussion

The C. thermocellum Membrane Proteome

The 3214 putative proteins in the C. thermocellum proteome were interrogated for
membrane proteins using the Sosui algorithm (87). This program predicts the number of
TMDs in the amino acid sequences of proteins. Based on the analysis, 935 proteins
(29.1% of the total proteome) were found to contain at least one TMD. Furthermore, 492
proteins in the database contained at least two TMDs. Proteins containing such
hydrophobic domains were considered as integral membrane proteins. A virtual 2D gel
map of the C. thermocellum membrane proteome was generated using web-based JVirGel
software (88), as shown in Figure 2.3.4.

Membrane Proteome Analysis with Bicine-dSDS-PAGE

The highly purified membrane protein fraction obtained through SIDGC enabled
relative quantification of differentially expressed proteins in wild type and ethanoladapted C. thermocellum (Table 2.3.1). Many of these proteins were not observed in the
crude fraction, perhaps because of their low abundance compared to other proteins in the
sample, particularly cytosolic proteins. These experiments clearly demonstrated the
benefits of employing sample purification procedures to enrich membrane proteins, as
well as gel-based separation methods that are attentive to their physicochemical nature.
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Figure 2.3.4. Theoretical 2D gel of the C. thermocellum membrane proteome.

200

The two-stage Bicine-dSDS-PAGE analyses of wild type (Figures 2.3.2(A) and
(B)) and ethanol-adapted (Figures 2.3.3(A) and (B)) cells displayed similar protein spot
representation in the high and low molecular weight range. The tendency of membrane
proteins to have basic pI values is a significant contributor to their under-representation
in traditional 2D-PAGE (13). However, as demonstrated by the data presented here, pI
was not a limiting factor in the Bicine-dSDS-PAGE analyses (Table 2.3.1). In addition,
the generally hydrophobic nature of membrane proteins further contributes to their low
abundance in 2D gel maps. Here again, Bicine-dSDS-PAGE analyses proved to be a
suitable approach due to the fact that solubility issues of membrane proteins in the first
dimension or isoelectric focusing step of 2D-PAGE are completely circumvented by
applying molecular weight-based separations in both dimensions.

TMD and GRAVY Analysis of Membrane Proteins

The presence of hydrophobic domains in a majority of the proteins identified from
the SIDG fractions supported the contention that these proteins are intimately associated
with the cell membrane (Table 2.3.2). The membrane protein distribution as a function of
the number of transmembrane domains (TMDs) in both the C. thermocellum database
and the experimentally determined membrane proteins from SIDGC fractions revealed a
marked decline in the number of proteins with high numbers of TMDs, particularly in the
theoretical membrane population (Figures 2.3.5(A) and (B)). While the theoretical
membrane population showed a substantially high proportion of proteins with only one
TMD (47% of all predicted membrane proteins), this was not the case for the
experimentally determined set (17% of proteins). It should be noted that a sizable fraction
of proteins with only one TMD may not be true membrane proteins and the fact that this
set was under-represented in the experimental population is a measure of the
effectiveness of our sample preparation procedures in eliminating non-membrane protein
components. The experimental set also differed from the theoretical membrane protein
population in the representation of proteins with large numbers of TMDs. A possibility
for the under-representation of these highly hydrophobic proteins is likely related to
sample solubilization issues. Use of solubilizing detergents in the sample buffer in
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Figure 2.3.5. Membrane protein distribution as a function of the number of
transmembrane domains (TMDs) in (A) the C. thermocellum database and (B) the
experimentally determined membrane proteins from SIDGC fractions.
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conjunction with the first dimension of dSDS-PAGE could perhaps enhance the presence
of such proteins in the gels.
In a majority of the cases, proteins with a high number of TMDs corresponded
with more positive GRAVY values. The GRAVY analysis of identified proteins should
be considered with caution, however, as these scores represent the overall hydrophobicity
of the entire protein and not just the regions of TMDs. Integral membrane proteins often
have sizable hydrophilic sequences that are not embedded within the lipid bi-layer which
can contribute to the overall reduction (more negative) of the GRAVY score. An example
of such a protein is a glycosyl transferase (#59: gi 67916966). This protein had four
TMDs but its GRAVY score was slightly negative (-0.093). On the opposite end, AMPdependent synthetase and ligase (#3: gi 67874556) was determined to have no TMDs but
GRAVY analysis resulted in a very positive score (0.193). It is possible that such a
protein is associated with the cell membrane through protein – protein interactions but is
not necessarily an integral membrane protein.

Differential Protein Expression in C. thermocellum Strains

Herrero et al. (2) proposed that ethanol effects on membrane fluidity and the
inhibition of certain membrane-bound enzymes associated with carbohydrate metabolism
contributed to the ethanol sensitivity of the bacterium. Our results clearly demonstrated
that a significant proportion of membrane-associated proteins involved with carbohydrate
transport and metabolism, such as glycoside hydrolase (#45: gi 67874975), were present
at over 2-fold lower concentrations in the ethanol-adapted strain, compared to the wild
type organism. It is possible that these proteins are not being properly incorporated into
the ethanol-challenged cell membrane.
Studies have shown that in ethanol-challenged systems, membrane damage is
manifested by the leakage of small, albeit significant, quantities of proteins (11). A
survey of the proteins present in higher concentrations in the wild type strain showed that
one of the members of this category is the protein SecA (#6: gi 67916795). This is a
soluble protein, as demonstrated by the absence of TMDs and negative GRAVY score.
However, it binds peripherally to membranes with high affinity and supports
translocation of proteins across the cell membrane (89). Passive leakage of proteins
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through the membrane lipid bi-layer can potentially account for the down-regulation of
this protein observed in ethanol-adapted cells.
Previous investigations have reported that ethanol-challenged cells are
characterized by the acceleration of a diverse range of processes, including survival,
chemotaxis, growth and spore germination, particularly at very low ethanol
concentrations (89). While only a few of the analyzed proteins were found to be upregulated in the ethanol-adapted organisms, several of these proteins were observed to
have signal transduction and/or chemotaxis function, such as the chemotaxis sensory
transducer (#37: gi 67873910). Some proteins involved with cell motility, such as the
flagellar biosynthetic protein FlhB (#67: gi 67875429), were also present at higher levels
in the ethanol-adapted cell membrane.
Some membrane-bound magnesium ion transporters were up-regulated in the
ethanol-tolerant organism. These included the Mg2+-transporter protein, CorA-like (#26:
gi 67875293) and the divalent cation transporter (#61: gi 67916199). Earlier
investigations (11) have demonstrated that fermentation rates are closely related to
cellular magnesium concentrations. Leaky membranes, as are characteristic of ethanolchallenged organisms, can effect the loss of appreciable quantities of small, inorganic
ions, such as magnesium. It is possible that when adapting to ethanol, the organism
attempts to incorporate more magnesium ion transporters into the cell membrane, so as to
counterbalance the passive loss of this ion through the lipid bi-layer. Another protein
associated with magnesium transport that was up-regulated in ethanol-adapted strains was
the amino acid-binding ACT: MgtC/SapB transporter (#51: gi 67916179). This protein is
believed to act as an accessory protein for MgtB, thus mediating magnesium influx into
the cytosol (89).

Ethanol Exposure and the Membrane Proteome

A closer look at the physiological effects of ethanol on cell membranes may offer
explanations for the differential expression of membrane proteins observed in C.

thermocellum strains under investigation. The hydrophobic interior of the membrane lipid
bi-layer provides a barrier to the passive transport of polar molecules in and out of the
cell. The primary physiological effect of an ethanolic environment is a general tightening
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of the bi-layer as it becomes interspersed with ethanol molecules (11). The polarity of the
hydrophobic core is increased and the cell responds through mechanisms that attempt to
offset this increase in membrane rigidity. Ethanol-induced stress causes a reduction in the
hydrophobic interactions among acyl side chains and hydrophobic domains of proteins.
Increases in coulombic interactions stimulate a decrease in ionization and an elevation in
the strength of charge repulsions between the polar heads of membrane phospholipids.
The overall effect is an increase in surface area occupied per phospholipids molecule,
reduction in membrane thickness and increases in membrane fluidity (3). Ethanol
exposure clearly compromises lipid-lipid and lipid-protein interactions within the cell
membrane.
Roberts and co-workers (2) have shown that when ethanol is added to C.

thermocellum cultures, changes in membrane composition occur after the period of
growth arrest. They detected an increase in the proportion of normal and anteisobranched fatty acids (lower melting points) at the expense of iso-branched fatty acids
(higher melting points), which causes fluidizing of the membrane. Studies have shown
that key cellular targets for growth inhibition are hydrophobic in nature and that cessation
of growth is directly proportional to the concentration of perturbing molecules that have
partitioned into the hydrophobic milieu (2). It is evident that the cell membrane is an
organelle most vulnerable to ethanol-induced changes.
Hydrophobic interactions are the major driving force for the biological selfassembly of membranes and both electrostatic and hydrophobic interactions are involved
in preserving the spatial organization of membrane components, such as membraneassociated and integral membrane proteins (11). The positioning of proteins within the
lipid bi-layer is brought about through a complex balance of charge interactions and
hydrophobic associations. While the physical principles of ethanol action would be
similar for all proteins, both cytosolic and membrane-bound, the specific consequences
for a given protein would clearly depend on the physicochemical properties, structure and
immediate environment of that particular protein. Ethanol-induced changes in the
mechanics and chemical environment of the cell membrane can significantly affect the
tertiary and quaternary structure of membrane proteins, resulting in their inefficient
assimilation and folding within the lipid bi-layer. Previous investigations from our

205

laboratory (78) have suggested that cell surface proteins, such as different S-layer
components, could be accumulating at their site of manufacture (the cytosol), perhaps due
to the failure of chaperones and protein folding agents to successfully incorporate
membrane proteins into the cell membrane. It is worthwhile to mention that S-layer
proteins (#18: gi 67917201 and #23: gi 67916324) were observed to be up-regulated in
the wild-type organism in the investigations reported here.

Conclusions

Proteomics is a very powerful analytical tool for understanding how organisms
respond to environmental stress, such as ethanol exposure and adaptation. Nevertheless,
the use of proteomic techniques with C. thermocellum is limited. In fact, to our
knowledge, this is the first study of the C. thermocellum membrane proteome using
carefully designed proteomics approaches. In recent years, the realization that cellular
proteomes are comprised of diverse sub-proteomes which often require different
methodologies for effective characterization and analysis has brought about a marked
increase in resources dedicated to methods development for membrane proteome
analysis. The recently developed Bicine-dSDS-PAGE method was very well-suited for
studying differential protein expression in wild type and ethanol-adapted C.

thermocellum strains (34). Dramatic strides in membrane protein representation and
reduction of cytosolic protein contaminants were achieved through sucrose isopycnic
density gradient centrifugation techniques. This was corroborated by transmembrane
domain (TMD) and hydropathy (GRAVY) analyses of identified proteins.
It is evident from these investigations that the membrane proteomes of wild type
and ethanol-adapted species are dissimilar, with a majority of differentially expressed
proteins being under-represented in the ethanol-adapted bacterium (90). A close
investigation of differential protein expression can offer insights into the true nature of
ethanol tolerance. It is probable that the under-represented proteins are being produced in
lower quantities in the ethanol-adapted cells. Another possibility is that the organism
simply fails to incorporate the proteins into the cell membrane. The latter option would
perhaps result in a build-up of integral membrane and membrane-associated proteins in
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the cytosol, hinting at an inadequate environment in the lipid bi-layer for proper protein
assimilation and folding to occur. Investigations to determine which possibility is the
more likely answer are definitely worthwhile in the interest of better understanding
ethanol adaptation.

207

Chapter 2.4
Conclusions

Proteomics has emerged, in the wake of the genomics era, as a powerful
analytical tool for the large-scale study of proteins in cells, the minute specks of universe
termed living. While the genome is a rather constant, unchanging entity, the proteome
differs from cell to cell and is frequently altered through biochemical interactions with
the genome and the environment. An organism will have radically different protein
expression patterns in different parts of the body, during different stages of the life cycle
and in different types of environmental conditions. A host of environmental stressors,
such as disease, climactic changes, fluctuations in nutrient levels and the presence of
toxins can cause specific alterations in the cellular proteome that can be effectively
studied using proteomics approaches. A survey of the diversity of living organisms and
the ecological niches they occupy, ranging from hot sulfur springs to the polar ice caps, is
a clear indication of the adaptability and versatility of life. It has long been known that
fermenting organisms, such as yeast and certain thermophilic bacteria including

Clostridium thermocellum, can be adapted to an environment of accumulating
fermentation byproducts, such as ethanol. These organisms and their ability to generate
ethanol have recently generated interest in bio-fuels research and development. This area
of research has become increasingly important in the current geo-political climate, as the
trend towards developing cleaner and more efficient fuels becomes critical. A study of
differential protein expression can offer clues into how these organisms respond to an
ethanolic environment in an effort to adjust and adapt to existing living conditions.
Industrial-scale production of bio-ethanol has traditionally been the realm of
yeast. However, this fungus has the significant drawback of only being able to ferment
expensive simple sugars, such as maize starch, through multi-step mechanisms. The cost
of generating large quantities of ethanol through yeast is a definite limitation in
exploiting this organism for competing with, and ultimately replacing, fossil fuels as the
chief energy source for human consumption. This is in contrast to anaerobic, cellulolytic,
thermophilic bacteria, such as C. thermocellum, that can ferment cheap cellulose
byproducts from the agricultural and forestry sectors via a single step process. Despite the
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benefits, C. thermocellum is inhibited by low ethanol concentrations (< 2%) in its
immediate environment, unlike yeast, which can tolerate high levels of ethanol (> 10%)
in the media. Through sequential transfer procedures, C. thermocellum strains able to
tolerate as high as 8% ethanol have been developed and preliminary proteomics
investigations have clearly demonstrated that critical changes in the membrane proteome
are brought about by ethanol adaptation. A closer look at the bacterial membrane protein
expression could therefore provide insight into how ethanol tolerance is developed.
With increasing research and development dedicated to understanding global
protein expression and changes came the understanding that the cellular proteome is
composed of many sub-proteomes that often require different experimental conditions for
optimum analysis. One such sub-proteome that stands apart from other cellular protein
components is the class of proteins in the cell membrane. These proteins are difficult to
analyze using traditional gel-based approaches that are the cornerstone of proteomics
investigations. This is largely due to their high hydrophobicity and solubility issues in the
first dimension or isoelectric focusing step of 2D-PAGE. A solid understanding of
differential protein expression in the C. thermocellum membrane proteome demands the
design of suitable proteomic methodologies geared towards the analysis of membrane
proteins. The newly developed Bicine-dSDS-PAGE method, described in Chapter 2.2,
provided a more effective means of separating membrane proteins compared to other
dSDS-PAGE and traditional 2D-PAGE approaches. This methodology featured
molecular weight-based separations in both dimensions of SDS-PAGE and completely
circumvented problems associated with pI-based separations (34).
Orthogonality of separation in Bicine-dSDS-PAGE was achieved through
manipulation of the parameter space for gel and electrophoresis buffer preparation.
Hydrophobicity and the relatively high pI values commonly observed in C. thermocellum
membrane proteins did not pose as a significant drawback in Bicine-dSDS-PAGE
analyses, in contrast to traditional 2D-PAGE. A comparison of this technique with the
established Glycine (Laemmli)- and Tricine-dSDS-PAGE protocols revealed significant
improvements in membrane protein representation and abundance. These differences
were explained to be the effect of differential electrophoretic migration of the trailing
ions in the three dSDS-PAGE approaches: bicine for Bicine-dSDS-PAGE, tricine for
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Tricine-dSDS-PAGE and glycine for Laemmli-dSDS-PAGE. While faster-moving tricine
is well-suited for separation of small proteins and the slower glycine is appropriate for
cytosolic proteins, intermediate mobility of bicine was adequate for effective separation
and resolution of membrane proteins.
The Bicine-dSDS-PAGE method was successfully applied towards the study of
differential protein expression in wild type and ethanol-adapted C. thermocellum strains,
as described in Chapter 2.3. To our knowledge, this is the first study of differential
protein expression in wild type and ethanol-adapted C. thermocellum cells (90). Highly
purified membrane fractions, obtained through sucrose isopycnic density gradient
centrifugation procedures (SIDGC), were employed. Hydropathy (GRAVY) and
transmembrane domain (TMD) analyses revealed substantial representation of membrane
proteins and dramatically reduced cytosolic proteins, compared to crude membrane
preparations. It was evident from these investigations that while protein spot
representation was fairly similar between the two strains, there were dramatic differences
in the abundance of several proteins. A majority of the proteins that were differentially
expressed in these studies were observed to be up-regulated in the wild type strain,
particularly those intimately involved with carbohydrate transport and metabolism. Of the
few proteins that were present in higher abundance in the ethanol-challenged strain,
several were associated with chemotaxis and sensory transduction. It is possible that the
lower levels of different proteins in the ethanol-adapted organism is likely due to the
failure of chaperones and protein folding agents to properly incorporate membrane
proteins into the very fluid lipid bi-layer that is so characteristic of these cells.
These investigations have clearly highlighted the importance of careful sample
preparation and methods development in proteomics investigations. A solid
understanding of the chemistry and biochemistry of the target analytes, such as
membrane proteins, in the development of appropriate methodologies can substantially
improve the quality of data obtained. The study of the C. thermocellum membrane
proteome with specially designed gel-based technology provided a basic understanding of
ethanol-induced changes. A closer look at these proteins, investigations into their
metabolic pathways and whether or not they are under-produced or inefficiently
incorporated into the cell membrane will no doubt significantly add to existing
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knowledge about ethanol adaptation. These are the key initial steps towards the eventual
design of more ethanol-resistant C. thermocellum strains and their exploitation as bioenergy producers.
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Appendix

COG function classes of proteins and their abbreviations.

C

Energy production and conversion

D

Cell cycle control, cell division, chromosome partitioning

E

Amino acid transport and metabolism

F

Nucleotide transport and metabolism

G

Carbohydrate transport and metabolism

H

Coenzyme transport and metabolism

I

Lipid transport and metabolism

J

Translation, ribosomal structure and biogenesis

K

Transcription

L

Replication, recombination and repair

M

Cell wall/membrane/envelope biogenesis

N

Cell motility

O

Posttranslational modification, protein turnover, chaperones

P

Inorganic ion transport and metabolism

Q

Secondary metabolites biosynthesis, transport and catabolism

R

General function prediction only

S

Function unknown

T

Signal transduction mechanisms

U

Intracellular trafficking, secretion, and vesicular transport

V

Defense mechanisms
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CONCLUSIONS
In the year 1803, when John Dalton proposed that matter was composed of small,
indivisible particles called atoms, it was popularly believed that mankind was fast
approaching the frontiers of what can be known about the fabric of the cosmos. Smashing
the atom quickly dissipated such ideas as matter was probed at increasingly detailed
levels to reveal a whole new universe of understanding in quantum mechanics. A major
contributor to the power of mass spectrometry, particularly in the bioanalytical world, lies
in its ability to deliver sensitive and selective quantitative and qualitative data at
vanishingly lower detection levels, resulting in very accurate and detailed analysis. Full
exploitation of such characteristics of this analytical tool is realized through careful
methods development geared towards specific analytes. By repeatedly challenging the
frontiers of mass spectrometry through instrument development and experimental design,
it can be possible to broaden the scope of scientific analysis to even lower limits of
detection and quantification. The ability to measure minute quantities of analytes, such as
detection of subtle changes between diseased and control data sets, can vastly improve
knowledge of the biological system under investigation, both in the realms of small and
large molecule research. How low is low enough? The pioneers of string theory and M
theory would probably say “as low as technologically possible and then lower”.
Discovery of biomarkers, which have traditionally been small organic molecules,
in disease progression research would be of little use for the development of disease
diagnostics and cures if those biomarkers could not be accurately detected and quantified.
There are numerous diseases with poor diagnostic methods and treatments that claim
untold lives every year. Of all the cancers that afflict women, ovarian cancer is one of the
deadliest and by the time it is diagnosed, the odds of a cure have generally dropped to
little more than 1 in 10. While there are many terminal diseases, such as AIDS,
Alzheimer’s disease and several types of cancer, in many cases, early diagnosis renders
the diseases treatable, if not curable, in a manner that can improve the quality of life
during the lifetime of the afflicted individual. The ultimate goal of disease research
should be the development of complete cures. However, in the interest of those who will
succumb before such cures come to pass, an equally strong emphasis ought to be placed
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on early detection and symptom alleviation. Human lives and the quality of life itself
depend on the design of reliable, sensitive and accurate clinical diagnostics.
Retirement of the baby boom generation will place a significant fraction of the
elderly populace, unmatched in history, in the hands of the geriatric physician. The aging
population, particularly in the western world, will clearly demand greater medical and
social attention for diseases of the elderly, such as Alzheimer’s disease. The first part of
this dissertation described the development of MS-based sensitive, selective and accurate
methodologies for the quantification of biogenic aldehydes, potential biomarkers for this
debilitating illness. This was achieved through a solid understanding of the chemistry of
these analytes, along with careful experimental design in HPLC separation and mass
spectrometry. The reliability of biogenic aldehydes as AD biomarkers renders them wellsuited for exploitation as a clinical diagnostic, through analysis of human cerebrospinal
fluid (CSF) samples, for instance. It can be possible to improve the quantitative power of
this methodology through the use of radioactively labeled internal standards in isotope
dilution mass spectrometry. Greater similarity between the physicochemical properties of
internal standard and target analyte will produce a more effective and reliable analytical
methodology.
Application of the developed LC-MS method to measuring biogenic aldehydes in
different regions of the human brain for individuals who displayed varying levels of AD
pathology clearly demonstrated the power of MS-based methods development in disease
progression research. The data confirmed that AD pathology appeared early in the
disease, at the mild cognitive impairment (MCI) stage. To design reliable diagnostics and
effect a cure for AD, it is imperative that research focus on the MCI stage. A sizable
proportion of acrolein and HNE are known to be bound to proteins in the AD brain.
Tapping into these reservoirs of biogenic aldehydes using similarly designed LC/MS
methods can offer a clearer understanding of their prevalence in the brain. No doubt, one
can also envision developing LC/MS techniques for the analysis of other possible AD
biomarkers, such as isoprostanes. Metabolic and mutation studies coupled to LC/MS for
detection of these compounds can further provide information on the circumstances of
lipid peroxidation and AD occurrence. The possibilities of applying LC/MS-based
methods for biomarker studies in other diseases are also very promising, especially in
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view of the large parameter space of LC/MS experiments – ranging from LC column
makeup to ion fragmentation techniques in MS – which can be manipulated to tailor
experimental design towards the analyte of interest.
The knowledge base for Alzheimer’s disease has grown significantly in the past
decade and many believe that a viable clinical diagnostic lies within the foreseeable
future. Understanding the etiology of the disease will pave the way to the discovery of
effective biomarkers. The MCI stage is considered to be the earliest time when AD
pathology appears. It is very likely that with improvements in the detection of AD
pathology, a time even earlier than the MCI stage can be targeted in the development of
clinical tests. Early detection is the key. A deeper understanding of AD biomarker
generation, biochemistry, as well as careful evaluation of their relative abundance in the
body (as demonstrated in Part 1 of this dissertation) can only strengthen the power of
diagnostics based on these compounds. With the detection and quantification potential
available in mass spectrometry, it is not difficult to see why an MS-based clinical
diagnostic is a very practical and worthwhile avenue to pursue.
The power of mass spectrometry is such that it can be interfaced to a host of
separation techniques, in no way limited to chromatography, for the analysis of a variety
of compounds. While LC-based separations coupled to MS have had success in the area
of large molecule research such as proteomics studies, the Laemmli protocol of 2D-SDSPAGE remains the gold standard for protein separations. But proteins are a diverse group
of macromolecules which simply cannot be grouped together and effectively analyzed
through a single gel-based separation approach. Such an assumption produced
consistently low representation of cell membrane proteins in standard 2D gel maps.
Closer scrutiny of these proteins revealed that their hydrophobicity, generally basic pI
values and poor solubility in isoelectric focusing (first dimension of 2D-SDS-PAGE)
buffers rendered them unsuitable for analysis using traditional 2D-SDS-PAGE. Since the
membrane is the site of first contact of the cell with the exterior, membrane proteins play
a critical role in cellular processes, especially during changes in the organism’s
immediate environment. This was evident in ethanol tolerance studies of the
thermophilic, anaerobic, cellulolytic bacterium Clostridium thermocellum. This organism
has received attention in the area of bio-fuels research for its ability to ferment
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inexpensive cellulose-based biomass to ethanol. With changing climactic conditions from
burning of fossil fuels, national security issues, as well as predictions of an impending
energy crisis, the development of alternative sources of energy for human consumption
has become critical.
The second part of this dissertation focused on Clostridium thermocellum
membrane proteome research in an effort to obtain a clear understanding of membrane
protein expression patterns in wild type and ethanol-adapted strains. As with the AD
investigations in Part 1, careful methods development in gel-based separations of
membrane proteins proved to be highly beneficial in achieving desired goals. Bicinebased electrophoresis buffers in conjunction with dSDS-PAGE approaches that
circumvented solubility concerns encountered in the first dimension of 2D-SDS-PAGE
were well-suited for low abundance membrane protein analysis. Greater protein spot
representation was observed with Bicine-dSDS-PAGE, compared with conventional
dSDS-PAGE techniques. The rationale for the applicability of bicine as a trailing ion in
these investigations was explained through electrophoretic mobility studies using
capillary electrophoresis experiments (CE). One can envision the careful selection of
trailing ions through CE for specific analytes at hand to dramatically improve selectivity
and separation efficiency of electrophoresis methods. Tailoring analysis to the target
analyte, rather than employing generalized protocols for dissimilar classes of compounds,
will ensure reliable data. Chromatography has enjoyed decades of analytical research
culminating in a variety of mobile and stationary phases, as well as separation techniques.
There is no reason why similar success in broadening the versatility and applications of
gel electrophoretic methodologies should not be realized in the near future.
The Bicine-dSDS-PAGE method was successfully applied towards the analysis of
differential protein expression in the wild type and ethanol-adapted C. thermocellum
membrane proteomes. Definitive changes were observed, with a majority of differentially
expressed proteins being present at higher concentrations in the wild-type organism. It
was postulated that these proteins were either being under-produced by the ethanoladapted strain or the organism was unable to properly incorporate them into the
membrane proteome. The latter possibility would imply that membrane protein build-up
could be occurring at the site of manufacture (cytosol). While investigations presented

221

here offered a basic foundation for understanding ethanol tolerance at the membrane
level, a closer examination of the biochemistry of differentially expressed proteins will
surely provide a deeper appreciation of the underlying mechanisms for this phenomenon.
Many proteins in the C. thermocellum cell membrane have been studied but a sizable
fraction of the entire membrane proteome remains unexplored. One can envision using
multi-dimensional chromatographic separation methods (MudPIT) coupled with isotope
labeling to probe this class of proteins on a deeper level and obtain accurate relative
quantification data.
The ethanol adapted C. thermocellum strain is considerably less robust than its
wild type counterpart. Once a thorough understanding of differential protein expression
of the entire C. thermocellum membrane proteome is obtained, mutation studies and
metabolic experiments can shed light on which pathways are critical for ethanol
adaptation to develop and which mechanisms contribute to the poor growth and overall
health of the ethanol-adapted organism. Results from these investigations can definitely
enable the production of specially designed, genetically engineered ethanol-adapted
bacteria. These ‘super bugs’ would have certain genes with increased capabilities of upregulating ethanol production routes. Manipulation of other genes that effectively control
metabolic pathways, rendering the bacteria more robust than their ethanol-challenged
cousins, would also be beneficial. C. thermocellum strains with even as much ethanol
tolerance as yeast, the current industrial bio-ethanol producer, would be a remarkable
success. Unlike yeast which can only ferment expensive simple sugars, such bacterial
strains would be able to effectively produce ethanol from inexpensive cellulose-based byproducts out of the agricultural and forestry sectors. With high demands on cleaner, more
efficient fuel sources, along with increasing emphasis on recycling materials for human
consumption, a bacterium able to mass-produce bio-ethanol from cellulose waste would
be a highly promising outcome indeed.
The possibilities with methods development in MS investigations interfaced with
separation technology in the biological arena are truly limitless. No matter what the
analytes under investigation, be they small or large molecules, hydrophilic or
hydrophobic, acidic or basic, reliable quantification is only achieved through careful
consideration of analyte properties, as opposed to using generalized methodologies that
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have little regard for the specific needs of target compounds. The versatility of various
chromatographic and gel-based methods, coupled to the variety of ionization sources and
mass analyzers available, culminate in a marriage of incredible analytical potential. In
terms of biological systems that scientists desire to study and the permutations of
separation-based MS methods available with which to study them, we are truly at the tip
of a bioanalytical iceberg and the iceberg is growing every day.
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